Hyperadrenocorticism in ferrets by Schoemaker, N.J.
 
 
 
 
 
 
 
 
HYPERADRENOCORTICISM IN FERRETS 
 
 
 
 
HYPERADRENOCORTICISME BIJ FRETTEN 
(met een samenvatting in het Nederlands) 
 
 
 
 
 
 
 
 
 
 
 
 
PROEFSCHRIFT 
 
ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag 
 van de Rector Magnificus, Prof. dr. W.H. Gispen, ingevolge het besluit  
van het College voor Promoties in het openbaar te verdedigen 
op donderdag 27 november 2003 des middags te 16.15 uur 
 
 
 
 
 
 
 
door 
 
Nico Johannes Schoemaker 
 
Geboren op 20 maart 1967, te Amstelveen 
 
 
 
 
 
Promotor:  Prof. dr. A. Rijnberk 
 
Co-promotoren: Dr. J.T. Lumeij 
   Dr. ir. J.A. Mol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Department of Clinical Sciences of Companion Animals 
Faculty of Veterinary Medicine 
Utrecht University 
Utrecht, The Netherlands 
 
 
 
 
The studies described in this thesis were conducted at and financially supported by the 
Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, 
Utrecht university, Utrecht, The Netherlands 
 
 
 
Publication of this thesis was made possible by the generous support of: 
 
                      
 
  
 
    
 
         
 
 
 
Cover:  Joop Fama, Nico Schoemaker 
Illustrations: Joop Fama,  
Druk:  OPTIMA, Rotterdam 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CIP-DATA KONINKLIJKE BIBLIOTHEEK, DEN HAAG 
 
 
Schoemaker, Nico Johannes 
 
Hyperadrenocorticism in ferrets 
Nico Johannes Schoemaker, Utrecht 
Universiteit Utrecht, Faculteit Diergeneeskunde 
Thesis Universiteit Utrecht. – With ref. – With summary in Dutch. 
ISBN 90-393-3518-4 
 
 
 
 
 
 
Contents 
 
Chapter 1 Aims and scope of the thesis       7 
 
Chapter 2 General introduction       13 
 
Chapter 3 Effects of anesthesia and manual restraint on the plasma  27 
  concentrations of pituitary and adrenocortical hormones in 
  ferrets 
 
Chapter 4 Plasma concentrations of adrenocorticotrophic hormone and   39 
α-melanocyte-stimulating-hormone in ferrets (Mustela putorius 
furo) with hyperadrenocorticism 
 
Chapter 5 Urinary corticoid/creatinine ratios in healthy ferrets and ferrets  53 
with hyperadrenocorticism 
 
Chapter 6 Morphology of the pituitary gland in ferrets (Mustela putorius  67 
  furo) with hyperadrenocorticism 
 
Chapter 7 Correlation between age at neutering and age at onset of   83 
hyperadrenocorticism in ferrets  
 
Chapter 8 The role of luteinizing hormone in the pathogenesis of    93
 hyperadrenocorticism in neutered ferrets 
 
Chapter 9 Gonadotropin receptor expression in the adrenal gland of          109 
healthy ferrets and ferrets with hyperadrenocorticism 
 
Chapter 10 Current and future options for non-surgical neutering of ferrets 131 
  (Mustela putorius furo) 
 
Chapter 11 Summarizing discussion and conclusions   145 
 
Chapter 12 Samenvatting (Nederlands)     153 
 
Dankwoord         161 
 
Curriculum vitae        163 
 
List of publications and manuscripts      165 
 
Color section         167 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
 
 
Aim and scope of the thesis 
 
 
Aims and scope of the thesis 
 
 
 
 9 
The adrenal cortex produces mineralocorticoids, glucocorticoids, and sex steroids. 
Thus in principle, three distinct syndromes may arise as a result of adrenocortical 
hyperfunction. Indeed, syndromes of glucocorticoid excess are well-known in mammalian 
species such as dogs and cats. The occurrence of mineralocorticoid excess has also been 
described recently in dogs and cats. So far, distinct syndromes due to an excessive secretion 
of sex steroids have been described only in humans, 1, 5 although recent reports indicate that 
such syndromes also occur in dogs and cats. 2, 10, 11 There is increasing evidence that sex 
steroids play a primary role in hyperadrenocorticism in ferrets. 6, 8, 12 
The first case report on hyperadrenocorticism in ferrets was published in 1987. 3 In a 
series of 50 cases, hyperadrenocorticism appeared to be a common disorder, primarily 
affecting neutered ferrets. 9 Some of the signs (vulvar swelling in neutered jills and 
recurrence of sexual behavior in neutered hobs) pointed towards an excessive production of 
sex steroids rather than to an excessive production of glucocorticoids. 9 Consistent with this, 
elevated plasma concentrations of androstenedione, 17α-hydroxyprogesterone, 
dehydroepiandrosterone, and estradiol have been reported. 8 Only rarely do plasma cortisol 
concentrations exceed the upper limit of the reference range, 8 whereas the urinary excretion 
of cortisol is often increased. 4 The possible involvement of pituitary hormones in 
hyperadrenocorticism in ferrets has not been studied. 
In hyperadrenocorticism in ferrets, the adrenocortical lesion may be a unilateral 
adenoma or carcinoma. These tumors are not associated with atrophy of the contralateral 
adrenal cortex. 9 On the contrary, the contralateral adrenal cortex may be hyperplastic as 
well as tumorous. Indeed, the disease may also be due to bilateral adrenocortical 
hyperplasia. Macroscopic changes of the pituitary gland have not been reported. 7 Resection 
of a unilateral tumor usually leads to improvement, albeit without substantial lowering of 
the plasma cortisol concentration. 9 
The studies reported in this thesis, were aimed at the further characterization of 
adrenocortical hyperfunction in ferrets, in an attempt to elucidate the pathogenesis of the 
condition and to clarify some of the diagnostic problems. To this end, the literature was 
first reviewed (chapter 2). Then, to improve diagnostic accuracy, the influence of 
anesthesia and manual restraint on variables of the pituitary-adrenocortical axis was studied 
(chapter 3). Subsequently, reference ranges for plasma concentrations of 
adrenocorticotropic hormone (ACTH) and α-melanocyte-stimulating hormone (α-MSH) 
were established for normal ferrets and these concentrations were compared to those of 
ferrets with hyperadrenocorticism (Chapter 4). 
Urinary corticoid-creatinine ratios were measured in privately owned healthy ferrets 
and in ferrets with signs of hyperadrenocorticism to elucidate the contradiction between 
normal plasma cortisol concentrations and the increased urinary cortisol excretion. Possible 
seasonal variations in urinary corticoid excretion were studied in healthy ferrets and ferrets 
with hyperadrenocorticism for nineteen months (Chapter 5). 
The possible pathogenetic role of the pituitary gland in hyperadrenocorticism was 
investigated by comparing the histology of the pituitary gland in ferrets with 
hyperadrenocorticism and healthy ferrets (Chapter 6). The involvement of luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH) was investigated in a preliminary 
study by asking the owners of (castrated) ferrets whether they currently had ferrets with 
Chapter 1 
 
 
 10
signs of hyperadrenocorticism, or if they had such ferrets in the past, to find out whether 
there was any correlation between the age at neutering and the age at which 
hyperadrenocorticism developed (Chapter 7). 
The presence and functioning of LH and FSH receptors in adrenocortical tissue was 
examined by immunohistochemistry, RT-PCR, and in vitro and in vivo stimulation tests 
(Chapter 8 and 9). Possible alternatives to surgical neutering are discussed, with a view to 
eliminate the possible role that this type of neutering has on the development of 
hyperadrenocorticism (chapter 10). Lastly, findings are put in a broader context in a 
summarizing discussion (Chapter 11). 
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Hyperadrenocorticism in ferrets is thought to be primarily of adrenal origin. This 
introduction will provide an overview of current knowledge on adrenocortical morphology, 
(regulation of) adrenocortical steroidogenesis, and adrenocortical diseases. Only the 
literature on hyperadrenocorticism in ferrets published before our first publication (2000) 
will be discussed. 
 
1. Morphology of the adrenal cortex 
In ferrets the adrenal glands are paired structures, embedded in retroperitoneal fat 
craniomedially to the kidneys. The left adrenal gland, 6 – 8 mm long, usually lies close to 
the aorta, just cranial to the origin of the cranial mesenteric artery. The adreno-lumbar vein 
runs across its ventral surface. The right adrenal gland is larger, 8 – 11 mm long, and is 
located more cranially than the left gland and is always related to the latero-dorsal surface 
of the caudal vena cava.17 
The adrenal gland consists of two functionally distinct endocrine glands of different 
embryological origin. The medulla is of ectodermal origin and secretes epinephrine and 
norepinephrine, whereas the adrenal cortex is of mesodermal origin and contains three 
major zones. 
 
   
 
Figure 1. Histological sections of an adrenal gland of a healthy ferret: M = medulla, R = zona 
reticularis, F = zona fasciculata, I = zona intermedia, G = zona glomerulosa, C = capsule,  
V = adreno-lumbar vein. 
 
The outermost zone of the adrenal cortex is the zona glomerulosa, which produces 
mineralocorticoids (primarily aldosterone). Further inward is the zona intermedia. The cells 
in this zone are smaller than those in either of the adjacent zones,17 and are regarded as the 
progenitors of the cells of the adrenal cortex.30,50 In rats, the cells of the zona intermedia 
lack the enzymes aldosterone synthase and 11β-hydroxylase, and thus mineralocorticoids 
and glucocorticoids are not produced in this zone. Yet these cells can be stimulated by 
ACTH to replicate and migrate toward the zona fasciculata, the second major zone (Fig 1). 
Activation of the renin-angiotensin system, by providing a Na-deficient diet to rats, results 
in cell replication in the innermost portion of the zona glomerulosa.30 
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The zona fasciculata consists of an outer and inner part, and produces glucocorticoids 
(cortisol and corticosterone) and androgens. The cells in both parts are usually arranged in 
columns. The cells in the outer part are large, have a centrally located nucleus, and 
abundant, spongy appearing cytoplasm. The cells of the inner part are smaller and stain 
more deeply than those of the outer part.17  
The most interior zone is the zona reticularis, which is extremely variable in its 
prominence and its cellular composition. This zone contains the smallest cells of the 
adrenal cortex17 and produces primarily androgens.27 A notable feature of the ferret adrenal 
gland is that islands of cortical cells can be found among the cells of the medulla. These 
cells resemble those of the inner part of the zona fasciculata.17 
One or more detached nodules of accessory adrenal tissue, consisting only of cortical 
cells, are sometimes seen, whereas intracapsular nodules containing cortical cells are more 
common.17 
 
2. Adrenocortical steroidogenesis 
Cholesterol is the precursor of adrenocortical steroidogenesis, which involves the 
concerted action of several enzymes, including a series of cytochrome P450 enzymes (Fig 
2). After side-chain cleavage pregnenolone is formed, which in turn is converted to 
progesterone or 17α-hydroxypregnenolone. 17-Hydroxylation is a prerequisite for 
glucocorticoid synthesis. Cytochrome 17-hydroxylase also possesses 17,20-lyase activity, 
which results in the production of the C19 adrenal androgens, dehydroepiandrosterone 
(DHEA) and androstenedione. 21-Hydroxylation of either progesterone (zona glomerulosa) 
or 17α-hydroxyprogesterone (zona fasciculata) is accomplished by 21-hydroxylase, to yield 
deoxycorticosterone or 11-deoxycortisol, respectively. The zona glomerulosa does not 
express 17-hydroxylase. The final step in cortisol biosynthesis involves the conversion of 
11-deoxycortisol to cortisol. In the zona glomerulosa, 11β-hydroxylase may also convert 
deoxycorticosterone to corticosterone. Aldosterone synthase converts corticosterone to 
aldosterone.50 Of the glucocorticoids, corticosterone is the predominant glucocorticoid in 
rodents and birds, whereas cortisol is the most important glucocorticoid in ferrets.47 
 
3. Regulation of adrenal steroidogenesis 
3.1 Functional zonation 
The localized expression of aldosterone synthase means that mineralocorticoids are 
only synthesized in the zona glomerulosa, whereas glucocorticoids are not synthesized in 
the zona glomerulosa because it lacks 17α-hydroxylase.50 Cortisol is mainly secreted from 
the zona fasciculata, while androgens predominantly originate from the zona reticularis.18 
 
3.2 The hypothalamus-pituitary-adrenocortical axis 
Adrenocorticotropic hormone (ACTH) is the principal pituitary-derived hormone that 
stimulates adrenocortical glucocorticoid secretion. ACTH is synthesized as part of a much 
larger precursor, pro-opiomelanocortin (POMC), which is then cleaved in a tissue-specific 
fashion. Other products that may be formed are melanocyte-stimulating hormones (MSHs, 
α, β, γ), β-lipoprotein, β-endorphin, and joining peptide. The function of many of these 
products is unknown.50 Corticotrophin-releasing hormone (CRH), which is synthesized in 
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neurons of the hypothalamus, is the main stimulant of ACTH secretion, although arginine-
vasopressin (AVP) may potentiate CRH-mediated ACTH secretion.50 Both ACTH and α-
MSH are secreted in a pulsatile fashion, but in the dog more ACTH pulses than α-MSH 
pulses per 24h are seen.22 Glucocorticoids exert a direct negative feedback control on their 
own secretion, by inhibiting POMC gene transcription in the pituitary and CRH and AVP 
synthesis in the hypothalamus (Fig 3).50 
 
 
 
 
3.3 Adrenal androgen secretion 
ACTH is also considered to be important in controlling the secretion of adrenal 
androgens.39 However, differences in the secretion of adrenal androgens and 
glucocorticoids have led to the suggestion of the existence of an additional androgen-
stimulating hormone.50 For example, cytochrome b5 has a profound effect on the activity of 
17,20-lyase, the enzyme that converts 17α-hydroxypregnenolone into DHEA and 17α-
hydroxyprogesterone into androstenedione.19 
 
 
 
 
Figure 2.  
Major pathways of adrenocortical steroid 
synthesis. 
SCC = side chain cleavage 
3β = 3β-hydroxysteroid dehydrogenase 
11 = 11β-hydroxylase 
17 = 17α-hydroxylase 
21 = 21-hydroxylase 
(Adapted from Rijnberk 41) 
Chapter 2 
 
 
 18
3.4 Mineralocorticoid secretion 
Aldosterone is secreted from the zona glomerulosa under the control of three secretagogues, 
angiotensin II, potassium, and to a lesser extent ACTH. It is beyond the scope of this 
introduction to discuss these factors in detail 
 
 
    
 
 
4. Adrenocortical disease 
4.1 Adrenocortical insufficiency 
Primary adrenocortical insufficiency, or Addison’s disease, occurs either 
spontaneously after progressive destruction of the adrenal cortices by more than 90%,41 
after surgical removal of both adrenal glands, or after chemotherapeutic destruction with 
o,p’-DDD.10 To date, spontaneous hypoadrenocorticism has not been diagnosed in ferrets. 
Subtotal bilateral adrenal surgery, however, may lead to this disease.58 
The main features of this disease in dogs, i.e. lethargy and weakness, are 
predominantly due to a deficiency of mineralocorticoids. Lethargy may be related to 
hypotonic dehydration due to sodium loss, while hyperkalemia affects neuromuscular 
function, in particular leading to conduction disturbances in the heart.41 The diagnosis is 
based on the results of the ACTH stimulation test with failure of low baseline plasma 
cortisol concentration to increase after ACTH administration being regarded as 
diagnostic.41 Weiss et al. used a plasma sodium-to-potassium ratio to determine whether 
ferrets had a mineralocorticoid deficiency after subtotal bilateral adrenalectomy.58 A ratio 
lower than 25:1 was considered indicative of adrenocortical insufficiency. An ACTH 
stimulation test, however, was not performed. Intramuscular injection of the 
mineralocorticoid deoxycorticosterone pivalate (DOCP; 2.2 mg/kg) provides adequate 
substitution for the deficiency in aldosterone.58 
 
 
 
 
Figure 3.  
Regulation of adrenal glucocorticoid 
secretion. Hypothalamic CRH and AVP 
stimulate ACTH secretion by the pituitary 
gland, which in turn stimulates the adrenal 
cortex to produce cortisol. Cortisol exerts a 
direct negative feedback on the 
hypothalamus and pituitary gland. 
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4.2 Hyperadrenocorticism 
In line with the three main groups of hormones secreted by the adrenal cortex, i.e. 
glucocorticoids, mineralocorticoids, and androgens, three hyperfunction syndromes exist: 
(1) hypercortisolism (Cushing’s syndrome), (2) hyperandrogenism, and (3) 
hyperaldosteronism (Conn’s syndrome). Hyperandrogenism may lead to hyperestrogenism. 
This introduction concentrates on hypercortisolism and hyperandrogenism / 
hyperestrogenism. 
 
4.2.1 Hypercortisolism 
Hypercortisolism (Cushing’s syndrome) is by far the most common of the three 
syndromes in humans, dogs, and cats. The clinical features in humans, which were first 
described by Harvey Cushing in 1932,9 include weight gain, lethargy, weakness, menstrual 
irregularities, loss of libido, depression, hirsutism, acne, purplish skin striae, and 
hyperpigmentation.37 Common symptoms in dogs with Cushing’s syndrome are centripetal 
obesity, alopecia, lethargy, weakness, polyuria, and polydipsia.41 In cats 
hyperadrenocorticism is almost without exception associated with concurrent insulin-
resistant diabetes mellitus.34 Cushing’s syndrome may be ACTH-dependent or ACTH-
independent. The most common form of this disease in humans (60% – 80% of cases),5 
dogs (approximately 85% of cases),41 and cats (approximately 80% of cases),34 termed 
Cushing’s disease, is generally due to an ACTH producing pituitary microadenoma. In 
humans, ACTH-dependent Cushing’s syndrome may also be caused by ectopic ACTH 
secretion by a non-pituitary tumor.37 
Unilateral hyperfunctioning adrenocortical tumors account for approximately 90 – 
98% of ACTH-independent forms of Cushing’s syndrome in humans,23 while other causes 
include ectopic CRH secretion,6 or stimulation of the adrenal cortex by gastric inhibitory 
polypeptide (GIP), β-adrenergic agonists, human chorionic gonadotropin (hCG)/LH, 
vasopressin, serotonin (5-HT4), and possibly leptin.23 Autonomous glucocorticoid-secreting 
unilateral adrenocortical tumors may be the sole cause of hyperadrenocorticism, but in dogs 
these tumors have also been observed to occur simultaneously with pituitary 
adenomas.16,53,55 
The diagnosis of Cushing’s syndrome is established by biochemical analysis of blood 
and urine, concentrating on the excessive secretion of endogenous cortisol and the loss of 
the normal feedback control of the hypothalamus-pituitary-adrenocortical axis. Abdominal 
ultrasound, pituitary computed tomography (CT), and magnetic resonance imaging (MRI) 
are used to further characterize and localize the lesion. 
Measurement of plasma cortisol concentrations has little diagnostic value because the 
episodic secretion of ACTH results in variable plasma cortisol levels, which may at times 
be within the reference range.41 Therefore (24-h) urinary cortisol is measured in humans,37 
dogs,1 and cats.14 To correct for urine dilution due to polyuria, the urinary cortisol 
concentration is expressed relative to the creatinine concentration.8,14,51 
A high dose dexamethasone screening test can be used to differentiate between a tumor 
of pituitary and non-pituitary origin (ectopic ACTH-secreting tumor or adrenocortical 
tumor). After the oral administration of dexamethasone, plasma cortisol concentrations or 
the urinary corticoid-to-creatinine ratio is measured. Suppression of the plasma cortisol 
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concentration, or of the urinary corticoid-to-creatinine ratio, by more than 50% is an 
indication of pituitary-dependent Cushing’s disease.13,14,54 Another way to distinguish 
between ACTH-dependent and ACTH-independent Cushing’s syndrome is to measure 
plasma concentrations of ACTH. Concentrations persistently below the detection limit of 
the assay are found in ACTH-independent Cushing’s syndrome, which may be due to 
cortisol-producing adrenal tumors, autonomous bilateral adrenal hyperplasia, or Cushing’s 
syndrome due to the administration of exogenous glucocorticoids.37,41 
Pituitary surgery is the most widely accepted treatment for Cushing’s disease in 
humans.5 Transsphenoidal hypophysectomy is also an effective treatment of Cushing’s 
disease in dogs and cats.28,29 Another option is bilateral adrenalectomy. Both options 
require subsequent glucocorticoid and mineralocorticoid replacement therapy.5,41 Unilateral 
adrenalectomy is performed for adrenal adenomas or carcinomas. Glucocorticoid-
replacement therapy is necessary after surgery for a few months until the function of the 
hypothalamic-pituitary adrenal axis is restored.5,41 
Many drugs have been used in the treatment of pituitary-dependent 
hyperadrenocorticism. The most commonly used inhibitors of steroid biosynthesis in 
clinical use are trilostane, metyrapone, aminoglutethimide, and ketoconazole. Side effects 
occur with each of these drugs.5,35,40 In dogs, trilostane provides the most satisfactory 
results.35 In addition, there is the option of selective or non-selective destruction of the 
adrenal cortices with o,p’-DDD. 10,20,42 
 
4.2.2 Hyperandrogenism / hyperestrogenism 
In some very rare cases androgen-secreting adrenal tumors have been documented in 
women.3,25 Hyperadrenocorticism due to unilateral adrenal tumors producing estradiol, 
progesterone, and 17α-hydroxyprogesterone has been described in two dogs. In one of these 
dogs plasma concentrations of androstenedione were also elevated.52 Hyperadrenocorticism 
due to unilateral adrenal carcinomas producing progesterone has been described in two 
cats.4,48 In contrast, the overproduction of sex steroids seems to be the rule, rather than the 
exception in ferrets with hyperadrenocorticism.26,45,56 
 
5. Hyperadrenocorticism in ferrets 
Although hyperadrenocorticism is now generally considered to be a common disease 
in ferrets,43,57 the first case was only published in 1987.12 The clinical features include 
symmetrical alopecia (Fig 4), vulvar swelling in neutered female ferrets (jills), recurrence 
of sexual behavior after neutering in male ferrets (hobs), and pruritus.26,46,57 The alopecia 
usually begins in spring, which coincides with the start of the breeding season, and may 
disappear without treatment. The next year the alopecia usually returns but does not resolve 
spontaneously at the end of the breeding season.46 
Other concurrent signs include urinary blockage in males, due to prostatic enlargement 
and cysts,7,44 and occasionally mammary gland enlargement in jills.31 The pathogenesis of 
this disease is unknown in ferrets, but it has been suggested that early neutering could play 
a role,26,46 because in certain strains of mice nodular adrenocortical hyperplasia and 
adrenocortical tumors occur after neutering at an early age.11,33,49 
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Routine neutering of ferrets started in the early 1980s, following the publications of 
studies showing estrogen-induced bone marrow suppression in jills with prolonged 
estrus.2,21 There is no medical reason to castrate hobs, but castration reduces aggression, so 
that hobs can be kept in groups, and decreases the intensity of the musky odor produced by 
the sebaceous glands.32 The hormonal regulation of reproduction in intact ferrets, the 
consequences of neutering, and the hypothesis concerning its possible role in the 
development of hyperadrenocorticism are represented in figure 5. 
 
 
Figure 4. Symmetrical alopecia in a ferret with hyperadrenocorticism 
  
In approximately 85% of ferrets with hyperadrenocorticism, one adrenal gland is 
enlarged without atrophy of the contralateral adrenal gland, while in the other 15% of cases 
there is bilateral enlargement.46,57 After unilateral adrenalectomy in the case of unilateral 
enlargement, the disease may recur due to enlargement of the contralateral adrenal gland.57 
The histological changes of the adrenals range from (nodular) hyperplasia to adenoma and 
adenocarcinoma.46 No macroscopically visible changes have been found in the pituitary 
glands of ferrets with hyperadrenocorticism.43 
The diagnosis of hyperadrenocorticism in ferrets is usually based on plasma 
concentrations of androstenedione, 17α-hydroxyprogesterone, dehydroepiandrosterone 
sulfate, and estradiol;45 urinary corticoid/creatinine ratios; 15 and ultrasonography of the 
adrenals.43 Because plasma cortisol concentrations are rarely elevated in ferrets with 
hyperadrenocorticism,45 the merit of measuring the urinary corticoid/creatinine ratio has 
been questioned.43 Ultrasonography has been reported to be only accurate in 50 % of the 
cases,43 while others reported much more positive on the detection of adrenal glands in 
ferrets.36,38 One of the latter reports, however, stated that there was no statistical significant 
difference between the ultrasonographic or gross size of normal adrenal glands and those 
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with hyperplasia.36 The results of ACTH stimulation tests 46,56 and dexamethasone 
suppression tests are not considered diagnostic in ferrets.43 Pituitary hormones have not 
been measured in ferrets in relation to hyperadrenocorticism. 
 
 
Figure 5. Scheme showing aspects of the regulation of reproduction in intact ferrets, the 
consequences of neutering, and its possible role in the development of 
hyperadrenocorticism in this species. High melatonin concentrations for more than 12 
hours/day suppress the release of gonadotropin releasing hormone (GnRH). With 
increasing day length this suppression is lost and GnRH is released in a pulsatile fashion, 
resulting in the release of luteinizing hormone (LH) and follicle-stimulating hormone 
(FSH), which in turn stimulate the release of estrogen and testosterone from the gonads. 
These hormones exert a negative feedback on the hypothalamus and pituitary gland. 
When ferrets are neutered, this negative feedback is lost, resulting in an increased release 
of gonadotropins, which may promote steroidogenesis and induce non-neoplastic and 
neoplastic adrenocortical enlargement. 
 
The most common form of therapy is adrenalectomy,24,46,56,57 which may include 
partial resection of the contralateral adrenal gland.43,58 Glucocorticoid-replacement therapy 
is rarely necessary after surgery, because the contralateral adrenal gland is usually not 
atrophic.43,57 Both o,p’-DDD and ketoconazole have been used for the medical treatment of 
ferrets with hyperadrenocorticism, but neither is considered to be very effective.43 
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Summary 
 
Two experiments were carried out to investigate the effect of sampling techniques on 
the plasma concentrations of pituitary and adrenocortical hormones in ferrets (Mustela 
putorius furo). In the first experiment blood was collected on two occasions from 29 ferrets 
that were either manually restrained or anaesthetized with isoflurane. In the second 
experiment eight intact ferrets were fitted with jugular catheters and blood was collected on 
four occasions, just before and as soon as possible after they had been manually restrained 
or anaesthetized with medetomidine or isoflurane; blood was also collected 10 and 30 
minutes after the induction of anesthesia. Medetomidine anesthesia had no effect on the 
plasma concentrations of pituitary and adrenocortical hormones. Isoflurane anesthesia 
resulted in a significant increase in the plasma concentration of alpha-melanocyte-
stimulating hormone (α-MSH) directly after the induction of anesthesia. Manual restraint 
resulted in a significant increase in the plasma concentrations of cortisol and 
adrenocorticotropic hormone (ACTH) and a decrease in the plasma concentration of α-
MSH. 
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Introduction 
 
Hyperadrenocorticism is a common disease in pet ferrets. The disease differs from that 
in human beings and dogs in that there are increases in the basal plasma concentrations of 
the adrenal androgens 17α-hydroxyprogesterone, androstenedione, and to a smaller extent 
dehydroepiandrosterone, rather than in cortisol.13 In some cases, the plasma concentration 
of oestradiol is also increased.6,13,22 The signs of hyperadrenocorticism in ferrets, which 
initially occur only during the breeding season, are dominated by the effects of the 
excessive production of these steroids, for example, symmetrical alopecia, vulvar swelling 
in neutered jills and the recurrence of sexual behavior after neutering.6,13,14,20,23 
To elucidate the pathophysiology of hyperadrenocorticism in ferrets, it is important to 
measure the plasma concentrations of cortisol, adrenocorticotropic hormone (ACTH), 
alpha-melanocyte-stimulating hormone (α-MSH), androstenedione and 17α-
hydroxyprogesterone.13,19 However, the influence of sampling technique on the plasma 
concentrations of these hormones has not been studied. 
For the collection of blood from ferrets, four veins are commonly used: the jugular, 
cephalic, lateral saphenous and anterior caval veins.10 The lateral saphenous and cephalic 
veins can be used to collect only small amounts of blood, but the other two can be used to 
collect the larger samples needed for hormone measurements. However, the collection of 
these larger samples requires the ferrets to be kept under firm manual restraint or to be 
anaesthetized, and these procedures are known to affect the results. Manual restraint causes 
significant increases in the plasma levels of cortisol, ACTH and α-MSH in cats,24 and in 
ferrets hematological variables have been shown to decrease during isoflurane anaesthesia.7 
Different injectable anesthetics have also been found to either increase or decrease plasma 
androstenedione concentrations in cats.1 
The objective of this study was to determine the effects of manual restraint and 
anesthesia on the plasma concentrations of pituitary and adrenocortical hormones in ferrets 
as they might occur during routine blood collection in a clinical setting. 
 
 
Materials and Methods 
 
Two experiments were carried out, both of which were approved by the Ethics 
Committee of the Faculty of Veterinary Medicine, Utrecht University. 
 
Experiment 1 
Twenty-nine healthy ferrets, approximately three years old (14 intact and four 
neutered females, and six intact and five neutered males), were used. They had been 
purchased at six weeks of age, and were individually housed in outdoor suspended cages 
with a night box. No additional lighting was provided. Water and ferret pellets (FerRet; 
Hope Farms) were provided ad libitum. 
The ferrets were randomly divided, by using the statistical computer program S-PLUS 
2000 (MathSoft) into groups of 14 and 15. Blood samples were taken from all the ferrets on 
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two occasions, one week apart. For the first blood collection all the ferrets of group 1 were 
manually restrained, and the ferrets of group 2 were anaesthetized with 4 per cent isoflurane 
(IsoFlo; Schering-Plough Animal Health), inhaled through a mask in oxygen delivered at 
one liter per minute. As soon as the ferret could be placed in dorsal recumbency without 
restraint, the blood sample was collected, while anesthesia was maintained with 2 per cent 
isoflurane in oxygen delivered at 1 liter per minute. This protocol is similar to that 
commonly used for taking blood samples in a clinical setting.18 No stimuli were applied to 
assess the depth of anesthesia, because they might have evoked an endocrine response.21 
The ferrets did not react to the blood collection, and after it had been completed they were 
allowed to wake up, which they usually did within five minutes. One week later the same 
protocol was followed, but in this case the groups were switched. In both groups the blood 
samples for the measurement of ACTH, α-MSH and cortisol were collected from the 
cranial vena cava. 
 
Experiment 2 
Eight healthy, intact three-year-old ferrets (three male and five female) were used 
during the reproductive season, so that 17α-hydroxyprogesterone could be measured 
together with cortisol, ACTH and α-MSH. 
A jugular catheter was introduced, via vena section, under isoflurane anesthesia, into 
each of the ferrets. The catheters were tunneled subcutaneously to the base of the skull and 
connected to a 20-gauge cannula with an injection port (Vasofix Braunüle; Braun). The 
injection port was attached to the skin with polyglactin 910 (Vicryl; Ethicon) 2-0 USP 
sutures. The catheters (Silastic Medical Grade Tubing 602-155; Down Corning) had an 
internal diameter of 0.64 mm and an external diameter of 1.19 mm. To keep the catheter 
patent it was filled with a mixture of polyvinyl pyrrolidone (PVP) and heparin (60 g PVP / 
54 ml 0.9 percent sodium chloride + 6 ml heparin [5000 IU/ml]). 
Three days after the introduction of the catheters anesthesia was induced and 
maintained with isoflurane as in experiment 1. As soon as the animals could be placed in 
dorsal recumbency the isoflurane concentration was reduced to 2 per cent, and this 
concentration was maintained during the 30 minutes of anesthesia. Two days later 
anesthesia was induced by the administration of 100 µg/kg medetomidine (Domitor; Pfizer 
Animal Health) into the lateral muscles of the thigh.18 This dose allowed the ferrets to be 
kept in dorsal recumbency for 30 minutes. Again, no stimuli were applied to assess the 
depth of anesthesia. On both occasions blood samples were collected through the jugular 
catheter before the ferrets were anaesthetized, immediately after induction, and 10 and 30 
minutes later. 
Three days later a blood sample was collected via the jugular catheter, followed as 
soon as possible, by another blood sample taken by venepuncture of the anterior vena cava 
while the ferret was restrained manually. The interval between the collection of the two 
samples differed, depending on how much the ferrets resisted the procedure. 
In five of the ferrets the catheter became occluded between test days. In one of them a 
new catheter was introduced and all the blood samples were obtained; in three of them 
blood samples were obtained on two occasions; and in the other ferret only on one occasion 
blood samples could be collected. 
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Sample handling and hormone determination 
After collection, the blood samples were placed immediately in chilled EDTA-coated 
tubes and centrifuged at 4ºC. Plasma samples were stored at – 20ºC until they were 
analyzed within three months. 
Plasma ACTH concentrations were measured with a commercially available 
immunoradiometric assay (Nichols Institute Diagnostics). The interassay coefficient of 
variation was 7.8 per cent and the sensitivity was 1 ng/l. There was no cross reaction with 
α-MSH. 
Plasma concentrations of α-MSH were measured by radioimmunoassay (RIA), using 
antiserum to synthetic human α-MSH as described previously.12 This antiserum had full 
cross reactivity with desacetyl-α-MSH but less than 0.1 per cent cross reactivity with 
ACTH (1-39) and 4 per cent cross reactivity with ACTH (1-24). Synthetic human α-MSH 
was used as a standard. The limit of detection was 5 ng/l and the intra- and interassay 
coefficients of variation were 10 per cent and 23 per cent, respectively. 
Both assays were validated for use in ferrets. Dilution curves of a ferret plasma 
sample were compared with standard curves for ACTH (Nichols Institute Diagnostics) and 
α-MSH (Bachem AG). In both cases the curves followed the standard curve.18 
Plasma 17α-hydroxyprogesterone concentrations were measured after toluene extraction by 
using a competitive RIA and a polyclonal anti-17α-hydroxyprogesterone-antibody (UCB 
i903, UCB Bioproducts). 17α-Hydroxy[1,2,6,7-3H]-progesterone (TRK 611, Amersham 
Pharmacia Biotech Benelux) was used as a tracer after chromatographic purification. The 
lower limit of detection was 0.2 nmol/l and interassay coefficients of variation were 9.0 per 
cent, 7.4 per cent and 9.9 percent at 0.89, 5.13 and 26.0 nmol/l, respectively. 
 
Statistics 
In experiment 1 the data were transformed logarithmically to obtain a normal 
distribution. The paired Student’s t test was used for the statistical analysis. In experiment 2 
the Friedman test (a non-parametric analysis of variance) was used, followed by a multiple 
comparison test (Dunnett: comparison with a control).25 Statistical significance was 
assumed at P < 0.05. 
 
 
Results 
 
Experiment 1 
The mean plasma ACTH concentration of the manually restrained ferrets and the ferrets 
anaesthetized with isoflurane did not differ significantly. However, the mean plasma α-
MSH concentration of the manually restrained ferrets was significantly lower, and their 
mean cortisol concentration was higher than those of the anaesthetized ferrets (Table 1). 
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Table 1. Mean (SEM) concentrations and (ranges) of plasma cortisol, adrenocorticotropic hormone 
(ACTH), and α-melanocyte-stimulating hormone (α-MSH) in 29 ferrets immediately after 
induction of anesthesia with isoflurane and during manual restraint. Asterisk indicates 
significant difference (P < 0.001). 
Variable Manual restraint Isoflurane anesthesia 
 Mean (SEM) Range Mean (SEM) Range 
ACTH (ng/l) 84 (9) 18 – 183  68 (6) 21 – 152 
Αlpha-MSH (pg/ml) 16 (2) * 4 – 44 50 (11) 4 – 283 
Cortisol (nmol/l) 43 (8) * 3 – 201 13 (1) 3 – 27 
 
Experiment 2 
The mean (SEM) plasma ACTH concentration of the ferrets was increased 
significantly by manual restraint from 35 (4) to 113 (15) ng/l and their mean plasma 
concentration of cortisol increased from 8 (3) to 47 (25) ng/l. In contrast, their mean plasma 
α-MSH concentrations decreased significantly from 27 (4) to 11 (2) ng/l. The plasma 
concentration of 17α-hydroxyprogesterone was not affected by manual restraint (Fig 1). 
Under isoflurane anesthesia the mean plasma α-MSH concentration of the ferrets 
increased significantly directly after induction, from 33 (4) to 103 (33) ng/l, but the plasma 
concentrations of ACTH, cortisol and 17α-hydroxyprogesterone remained unchanged. The 
plasma concentration of α-MSH was still significantly increased after 10 and 30 minutes of 
anesthesia (Fig 1). 
Medetomidine anesthesia caused no significant changes in the concentrations of any of 
the hormones (Fig 1). 
 
 
Discussion 
 
Stress is known to increase the rate of release of ACTH from the pituitary gland,8 and 
this in turn stimulates the secretion of adrenocortical hormones.9,11 ACTH enhances the rate 
of conversion of cholesterol to pregnenolone, and within minutes after its release the 
concentrations of adrenocortical steroids in adrenal venous blood start to rise.11 As would 
have been expected as a result of these physiological changes restraining the ferrets 
normally resulted in significant increases in their plasma concentrations of ACTH and 
cortisol; similar changes have been observed in rats and cats.4,5,24 
The secretion of α-MSH from the pars intermedia adenohypophysis has been studied 
extensively in rats. In this species, the secretion of α-MSH is inhibited by dopamine and 
aminobutyric acid, whereas serotonin, β-adrenergic agents and corticotrophin releasing 
hormone (CRH) may stimulate it.15 Tonic dopaminergic inhibition has also been recorded 
in dogs, cats, sheep and horses, but is absent in rabbits.8 In dogs the administration of CRH 
and various forms of neurogenic stress do not stimulate the secretion of α-MSH.3 In 
contrast, in cats a mild stress such as handling results in increased plasma α-MSH 
concentrations,24 as it does in rats. In the ferrets the plasma concentrations of α-MSH 
decreased after they were restrained manually, a change which, to the authors’ knowledge 
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has not been described in any other species. In rabbits glucocorticoids have an inhibitory 
effect on the release of α-MSH;17 if this were also true for the ferret, it would explain why 
the plasma α-MSH concentrations decreased, because the manual restraint was associated 
with a clear-cut increase in plasma cortisol concentrations. 
 
 
 
Figure 1. Mean (SEM) plasma concentrations of (a) adrenocorticotropic hormone (ACTH), (b) α-
melanocyte-stimulating hormone (α-MSH), (c) cortisol and (d) 17α-
hydroxyprogesterone (17-OH prog) in ferrets immediately before they were restrained 
manually or anaesthetized (P), during manual restraint (▲) [n = 6], and during 
anesthesia with isoflurane (■) [n = 7] or medetomidine (●) [n = 6]. Arrows indicate start 
of restraint or induction of anesthesia. An asterisk indicates significantly different from 
before restraint or anesthesia (P < 0.05) 
 
Another unexpected finding with respect to α-MSH was the increase in plasma 
concentration during isoflurane anesthesia, but not during medetomidine anesthesia. Since 
manual restraint decreased rather than increased the concentration of α-MSH, it is not likely 
that the stress of mask induction was responsible for this increase, as suggested 
previously.19 it is more likely that the increase was caused by an effect of isoflurane itself. 
One possible explanation might be that isoflurane has an antidopaminergic effect, because 
it has been shown that isoflurane can reduce the release of dopamine induced by either N-
methyl-D-aspartate or nicotine.2,16 
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In both experiments no stimuli, other than dorsal recumbency and blood collection, 
were applied to assess the depth of anesthesia because such stimuli might have induced an 
endocrine response.21 None of the anaesthetized ferrets reacted either to being placed in 
dorsal recumbency or having a blood sample taken. The differences between the hormone 
concentrations observed in the ferrets anaesthetized with isoflurane or medetomidine could 
theoretically have been due to the differences in the depth of anesthesia. However, from the 
uniform absence of any response to their placement or to the introduction of a needle, it is 
likely that the depth of anesthesia was very similar in both cases. It was the purpose of this 
study to determine whether two standardized anesthetic procedures, which are routinely 
used in practice, would affect the results of hormone measurements. In the absence of any 
evidence of a difference in the depth of anesthesia, the results suggest that different 
protocols used for blood collection may lead to different results. 
In veterinary practice blood samples are usually collected immediately after the 
induction of anesthesia. A false increase in the plasma concentrations of ACTH, cortisol, 
and 17α-hydroxyprogesterone would therefore not be expected. Nevertheless, 
medetomidine anesthesia should be preferred to isoflurane anesthesia because the 
isoflurane anesthesia caused a significant increase in plasma α-MSH concentrations, which 
may affect the release of adrenocortical hormones. Medetomidine anesthesia did not affect 
the plasma concentrations of the pituitary and adrenocortical hormones. 
Given that the levels of pituitary and adrenocortical hormones were not affected by 
medetomidine anesthesia, the question arises whether the reference ranges for the plasma 
concentrations of ACTH and α-MSH (13 to 98 ng/l and 16 to 74 ng/l respectively), which 
have been determined in blood samples collected during isoflurane anesthesia 19 are still 
valid. The mean (range) of plasma concentrations of ACTH and α-MSH measured in the 
present study were not significantly different from the values recorded in the previous study 
(68 [21 – 152] ng/l v 53 [4 – 145] ng/l for ACTH and 50 [4 – 283] ng/l v 56 [<5 – 238] ng/l 
for α-MSH) and it is therefore considered that these reference ranges can still be used, 
provided that the blood samples are collected under the same conditions. 
Anesthesia is to be preferred to manual restraint when blood samples have to be 
collected from ferrets for the measurement of hormones of the pituitary-adrenocortical axis. 
Medetomidine anesthesia is to be preferred to isoflurane anesthesia because the latter 
causes a sharp rise in the concentrations of α-MSH. 
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Summary 
 
Objective – To determine plasma concentrations of adrenocorticotrophic hormone (ACTH) 
and α-melanocyte-stimulating-hormone (α-MSH) in healthy ferrets and ferrets 
with hyperadrenocorticism. 
Animals –16 healthy, neutered privately owned ferrets, 28 healthy laboratory ferrets (21 
sexually intact and 7 neutered), and 28 ferrets with  hyperadrenocorticism. 
Procedures – Healthy ferrets were used for determination of reference plasma 
concentrations of ACTH and α-MSH.  Diagnosis of hyperadrenocorticism was 
made on the basis of history, clinical signs, urinary corticoid-to-creatinine ratios, 
ultrasonography of the adrenal glands, and macroscopic or microscopic evaluation 
of the adrenal glands. Blood samples were collected during isoflurane anesthesia. 
Plasma concentrations of ACTH and α-MSH were measured by 
radioimmunoassay. 
Results – Plasma concentrations of ACTH in 23 healthy neutered ferrets during the 
breeding season ranged from 4 – 145 ng/l (median 50 ng/l). Plasma concentrations 
of α-MSH in 44 healthy neutered or sexually intact ferrets during the breeding 
season ranged from <5 – 617 ng/l (median 37 ng/l). Reference values (the central 
95% of the values) for ACTH and α-MSH were 13 – 100 ng/l and 8 – 180 ng/l 
respectively. Plasma concentrations of ACTH and α-MSH in ferrets with 
hyperadrenocorticism ranged from 1 – 265 ng/l (median 45 ng/l) and 10 – 148 ng/l 
(median 46 ng/l) respectively. These values were not significantly different from 
those of healthy ferrets. Plasma ACTH concentrations of sexually intact female 
ferrets in estrus were significantly higher than those of neutered females. 
Conclusions and Clinical Relevance –Ferrets with hyperadrenocorticism did not have 
detectable abnormalities in plasma concentrations of ACTH or α-MSH. The 
findings suggest that hyperadrenocorticism in ferrets is an ACTH and α-MSH 
independent condition.
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Introduction 
 
In humans, dogs, cats and horses the clinical signs of hyperadrenocorticism are 
primarily the result of excessive secretion of cortisol.3,9,11,16 Hypercortisolism leads to 
muscle wasting, skin atrophy with alopecia, and centripetal obesity. In pet ferrets (Mustela 
putorius furo) the situation is different. The physical changes of hyperadrenocorticism are 
usually dominated by features of excessive production of sex steroid hormones, i.e., 
alopecia, vulvar swelling in neutered jills and recurrence of sexual behavior after 
neutering.8,19,20,21,23,29 In agreement with these physical changes, plasma concentrations of 
androstenedione, 17α-hydroxyprogesterone, and dehydroepiandrosterone sulfate are usually 
increased whereas those of cortisol are not.20 Besides these adrenal androgens, plasma 
concentrations of estradiol have also been reported to be increased in ferrets with 
hyperadrenocorticism.8,20,28 
In ferrets, hyperadrenocorticism has been reported to be associated with 
adrenocortical hyperplasia and adrenocortical tumors.21 In approximately 85% of ferrets 
with hyperadrenocorticism only 1 adrenal gland is enlarged, without atrophy of the 
contralateral adrenal gland.21,29 After unilateral adrenalectomy there may be recurrence of 
the disease due to enlargement of the contralateral adrenal gland.29 The presence of 
bilaterally affected adrenal glands in 15% of affected ferrets, and recurrence of the disease 
after unilateral adrenalectomy suggest that extra-adrenal tropic factors play a role in the 
pathogenesis of this disease. 
In humans, dogs and cats the most common form of hyperadrenocorticism is pituitary-
dependent, in which excessive adrenocorticotropic hormone (ACTH) is secreted by 
adenomas that may originate from corticotropic cells of the anterior lobe of the pituitary 
gland. In addition there is the possibility that neoplastic transformation of melanotropic 
cells of the pars intermedia, primarily producing the ACTH derivative α-melanocyte-
stimulating hormone (α-MSH), causes hyperstimulation of the adrenal cortices.10,16,22 This 
results primarily in hypersecretion of cortisol. The secretion of other adrenal steroids such 
as androstenedione, 17α-hydroxyprogesterone and dehydroepiandrosterone sulfate, 
however, may also be increased.13 
In ferrets it is suggested that hyperadrenocorticism may be LH-dependent. First, there 
is the observation that hyperadrenocorticism is almost exclusively seen in castrated ferrets, 
with a significant correlation between the age at neutering and the age at diagnosis of 
hyperadrenocorticism.23 Second, it has been reported that ferrets with hyperadrenocorticism 
can be treated successfully with depot GnRH-agonist leuprolide acetate.27  
LH-dependent hyperadrenocorticism and LH-dependent adrenal androgen-secreting 
tumors have been described in humans.6 In LH-dependent hyperadrenocorticism 
hypercortisolism is associated with suppressed concentrations of ACTH. In LH-dependent 
adrenal androgen-secreting tumors both cortisol and ACTH concentrations have been 
reported to be within the reference range.7 
Thus there are several questions with regard to the factors involved in the 
development of hyperadrenocorticism in ferrets, such as the role of secretion of ACTH and 
α-MSH. In ACTH-dependent hyperadrenocorticism one would expect increased plasma 
concentrations of ACTH and possibly α-MSH. With hypercortisolism, the LH-dependent 
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form of hyperadrenocorticism would lead to suppressed plasma ACTH concentrations. To 
the authors’ knowledge, there are no reports on plasma concentrations of ACTH or α-MSH 
in ferrets with hyperadrenocorticism. 
The purpose of the study reported here was to determine plasma concentrations of 
ACTH and α-MSH in 28 ferrets with hyperadrenocorticism. The values are compared with 
those of 23 castrated and 21 sexually intact healthy ferrets. 
 
 
Materials and Methods 
 
Control ferrets 
A group of 23 neutered control ferrets (13 female and 10 male) comprised 16 privately 
owned ferrets that were house mates of the ferrets with hyperadrenocorticism and 7 ferrets 
kept under laboratory conditions, individually housed in outdoor suspended cages with a 
night box. No additional lighting was provided. Water and ferret pellets (FerRet, Hope 
Farms, Woerden, The Netherlands) were provided ad libitum. The ages of the 23 ferrets 
ranged from 1.5 to 8 years (median, 3 years). Blood samples were collected between March 
15 and September 29, 2000. None of the ferrets had any clinical signs of 
hyperadrenocorticism. All ferrets had urinary corticoid-to-creatinine ratio < 1.7 x 10-6. 
Urinary corticoid concentrations were measured by RIA for cortisol as described 
previously.18 The urinary corticoid concentration was related to the urinary creatinine 
concentration (Jaffé kinetic method, initial rate reaction) by calculation of its quotient  
(x 10-6).25 
In addition, blood was collected on April 4, 2000 from 21 sexually intact ferrets, aged  
2 – 3 years (14 female and 7 male), kept under the same laboratory conditions as described. 
 
Ferrets with hyperadrenocorticism 
The 10 female and 18 male ferrets with hyperadrenocorticism were evaluated between 
April 1998 and September 2000. All ferrets had been neutered at 0.5 to 1 year of age. At the 
time of evaluation their ages ranged from 3 to 7 years (median, 5 years). In 22 ferrets 
alopecia was the main clinical sign. Of the 6 other ferrets, 5 were evaluated for swelling of 
the vulva, and in 1 ferret, a large adrenal mass was incidentally detected on the left side 
when abdominal ultrasonography was performed for other reasons. After 2 months this 
ferret died with metastases of an adrenocortical tumor. 
The diagnosis of hyperadrenocorticism was made on the basis of history, physical 
signs, urinary corticoid-to-creatinine ratios 16,25 (range, 0.7 – 150 x 10-6; in 26 of 28 ferrets 
these exceeded the upper limit of the reference range 4 [1.7 x 10-6]), and ultrasonographic 
examination of the adrenal glands. Macroscopic appearance of the adrenal glands during 
surgery (n=23), histologic findings in the adrenal glands after surgery (n=19), or results of 
postmortem examination (n=9) provided additional support for the diagnosis. 
In 21 ferrets there was unilateral enlargement of the adrenal gland, on the left side in 
15 ferrets and on the right side in 6 ferrets. In all these ferrets the contralateral adrenal 
gland was of normal size (i.e. no atrophy). Seven ferrets had bilaterally enlarged adrenal 
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glands. In 24 of 26 ferrets ultrasonography had identified the alterations in the adrenal 
glands correctly. 
Histologic examination of the adrenal glands of 26 ferrets (10 female and 16 male) 
revealed hyperplasia (n=9), adenoma (n=15), and metastasized adenocarcinoma (n=2). In 1 
ferret the adrenal tissue was lost for histologic examination and in 1 ferret the adrenal tumor 
was left in place because of its growth into the caudal vena cava. 
 
Blood collection 
In affected ferrets and the control ferrets blood was collected between 2:30 and 4:00 
p.m. from the anterior vena cava, by use of isoflurane anesthesia. Blood was immediately 
placed in chilled EDTA-coated tubes, and centrifuged at 4ºC. Plasma was stored at – 20ºC 
pending analysis. Samples were analyzed within 6 months after collection. 
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Figure 1. Dilution curves (concentration vs counts per minute [cpm]) of 2 ferret plasma samples 
(□,▲) and a human adrenocorticotropic hormone (ACTH) standard (♦) analyzed by use 
of  a radioimmunoassay. 
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Hormone determination 
Plasma ACTH concentrations were measured by use of a commercially available 
radioimmunoassay (RIA) as per manufacturer’s instructions (Nichols Institute, Wijchen, 
The Netherlands). The interassay coefficient of variation was 7.8% and the sensitivity was 
1 ng/l. No cross-reaction with α-MSH could be measured. 
Plasma concentrations of α-MSH were measured by use of RIA with antiserum to 
synthetic human α-MSH, as described.17 This antiserum had full cross-reactivity with 
desacetyl-α-MSH but < 0.1% cross-reactivity with ACTH1-39 and 4% cross-reactivity with 
ACTH1-24. Synthetic human α-MSH was used as a standard. The limit of detection was 5 
ng/l and the intra- and interassay coefficients of variation were 10% and 23%, respectively. 
Both assays were validated for use in ferrets. Dilution curves were made from a ferret 
plasma sample and compared with a standard for ACTH (Nichols Institute, Wijchen, The 
Netherlands), and for α-MSH (Bachem AG, Bubendorf, Switzerland). For both hormones, 
the curves followed the standard pattern (Fig 1 and 2). 
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Figure 2. Dilution curves (concentration vs cpm) of a ferret plasma samples (▲) and a human 
melanocyte-stimulating hormone standard (♦) analyzed by use of  a radioimmunoassay. 
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Statistical analyses 
The percentile method was used to establish the reference ranges for plasma ACTH 
and α-MSH concentrations.2 The percentiles P2.5 and P97.5 were determined with a 
probability of 95%. The Wilcoxon Rank Sum test was used for comparison of plasma 
ACTH and α-MSH concentrations of neutered and sexually intact ferrets. 
Results were graphically represented in box-and-whisker plots. In these figures, the 
box represents the interquartile range from the 25th to 75th percentile, the horizontal bar 
through the box indicates the median, and the whiskers represent the main body of data, 
which in most instances is equal to the range.1 For all comparisons, a value of P < 0.05 was 
considered significant. 
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Figure 3. Boxplot of plasma ACTH concentrations in healthy sexually intact female ferrets 
(n=14) and healthy neutered female ferrets (n=13). Outlying data points are represented 
by dots. 
 
 
Results 
 
Healthy ferrets 
Plasma ACTH concentrations in 23 neutered healthy ferrets ranged from 4 to 145 ng/l 
(median 50 ng/l; reference range, 13 – 100 ng/l). In the 21 sexually intact ferrets kept under 
laboratory conditions, plasma ACTH concentrations ranged from 38 to 144 ng/l (median 88 
Sexually intact Neutered female ferrets 
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ng/l; reference range, 53 – 109 ng/l). The plasma ACTH concentrations in the sexually 
intact ferrets were significantly (P<0.01) higher than in the neutered ferrets. 
Plasma ACTH concentrations in sexually intact female ferrets (n=14; range 62 – 144 
ng/l; median 94.5 ng/l) were also significantly (P<0.01) higher than in neutered female 
ferrets (n=13; range 8 – 145 ng/l; median 44 ng/l) (Fig 3). The difference in plasma ACTH 
concentrations between sexually intact male ferrets (n=7; range 38 – 133 ng/l; median 68 
ng/l) and neutered male ferrets (n=10; range 4 – 100 ng/l; median 66 ng/l) was not 
significant. 
Plasma α-MSH concentrations of sexually intact (n=21) and neutered (n=23) ferrets 
did not differ significantly, nor was there a significant difference in the sexually intact 
ferrets between males and female; therefore, the data were combined to establish reference 
values. Plasma α-MSH concentrations in the 44 ferrets ranged from <5 – 617 ng/l (median 
37 ng/l; reference range, 7 – 180 ng/l). 
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Figure 4. Boxplot of plasma ACTH concentrations in ferrets with hyperadrenocorticism (n=28) 
and healthy neutered ferrets (23). Outlying data points are represented by dots. 
 
Ferrets with hyperadrenocorticism 
Plasma ACTH concentrations in the 28 neutered ferrets with hyperadrenocorticism 
(range 1 to 265 ng/l; median 45 ng/l) were not significantly different from those in healthy 
neutered ferrets (Fig 4). In 6 hyperadrenocorticoid ferrets the plasma ACTH concentration 
exceeded the upper limit (100 ng/l) of the reference range of healthy ferrets. 
Healthy ferrets Clinical cases
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The plasma α-MSH concentrations in ferrets with hyperadrenocorticism (n = 27, range 
10 to 148 ng/l; median 46 ng/l) were not significantly different from those in healthy ferrets 
(Fig 5). The plasma α-MSH concentration did not exceed the upper limit (180 ng/l) of the 
reference range of healthy ferrets in any of the hyperadrenocorticoid ferrets. 
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Figure 5. Boxplot of plasma α-MSH concentrations in ferrets with hyperadrenocorticism (n=27) 
and healthy ferrets (n=44). Outlying data points are represented by dots. 
 
 
Discussion 
 
In this study, plasma ACTH concentrations of healthy neutered ferrets ranged from 4 
to 145 ng/l, which is similar to the ranges reported for dogs, cats and horses.5,12,14,16 Plasma 
ACTH concentrations in sexually intact female ferrets were significantly higher than in 
neutered ferrets. This may be attributable to the fact that the blood samples were collected 
during the breeding season. In female frogs, secretory activity of ACTH cells increases 
during the breeding season.15 The question remains whether this is due to the arousal 
associated with the breeding season or to a direct effect of the activated pituitary-ovarian 
axis on the corticotropic cells. The latter is the most likely explanation, because the plasma 
ACTH concentrations of sexually intact male ferrets were not significantly different from 
those of neutered male ferrets. 
Healthy ferrets Clinical cases
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In our study basal plasma α-MSH concentrations in ferrets were similar to those in 
cats, which are somewhat higher than in dogs.5,14 The values in ferrets may have been 
artificially increased by placement of a mask and induction of isoflurane anesthesia, 
because isoflurane has an unpleasant odor. It is known that, particularly in cats, handling 
may lead to increases in plasma concentrations of α-MSH,30 and this may be true for ACTH 
concentrations as well. In addition, ACTH and α-MSH are released in a pulsatile manner in 
dogs.5 Consequently, an occasional high value might be found with single measurements, 
although – particularly with α-MSH – the pulse frequency is low.5 To our knowledge, there 
are no reports on the release patterns of ACTH and α-MSH in ferrets, but pulsatile release 
is likely because it has been found in all species studied. These considerations should be 
taken into account when individual values are interpreted. In our study, group values were 
evaluated instead of individual samples. We believe that the effects of possible pulsatile 
hormone release were outweighed by the numbers of animals per group. 
Because we found that plasma concentrations of ACTH and α-MSH of ferrets with 
hyperadrenocorticism are essentially identical to those of healthy neutered ferrets, we 
believe that the adrenocortical changes and clinical signs cannot be ascribed to 
hypersecretion of ACTH. In addition, it is likely that there was no primary hypercortisolism 
either, because this finding should be associated with either decreased or increased plasma 
ACTH concentrations. Consequently, the increased corticoid-to-creatinine ratios might not 
be a reflection of hypercortisolism but rather the result of other urinary steroid hormones or 
steroid hormone metabolites cross-reacting in the cortisol assay. The antibody used in the 
assay for measurement of urinary cortisol is known to cross-react with other endogenous 
corticosteroids such as 21-deoxycortisol (62%), corticosterone (11%), cortisone (2%), 11-
deoxycortisol (1.3%), deoxycorticosterone (1.3%) and 17α-hydroxyprogesterone (0.1%).26 
Thus, hyperadrenocorticism in ferrets should probably be regarded as a 
normocortisolemic and corticotrophin-independent hypersecretion of androgens, primarily. 
Many different ectopic and abnormal hormone receptors have been found in the adrenal 
cortices of humans with hyperadrenocorticism.6 In ferrets with adrenocortical 
hyperfunction, involvement of the LH receptor is likely. Recent preliminary 
immunohistochemical studies by Wagner et al 27 and our group 24 have revealed that adrenal 
tumors possess cells with LH-receptors. 
Results of our study suggest that hyperadrenocorticism in ferrets may be an ACTH- 
and α-MSH-independent condition accompanied by unchanged plasma cortisol 
concentrations. 
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Summary 
 
Hyperadrenocorticism in ferrets is usually associated with unaltered plasma 
concentrations of cortisol and ACTH, although the urinary corticoid/creatinine ratio 
(UCCR) is usually elevated. In this study cortisol metabolism and urinary steroid profiles in 
healthy ferrets and in ferrets with hyperadrenocorticism were investigated, as well as 
possible seasonal fluctuations in the UCCR. 
In healthy ferrets and in one ferret with hyperadrenocorticism, approximately 10% of 
plasma cortisol and its metabolites was excreted in the urine. High-performance liquid 
chromatography revealed one third of the urinary corticoids to be unconjugated cortisol; the 
other peaks mainly represented cortisol conjugates and metabolites. 
In 21 healthy sexually intact ferrets, the UCCR started to increase by the end of March 
and declined to initial values halfway the breeding season (June). In healthy neutered 
ferrets there was no significant seasonal influence on the UCCR. In two neutered ferrets 
with hyperadrenocorticism the UCCR was raised, primarily during the breeding season. 
In 27 of 31 privately owned ferrets with hyperadrenocorticism, the UCCR was higher 
than the upper limit of the reference range (2.1 x 10-6). In 12 of 14 healthy neutered ferrets 
dexamethasone administration decreased the UCCR by more than 50%, whereas in only 
one of the 28 hyperadrenocorticoid ferrets did the UCCR decrease by more than 50%. 
We conclude that the UCCR in ferrets primarily reflects cortisol excretion. In healthy 
sexually intact ferrets and in ferrets with hyperadrenocorticism the UCCR increases during 
the breeding season. The increased UCCR in hyperadrenocorticoid ferrets is resistant to 
suppression by dexamethasone, indicating ACTH-independent cortisol production. 
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Introduction 
 
Hyperadrenocorticism leading to a glucocorticoid-induced catabolic state, 
characterized by muscle weakness, skin atrophy, and centripetal obesity, occurs in humans,1 
dogs,5,16 cats,13,15 and horses.11 The glucocorticoid excess may be due to an adrenocortical 
tumor or over-stimulation of the adrenal cortex. In pet ferrets (Mustela putorius furo) the 
situation is different. In this species hyperadrenocorticism is characterized by signs of 
excessive production of steroids (androstenedione, 17α-hydroxyprogesterone, 
dehydroepiandrosterone sulfate, and/or estradiol), leading to symmetrical alopecia, vulvar 
swelling in neutered female ferrets (jills), and recurrence of sexual behavior after neutering 
in male ferrets (hobs).10,19,20,21,24,35 Plasma concentrations of cortisol are only increased in a 
minority of cases.20 
In humans, dogs, cats, and horses, the assessment of basal adrenocortical function 
usually includes the measurement of urinary corticoids relative to the urinary creatinine 
concentration, 1,7,18,31 and is expressed as the urinary corticoid/creatinine ratio (UCCR). The 
main advantage of the UCCR over plasma cortisol concentrations is that urinary corticoid 
excretion reflects the free plasma cortisol concentration over a period of time, and is thus 
less influenced by the pulsatile secretion of this hormone than is the plasma cortisol level. 
A practical advantage of this measurement is that urine samples can be collected at home 
without the stress of a clinic visit and the blood sampling, thereby avoiding iatrogenic 
elevations. 
In ferrets the UCCR has also been assessed for diagnosing hyperadrenocorticism, with 
a UCCR higher than 1.6 x 10-6 being regarded as diagnostic for hyperadrenocorticism.8 
However, other have questioned whether measurement of the UCCR is an appropriate way 
to diagnose hyperadrenocorticism in ferrets,19 because hypercortisolism is not considered to 
play an important role in hyperadrenocorticism in ferrets.20 
Recently, we reported that urinary corticoid levels are increased during the breeding 
season in ferrets with hyperadrenocorticsm.25 This increase coincided with the reported 
increase in plasma luteinizing hormone (LH) concentrations.9 It is not clear whether the 
increased UCCR associated with hyperadrenocorticism in ferrets is due to hypercortisolism 
or the result of cross-reaction of other urinary steroids in the cortisol assay.25 
Here, we report on the results of studies of cortisol metabolism and urinary steroid 
profiles in healthy ferrets and ferrets with signs of hyperadrenocorticism. In addition, we 
present the results of UCCR measurements performed at 2-week intervals in intact and 
neutered ferrets for a period of 19 months. 
 
 
Materials and Methods 
 
HPLC and radioimmunoassay 
Urine samples (10-15 ml) for high-performance liquid chromatography (HPLC) were 
extracted on a C18 SepPak cartridge (Millipore, Bedford, MA). Urine samples were passed 
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over the cartridge followed by a wash step with water. Steroids were eluted with 100% 
methanol, evaporated to dryness, and dissolved in mobile phase before chromatography. 
Steroids were separated by HPLC (Pharmacia, Uppsala, Sweden) on a reversed phase 
C18 column (Merck, Darmstadt, Germany; particle size, 5 µm) using a mobile phase of 
HPLC-quality MeOH (Labscan Ltd, Dublin, Ireland) and double-distilled water (60:40 v/v) 
at a flow rate of 1 ml/min. Retention times of synthetic steroids (Sigma-Aldrich, St. Louis, 
USA) were determined using UV detection at 254 nm and were: aldosterone, 4.5 min; 
dehydrocorticosterone, 6 min; hydrocortisone (cortisol), 6.5 min; corticosterone, 9 min; 11-
deoxycortisol, 9.5 min; androstenedione, 14 min; 17β-estradiol, 15.5 min; progesterone, 
21.5 min and 17α-hydroxyprogesterone, 33 min. Fractions were collected every 30 sec for 
45 min for the measurement of their immunoreactivity in the radioimmunoassay (RIA) for 
cortisol, as described previously.18 The cortisol antiserum was raised in rabbits against a 
cortisol-21-hemisuccinate-bovine serum albumin conjugate. This antiserum is known to 
cross-react with other steroids such as 21-deoxycortisol (62%), corticosterone (11%), 
cortisone (2%), 11-deoxycortisol (1.3%), deoxycorticosterone (1.3%), and 17α-
hydroxyprogesterone (0.1%).30 The urinary corticoid concentration was related to the 
urinary creatinine concentration (Jaffé kinetic method, initial rate reaction) by calculation 
of its quotient (x 10-6).27 
 
Urinary excretion of corticoids 
Animals 
For this study, which was approved by the Ethics Committee of the Faculty of 
Veterinary Medicine, Utrecht University, three male and three female 5-year-old ferrets 
were used. All ferrets had been neutered. One of the neutered hobs had 
hyperadrenocorticism diagnosed on the basis of increased plasma concentrations of 
androstenedione and 17α-hydroxyprogesterone, and ultrasonography of the adrenals. There 
was a (histologically confirmed) adenoma in the left adrenal gland. 
All ferrets were individually housed in outdoor suspended cages with a night box. 
Water and ferret pellets (FerRet®, Hope Farms, Woerden, The Netherlands) were available 
ad libitum. 
 
Experimental procedure 
The ferrets were sedated with an intramuscular injection of medetomidine (100 µg/kg; 
Domitor®, Pfizer Animal Health BV, Capelle a/d IJssel, The Netherlands) for placement of 
a 24-gauge cannula with an injection port (Vasofix® Braunüle®, Braun, Melsungen, 
Germany) in the cephalic vein. Ferret plasma mixed with 5 µCi [1,2,6,7 3H]-cortisol 
(Amersham, Buckinghamshire, United Kingdom) was injected through the cannula which 
subsequently was flushed with 1 ml saline. Sedation was reversed with atipamazole (400 
µg/kg; Antisedan®, Pfizer Animal Health BV, Capelle a/d IJssel, The Netherlands). 
For the next 4 days urine was collected once daily by means of propylene litter boxes 
with macrolon plates placed underneath the cages. A 2-mm space between the plate and the 
wall of the litter box allowed urine to drain away from the feces.14 Ten 1-ml aliquots of 
each urine sample were mixed with 4 ml scintillation liquid (Ultimagold; Packard 
Instrument company, Downers Grove, IL), and after thorough mixing radioactivity was 
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measured in a β-counter (Rackbeta liquid scintillation counter; LKB, Bromma, Sweden). 
The percentage of [3H]cortisol excreted in the urine was calculated as [(∑3H/10) (dpm/ml) 
x U volume (ml) / 3H administered (dpm)] x 100. 
 
Seasonal influence on urinary corticoid/creatinine ratios (UCCR) 
The UCCRs of 21 healthy, intact ferrets (7 male, 14 female) and 9 gonadectomized 
ferrets (5 male, 4 female) were measured from February 2000 until September 2001. In 
February 2000 the ferrets were 2 to 3 years old. Eight ferrets had been gonadectomized at 6 
weeks of age and one hob at 9 months of age. The ferrets were housed and fed as described 
above. 
Although no signs of hyperadrenocorticism were present in any of the animals, two of 
the gonadectomized hobs appeared to have hyperadrenocorticism, based on increased 
plasma concentrations of androstenedione and 17α-hydroxyprogesterone and 
ultrasonographic findings. Later on, this was confirmed by histological examination of the 
adrenal glands. The UCCR of the 9 gonadectomized ferrets, recorded over a year, have 
been published previously.25 
Overnight urine samples were collected in litter boxes (see above) which were 
underneath the cages from 17:00 – 8:00 hours. Urine was stored in tubes at 4ºC pending 
analysis, which was performed within 5 days of urine collection. 
 
UCCRs with HDDST in healthy neutered ferrets 
Between March 15 and September 29 2001, the owners of 17 (8 male, 9 female) 
neutered ferrets (median age 3.5 years, range 1.5 to 8 years) collected urine samples from 
their ferrets. These ferrets were housemates of ferrets that had been presented with signs of 
hyperadrenocorticism. On physical examination no abnormalities were found in these 
ferrets. In 12 of these ferrets plasma concentrations of androstenedione and 17α-
hydroxyprogesterone were within the reference ranges.25 
The owners were requested to collect the first morning urine produced on 3 
consecutive days. The ferrets were allowed to urinate on a smooth floor from which the 
urine could easily be collected. After the second urine collection, the owners administered 
0.1 mg dexamethasone orally, 3 times at 8-hour intervals (high-dose dexamethasone 
suppression test; HDDST). The next morning the third urine sample was collected. Urine 
samples were stored in the refrigerator and sent to the laboratory of the Department of 
Clinical Sciences of Companion Animals of Utrecht University for analysis within one 
week. 
Two consecutive morning urine samples were also collected in seven 4-year-old 
neutered ferrets (2 male, 5 female) kept under laboratory conditions. 
 
UCCRs with HDDST in privately owned ferrets with hyperadrenocorticism 
From 1997 through 1999, hyperadrenocorticism was diagnosed in 31 neutered ferrets 
(25 male, 6 female; median age 5 years, range 2 to 8 years). The history included 
symmetrical alopecia (27 of 31 ferrets), an enlarged vulva (5 of 6 jills), and increased libido 
(6 of 25 hobs). An enlarged adrenal gland was palpated in 8 ferrets. In 22 of 28 ferrets in 
which ultrasonography was performed, the results were consistent with surgical findings. 
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Histological examination of the adrenal glands collected at surgery or at post mortem 
examination revealed hyperplasia (n=10), adenoma (n=16), and adenocarcinoma (n=5). 
Urine samples were collected as described above for the healthy ferrets. A HDDST 
was performed in 28 of 31 ferrets. 
 
Calculations and statistics  
In the serial measurements of UCCRs, the values are expressed as mean ratios ± 
standard error of the mean (SEM). The paired Student’s t test was used to compare the 
mean UCCRs of intact ferrets in April with those in December, and the serial UCCR 
measurements for the 2 ferrets with hyperadrenocorticism with those of the 7 healthy ferrets 
during both the breeding season (March until September) and the non-breeding season 
(September until March). Statistical significance was assumed at P < 0.05. 
In the diagnostic assessment of the UCCR, the mean of the ratios of the samples 
collected on two consecutive days was used. The percentile method was used to establish 
the reference range for the UCCR in healthy ferrets.4 The percentiles P2.5 and P97.5 were 
determined with a probability of 95%. 
 
 
Results 
 
Urinary excretion of corticoids 
Within two days of intravenous administration of [1,2,6,7 3H]cortisol in the 5 healthy 
ferrets, 10.1% (range, 1.7% – 22.5%) of the administered cortisol was cleared in the urine. 
The urinary excretion of [3H]cortisol in the ferret with hyperadrenocorticism was 10.4%. 
Urine samples collected on the two following days contained practically no radioactivity, 
indicating that all [3H]cortisol had been excreted in two days. 
The HPLC fraction eluting at the retention time of cortisol (t = 6.5 min) contained 33.2 
± 4.5% (mean ± SEM, n=10) of the total urinary corticoids (measured by RIA). The other 
two peaks with retention times of 3.5 and 5.5 min were probably conjugated or 
hydroxylated cortisol metabolites. No immunoreactivity eluted with retention times longer 
than 10 min, indicating that other steroids, such as androstenedione, 17β-estradiol, 
progesterone, or 17α-hydroxyprogesterone, did not interfere with the assessment of the 
UCCR. 
 
Seasonal influence on urinary corticoid/creatinine ratios 
Intact ferrets: - In both years of the study the UCCRs of the 21 intact healthy ferrets 
started to increase toward the end of March, reaching a peak in April. The ratios returned to 
initial values by the end of June (Figure 1). These UCCR peaks at the beginning of the 
breeding season were similar in both genders; at the end of April 2000 and 2001 the UCCR 
(± SEM) for 7 intact hobs was 5.9 ± 0.7 x 10-6 and 4.3 ± 1.0 x 10-6, respectively, and that 
for 14 intact jills was 6.0 ± 0.7 x 10-6 and 3.2 ± 0.3 x 10-6, respectively. At the end of April 
2000 and 2001, the UCCR in all healthy ferrets (6.0 ± 0.5 x 10-6 and 3.5 ± 0.4 x 10-6, 
respectively) was significantly higher than at the end of December 2000 (1.4 ± 0.1 x 10-6). 
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Figure 1. The mean (± SEM) urinary corticoid/creatinine ratio (x 10-6) of 21 healthy intact ferrets 
from February 2000 until September 2001. 
 
Neutered ferrets: - The UCCR was not affected by seasonal influences in healthy 
neutered ferrets. The mean value (1.3 ± 0.1 x 10-6) was not significantly different from that 
of the intact ferrets in the non-breeding season (1.5 ± 0.2 x 10-6). During the breeding 
seasons, the UCCR (± SEM) of the two hyperadrenocorticoid ferrets (3.5 ± 0.2 x 10-6 and 
2.9 ± 0.2 x 10-6) was significantly higher than that of the neutered control animals (1.0 ± 0.2 
x 10-6). Early in the non-breeding season, the UCCR of one of the hyperadrenocorticoid 
ferrets was still significantly higher (2.9 ± 0.3 x 10-6) than that of the healthy control 
animals (1.6 ± 0.3 x 10-6). In November and December, however, the UCCR of this ferret 
was no longer higher than that of the other animals (1.9 ± 0.4 x 10-6 versus 1.8 ± 0.2 x 10-6) 
(Figure 2). 
 
UCCRs and HDDST in healthy neutered ferrets 
The mean UCCR of two consecutive morning urine samples in 24 healthy neutered 
ferrets ranged from 0.35 to 2.6 x 10-6 (median, 1.3 x 10-6). The reference range (percentiles 
P2.5 and P97.5 with a probability of 95%) was 0.6 – 2.1 x 10-6. Oral dexamethasone 
administration to 14 healthy neutered ferrets resulted in a more than 50% decrease in the 
UCCR in 12 ferrets, a 30% decrease in one ferret, and a 6-fold increase in another ferret 
(Figure 3). 
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Figure 2. The mean (± SEM) urinary corticoid/creatinine ratio (UCCR) (x 10-6) of 7 healthy 
neutered control ferrets (z), and the UCCR of 2 neutered ferrets (, x) with 
hyperadrenocorticism from February 2000 until September 2001. 
 During both breeding seasons (March to August) the mean UCCR of both ferrets with 
hyperadrenocorticism was significantly higher than the mean UCCR of the 7 control 
ferrets (P < 0.025). 
 
UCCRs and HDDST in privately owned ferrets with hyperadrenocorticism 
The median UCCR in ferrets with hyperadrenocorticism was 6.8 x 10-6 (range, 1.5 – 96 
x 10-6). In 27 of 31 ferrets (87%) the UCCR was higher than the upper limit of the reference 
range (see above). Oral dexamethasone administration to 28 hyperadrenocorticoid ferrets 
resulted in an increase in the UCCR in 12 ferrets. In one ferret no change was seen while in 
15 ferrets a decrease occurred. In only one of the latter ferrets was the decrease more than 
50% (Figure 3). 
 
 
Discussion 
 
The present results indicate that in ferrets approximately 10% of cortisol and its 
metabolites is excreted in the urine, which is higher than the 2% found in cats,7 but much 
lower than the 55% in dogs.17 Apparently in ferrets, as in cats, the majority of cortisol is 
cleared by hepatobiliary excretion. Nevertheless, urinary cortisol concentrations can be 
measured by RIA. 
Plasma cortisol concentrations in ferrets with hyperadrenocorticism are similar to those 
of healthy ferrets.20 In contrast, UCCRs of hyperadrenocorticoid ferrets are significantly 
higher than those of healthy ferrets.8 It has been hypothesized that urinary steroids or their 
metabolites, other than cortisol, cross-react in the cortisol assay.25 For example, estrogens 
or androgens of adrenal origin and/or their precursors might cross-react in the urinary 
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cortisol assays. However, although the antibody used in the cortisol RIA cross-reacts with 
other steroids, no immunoreactivity was found in HPLC fractions corresponding with the 
elution of androstenedione, 17β-estradiol, progesterone, and 17α-hydroxyprogesterone. 
Thus the UCCR in ferrets mainly reflects urinary cortisol excretion. In our study, the upper 
limit of the reference range for the UCCR was 2.1 x 10-6, which is slightly higher than the 
1.6 x 10-6 reported previously.8 Different methodology, e.g. the antibody used in the 
measurement of cortisol, might explain this difference. 
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Figure 3. Logarithmic representation of the mean urinary corticoid/creatinine ratio (x 10-6) 
measured in two consecutive morning urines (CC) from healthy ferrets and ferrets with 
hyperadrenocorticism. After the collection of these two urine samples the ferrets received 
three oral doses of dexamethasone (0.1 mg/kg) at 8-h intervals. The next morning a third 
urine sample was collected (CC dex). In ferrets with hyperadrenocorticism, the 
suppression of urinary corticoid excretion by dexamethasone was less than 50%, while in 
almost half of the cases a paradoxical rise occurred. 
 
Interestingly, in healthy intact ferrets a distinct seasonal variation in the UCCR was 
observed. The ratio increased significantly in the middle of March, peaked at the beginning 
of April, and returned to basal values by the end of June. Similar variations in cortisol 
(metabolite) excretion have been found in non-human primates during periods of increased 
sexual activity.12,29 
From a mechanistic point of view, there are several possible explanations for the 
increase in cortisol levels during the breeding season. First, there is the possibility that the 
elevated UCCR is due to activation of the pituitary-adrenocortical axis associated with the 
increased sexual activity. Our hobs and jills were housed in each other’s vicinity without 
having the possibility to mate, and thus the hightend arousal may well have increased the 
UCCR. From studies of healthy pet dogs it is known that minor stresses, such as being 
briefly in a consultation room and hospitalization, can increase the UCCR.32 In support of 
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this possibility is the fact that during the breeding season plasma adrenocorticotropic 
hormone (ACTH) concentrations are higher in intact jills than in neutered jills.23 However, 
in intact hobs plasma ACTH concentrations are similar to those of neutered hobs.23 This 
may be due to the effect of testosterone, which is known to inhibit the response of the 
hypothalamus-pituitary-adrenocortical axis to stress.33 Since the peak UCCR at the end of 
April was similar in both genders, this rise cannot fully be ascribed to sexual arousal. 
Another explanation for the elevated UCCR in the breeding season of ferrets concerns 
LH. The sexual maturation of ferrets, under the influence of stimulatory photoperiods, is 
associated with increased LH secretion.22 Moreover, LH-receptors (LH-Rs) have been 
detected in the adrenal cortex of ferrets,25 and in vitro stimulation tests have shown that LH 
stimulates adrenocortical cortisol secretion (Schoemaker et al., in preparation). One would 
expect, however, that the LH-R-mediated cortisol secretion would suppress endogenous 
plasma ACTH concentrations during the breeding season, which is not the case.23 In 
addition, administration of a GnRH analogue to healthy (neutered) ferrets does not increase 
plasma concentrations of adrenocortical steroids.25 
A third explanation for the increased cortisol excretion during the breeding season is 
that altered concentrations of sex steroids might influence of cortisol metabolism, for 
example, the capacity of cortisol-binding globulins (CBG) in plasma. In male sugar gliders, 
an inverse relationship has been found between testosterone concentrations and the CBG-
binding capacity, resulting in increased plasma concentrations of free cortisol during the 
breeding season.2 Changes in the concentration of carrier globulins may affect urinary 
cortisol excretion, as observed in a woman with clinical Cushing’s disease and CBG 
deficiency. In this woman, total plasma cortisol concentrations were within the normal 
range, whereas plasma concentrations of free cortisol and the urinary corticoid excretion 
were elevated.34 
In the healthy neutered ferrets there were no seasonal changes in the UCCR. The ratio 
remained constant at the same low level as in the intact ferrets during the non-breeding 
season. In contrast, two neutered hyperadrenocorticoid ferrets had an elevated UCCR 
during the breeding season. It is possible that under the influence of the castration-induced 
increased of gonadotropic hormones, the adrenocortical cells had become receptive to 
stimulation, e.g. by increased expression or a regain of functionality of LH-receptors.26 As 
in sexually intact ferrets, plasma LH concentrations, which are influence by the 
photoperiods, 3 may have been low during the non-breeding season and high during the 
breeding season. The latter, in combination with adrenocortical responsiveness, may have 
led to an increase in the secretion of steroids. In turn, this may have led to an increase in the 
plasma free cortisol concentration and consequently to an increased UCCR. However, this 
explanation should be considered with some reservation. While LH-R-mediated cortisol 
production may contribute to the elevated UCCR in the breeding season, in the two 
hyperadrenocorticoid ferrets, hCG administration caused plasma concentrations of 
androstenedione and 17α-hydroxyprogesterone to rise without a concomitant increase in 
plasma cortisol concentrations.25 However, sexual arousal and lowering of the CBG levels 
may have contributed to cortisol excretion, as described above for the sexually intact 
ferrets. 
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In 27 of the 31 privately owned ferrets with hyperadrenocorticism, the UCCR was 
higher than the upper limit of the reference range, confirming the previously reported 
increase in the UCCR in ferrets with hyperadrenocorticism.8 In almost all of the healthy 
neutered ferrets, dexamethasone administration decreased the UCCR by more than 50%, 
whereas in the great majority of clinical cases there was resistance to suppression. In some 
cases, the UCCR even increased after dexamethasone administration. Such paradoxical 
increases, which have also been observed in humans 28,36 and dogs 6 with adrenocortical 
tumors, have been ascribed to a direct effect of dexamethasone on the adrenocortical 
tumor.6,36 
Dexamethasone resistance is compatible with autonomy at adrenocortical level, 
although it may also be associated with some pituitary tumors. Autonomy at a pituitary 
level is very unlikely because hyperadrenocorticism is not associated with corticotropic 
adenomas in ferrets.19, Schoemaker et al., submitted Therefore ACTH-independent production of 
corticosteroids has to be assumed, for instance, LH-dependent production of adrenal 
steroids, including cortisol. The initially LH-dependent production of adrenal steroids may 
become LH-independent as the adrenal gland undergoes neoplastic transformation. 
Irrespective of which mechanism is operational, yet another mechanism has to be 
considered as explanation for the combination of an elevated UCCR, normocortisolemia, 
and unaltered plasma ACTH concentrations,23 namely an increased production of steroids. 
These would affect the CBG concentration, leading to elevated free cortisol concentrations 
without an elevation of total cortisol levels. It is also possible that ACTH levels are not 
suppressed by the LH-dependent or autonomously hypersecreting adrenal lesions, because 
cortisol secretion was only marginally elevated. 
In conclusion, our results indicate that the UCCR in ferrets primarily reflects cortisol 
excretion. In healthy ferrets and in ferrets with hyperadrenocorticism, the UCCR increases 
during the breeding season. The increased UCCR in hyperadrenocorticoid ferrets is 
resistant to suppression by dexamethasone, indicating ACTH-independent cortisol 
production. 
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Summary 
 
Pituitary tumors are the cause of hyperadrenocorticism in a variety of species, but the 
role of the pituitary gland in hyperadrenocorticism in ferrets is not known. In this species, 
the condition is mediated by the action of excess gonadotropins on the adrenal cortex and is 
characterized by an excessive secretion of sex steroids. 
In this study, the pituitary gland of four healthy control ferrets, both intact and 
neutered, and ten neutered ferrets with hyperadrenocorticism was examined histologically 
following staining for adrenocorticotropic hormone (ACTH), α-melanocyte-stimulating 
hormone (α-MSH), growth hormone (GH), thyroid-stimulating hormone (TSH), luteinizing 
hormone (LH), follicle-stimulating hormone (FSH) and prolactin. Immunohistochemistry 
revealed that somatotropes, thyrotropes and lactotropes are the most abundant cell types of 
the pars distalis of the pituitary gland in healthy ferrets. The distribution of corticotropes 
was similar to that in dogs and humans. In ferrets, similar to dogs, the melanotropic cell is 
almost the only cell type of the pars intermedia. Gonadotropes were found in the pars 
distalis of neutered individuals, but not intact, ferrets. 
All the ferrets with hyperadrenocorticism had uni- or bilateral tumors of the adrenal 
gland. In addition, in the pituitary gland of two of these ferrets a tumor was detected. These 
tumors did not stain for any of the pituitary hormones, and had characteristics of clinically 
non-functional gonadotrope tumors seen in humans. In some of the other ferrets low 
pituitary immunoreactivity for gonadotropic hormones was detected, which might be due to 
the feedback of autonomous steroid secretion by the neoplastic transformation of the 
adrenal cortex. 
It is concluded that the initially high concentrations of gonadotropins, as a result of 
castration, may initiate hyperactivity of the adrenal cortex. The low incidence of pituitary 
tumors and the low density of gonadotropin-positive cells in non-affected pituitary tissue in 
this study, suggest that persistent hyperadrenocorticism is not dependent on persistent 
gonadotropic stimulation. 
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Introduction 
 
Hyperadrenocorticism occurs in several mammalian species, including humans,25 
dogs,9,28 and cats.18,26 In these species, the glucocorticoid excess leads to a catabolic state 
characterized by muscle weakness, skin atrophy, and centripetal obesity. The glucocorticoid 
excess may be due to an adrenocortical tumor or pituitary stimulation of the adrenal cortex. 
In humans, 60% to 80% of cases of hyperadrenocorticism are pituitary dependent,5 while in 
dogs and cats, over 80% of the cases are secondary to a pituitary tumour.9,24,28 
The situation is different in pet ferrets (Mustela putorius furo). In these animals, the 
changes associated with hyperadrenocorticism are dominated by signs of excessive 
production of sex steroids, i.e. symmetrical alopecia, vulvar swelling in neutered jills, and 
recurrence of sexual behavior after neutering.16,30,31,32,34,40 Plasma concentrations of 
androstenedione, 17α-hydroxyprogesterone, dehydroepiandrosterone sulfate and/or 
oestradiol are increased, consistent with these signs.31 In addition, elevated urinary 
corticoid/creatinine ratios have been reported in ferrets with hyperadrenocorticism.10 
In most ferrets with hyperadrenocorticism (85%), only one adrenal gland is enlarged 
and there is no atrophy of the contralateral gland.32,40 After unilateral adrenalectomy, the 
disease may recur in association with enlargement of the contralateral adrenal gland.40 The 
histological changes of the adrenal glands range from (nodular) hyperplasia to adenoma and 
adenocarcinoma.32 
The characteristics of hyperadrenocorticism in ferrets resemble those of some strains of 
mice in which nodular adrenocortical hyperplasia and adrenocortical tumors occur after 
neutering at an early age.8,23,36 It has been suggested that castration also plays a role in the 
pathogenesis of hyperadrenocorticism in ferrets,16,32 and recently the age at neutering was 
found to be significantly correlated with the age at onset of hyperadrenocorticism.34 This 
suggestion, together with the observation that the signs of hyperadrenocorticism initially 
occur only during the breeding season,30 that treatment with the gonadotropin-releasing 
hormone (GnRH)-agonist leuprolide acetate has beneficial effects,39 and that functional 
luteinizing hormone (LH) receptors are present in the altered adrenal cortices of ferrets with 
hyperadrenocorticism 35 has strengthened the hypothesis that hyperadrenocorticism in 
ferrets is mediated by gonadotropic influence. 
Given that the pituitary derived gonadotropic hormones play a role in the pathogenesis 
of hyperadrenocorticism in ferrets, it is of interest to know whether the disease in ferrets is 
associated with morphological changes in the pituitary. Previous reports indicate that there 
are no macroscopically visible changes in the pituitary glands of ferrets with 
hyperadrenocorticism,30 or neoplastic diseases.3,6,15 Here, we report on the pituitary 
histology of ten ferrets with hyperadrenocorticism and four control ferrets. 
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Materials and Methods 
 
Healthy ferrets 
Four healthy ferrets (two 1-year-old intact males, two 2-year-old neutered females) 
were euthanased during the breeding season, after which routine post-mortem examinations 
were performed within four hours of death. No histological abnormalities were found in the 
adrenal glands of these ferrets. 
 
Table 1. Physical and histopathological data of ten neutered ferrets with hyperadrenocorticism 
histology  
Ferret 
 
sex 
 
age 
(year) 
 
alopecia 
 
miscellaneous 
 
surgery 
left adrenal right adrenal pituitary 
gland 
1 m 6 yes Increased libido yes hyperplasia hyperplasia NAF* 
2 m 4 no   carcinoma carcinoma NAF 
3 m 5 yes  yes hyperplasia carcinoma adenoma 
4 m 7 yes   carcinoma carcinoma NAF 
5 m 5 yes   adenoma hyperplasia NAF 
6 m 4 no  yes carcinoma carcinoma NAF 
7 f 5 yes  yes adenoma hyperplasia NAF 
8 m 5 no enlarged prostate yes carcinoma hyperplasia NAF 
9 m 6 yes  yes hyperplasia hyperplasia NAF 
10 m 5 no   hyperplasia carcinoma adenoma 
* NAF = no abnormalities found 
 
Clinical Cases 
Ten (9 male, 1 female) neutered ferrets (age 4 – 7.5 years; median 5 years) were 
presented with signs of hyperadrenocorticism. At first presentation the following findings 
were observed. Six ferrets had alopecia. The female ferret had a slightly swollen vulva. One 
male ferret had an increased libido and another male had stranguria due to an enlarged 
prostate (Table 1). Mean urinary corticoid/creatinine (C/C) ratios (n=8) in two consecutive 
morning urines ranged from 3.2 to 86.5 x 10-6 (reference < 1.66 x 10-6)10. In two other 
ferrets only one urine sample was collected (Table 2); these C/C ratios also exceeded the 
reference range. Immediately after collection of the basal urine samples, a high-dose 
dexamethasone suppression test 29 was performed in six ferrets by oral administration of 
dexamethasone (0.1 mg/kg; 3 times at 8-hour intervals). The urinary C/C ratios after 
dexamethasone administration were compared to the mean urinary C/C ratios of the 
previous 2 days. The mean percentage change after dexamethasone administration in the six 
ferrets was 107.6% (range 11.5 – 276.3%).  
Plasma concentrations of adrenocorticotropic hormone (ACTH), α-melanocyte-
stimulating hormone (α-MSH), androstenedione and 17α-hydroxyprogesterone are 
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summarized in Table 2. Concentrations of androstenedione and 17α-hydroxyprogesterone 
exceeded the reference range in all cases (n=7) in which these hormones were measured. 
 
Table 2. Laboratory data of ten neutered ferrets with hyperadrenocorticism 
 Urine (C/C x 10-6) Plasma 
Ferret day 1* day 2 day 3* ACTH  
(pmol/l) 
α-MSH 
(pmol/l) 
a’dione* 
(nmol/l) 
17-OH-prog* 
(nmol/l) 
1 5.2 3.5 0.5 18.5 16.2   
2  4.6      
3  5.5    0.6 0.9 
4 3.6 4.6 2.6 4.8 15.6 0.4 13.3 
5 3.0 3.6  26.6 20.4 15.7 3.7 
6 7.7 6.1 3.5 1.8 45.6 0.3 1.1 
7 23 150 239 0.2 43.8 2.3 3.5 
8 3.8 2.5 0.9 11.4 42.6 1.5 1.5 
9 4.6 4.7 10 1.8 18.6   
10 2.9 3.8    4.2 6.8 
reference < 1.66 10 < 1.66  2.9 – 21.6 33 9.6 – 44.4 33 0.1 – 0.4 35 0.3 – 0.7 35 
* C/C = corticoid/creatinine ratio; C/C day 3 = corticoid creatinine ratio after dexamethasone suppression; 
a’dione = androstenedione; 17-OH-prog = 17α-hydroxyprogesterone 
 
Within four weeks after first presentation six ferrets underwent a laparotomy. Of these 
ferrets, one had left, three had right, and two had bilateral adrenal involvement. In three 
ferrets the adrenal glands were left in place because of either the extent of attachment of the 
gland to the wall of the vena cava or the presence of bilateral tumors. One ferret died 
immediately after surgery, and in two ferrets signs recurred after left adrenalectomy. 
Post-mortem examinations were performed within 4 hours of death. Histology revealed 
adenoma (n=2) and adenocarcinoma (n=1) in the surgically removed adrenal glands, and 
hyperplasia (n=2) and adenoma (n=1) in the contralateral adrenal glands. The other seven 
ferrets all had bilateral adrenocortical involvement at post-mortem examination (Table 1). 
 
Pituitary gland collection and tissue preparation 
The entire head of one of the healthy female ferrets was fixed in 4% phosphate-
buffered formalin. After 24 hours of fixation the skull was placed in a Na-EDTA solution 
(10%, pH = 7) for 2 weeks, to soften the bone before sectioning in a midsaggital plane. In 
this manner slides were obtained of the pituitary gland within the fossa hypophysis of the os 
basisphenoidal. 
In the other three healthy ferrets and seven ferrets with hyperadrenocorticism the 
sphenoid bone (os basisphenoidale) was cut around the pituitary gland. The brain including 
the pituitary gland and sphenoid bone was removed, and the pituitary gland was carefully 
dissected from under the dorsum sellae and its posterior clinoid processes. Sections were 
cut in a midsaggital plane. Consecutive sections were cut of the pituitary gland of one of 
the healthy ferrets to investigate the distribution of corticotropes throughout the pituitary 
The pituitary gland in ferrets 
 
 
 
 73
gland. In the three remaining ferrets with hyperadrenocorticism the skull was opened 
dorsally and the brain was lifted so that the pituitary gland came out of the pituitary fossa. 
The pituitary glands in these ferrets were cut in a horizontal plane. 
All tissues were fixed in 4% phosphate-buffered formalin for at least 24 hours and then 
embedded in paraffin wax. Sections (4 µm) were cut and stained with hematoxylin and 
eosin (HE). Multiple consecutive sections were stained with periodic acid-Schiff (PAS) or 
were used for immunohistochemistry of pituitary hormones. 
 
Immunohistochemistry 
Immunohistochemical staining of pituitary sections was performed with a monoclonal 
mouse antibody to synthetic ACTH1-24,17 a polyclonal rabbit antibody to synthetic α-MSH 
[PU060-UP, Biogenex Laboratories, San Remo, Ca, USA], a polyclonal rabbit antibody to 
porcine thyroid-stimulating hormone (TSH) [Biogenesis, Poole, England], a polyclonal 
rabbit antibody to porcine prolactin (PRL),4 a polyclonal rabbit antibody to porcine growth 
hormone (GH),37 a polyclonal rabbit antibody to human LH [DAKO, N 1543, ITK 
Diagnostics, Uithoorn, The Netherlands], and a polyclonal rabbit antibody to human 
follicle-stimulating hormone (FSH) [DAKO, N 1539, ITK Diagnostics, Uithoorn, The 
Netherlands]. Because of strong cross-reaction between the ACTH1-24 and α-MSH 
antibodies, two additional ACTH antibodies were used to stain the pituitary glands of two 
ferrets (a polyclonal rabbit antibody to human ACTH18-39 (hACTH) [Sigma-Aldrich 
Chemie bv., Zwijndrecht, The Netherlands] and a polyclonal rabbit antibody to synthetic 
carp ACTH10-23 (cACTH) [KLH-cys-GKPVGRKRRPIKVY, Eurogentec, Seraing, 
Belgium]. One of these two ferrets, a 5-year-old neutered male, was euthanased during the 
breeding season because of an insulinoma. The adrenal glands of this ferret did not show 
any abnormalities on histological examination. The pituitary gland of the other ferret was 
from one of the clinical cases (ferret 10). 
 
Specificity of the antibodies 
The specificity of the ACTH1-24, PRL, GH, and TSH antibody reactions was previously 
determined by staining of Western blots containing canine pituitary proteins.17 The ACTH1-
24 antibody cross-reacted with α-MSH.17 The GH antibody was highly specific, whereas the 
prolactin antibody showed considerable cross-reaction with other proteins. The TSH 
antibody reacted specifically with protein fragments with molecular weights of 23 and 27 
kDa. The 27-kDa fragment corresponds with the molecular weight of TSH.17 According to 
the manufacturer’s information, the LH and FSH antibodies show 10% cross-reaction with 
each other. 
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Figure 1. Midsagittal section of the pituitary gland of a 2-year-old neutered female ferret within the 
fossa hypophysis (FH) of the os basisphenoidale (OB). As an artifact the pars distalis 
adenohypophysis (PD) is pressed against the pars intermedia adenohypophysis (PI). Due 
to the artifact the cavum hypophysis (CH) is obscured (see figure 2). (D: dorsum sellae; I: 
infundibulum neurohypophysis; LN: lobus nervosus neurohypophysis; M: mammillary 
body; ME: median eminence; T: tuberculum sellae; TV: third ventricle; V: venous sinus 
connecting cavernous sinuses). Hematoxylin and Eosin. Bar is 0.5 mm. 
 
  
Results 
 
Healthy ferrets 
By observing a saggital section of the entire hypothalamo-pituitary system of a ferret it 
is clear that the dorsum sellae extends dorsally over the lobus nervosus neurohypophysis of 
the pituitary gland (Fig 1), which makes it difficult to lift the pituitary gland out of its fossa 
without rupturing the pituitary stalk. There is almost no pars tuberalis adenohypophysis in 
ferrets. At most there are only a few cell layers. This thin layer did not show 
immunoreactivity against any of the pituitary hormones. When the pituitary gland was 
taken from the fossa hypophysis, the infundibulum neurohypophysis retracted, giving it a 
curved appearance (Fig 2). 
Most of the ACTH1-24 / α-MSH positive cells of the pars distalis adenohypophysis 
were in the anterior and mid-ventral portion of the pituitary gland. The number of ACTH1-24 
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positive cells diminished with lateralization of consecutive sections. All of the cells in the 
pars intermedia adenohypophysis stained positive with these two antibodies (Color 
section; Fig 1). Cells in the pars intermedia adenohypophysis did not react with the 
hACTH antibody, whereas cells in the pars distalis adenohypophysis reacted with the 
hACTH (Color section; Fig 2) and cACTH antibodies (not shown). Only at high 
magnification a few cells staining with the cACTH antibody were seen in the pars 
intermedia adenohypophysis (not shown). 
 
 
 
Figure 2. Midsagittal section of the pituitary gland of a 2-year-old neutered female ferret after 
removal from the pituitary fossa, illustrating retraction of the infundibulum 
neurohypophysis. For explanation of lettering see legend to Figure 1.  
Hematoxylin and Eosin. Bar is 0.5 mm. 
 
By estimation, 30% to 40% of cells stained for PRL, another 30% to 40% of cells 
stained for TSH, and another 30% to 40% of cells stained for GH. The cells were diffusely 
scattered throughout the pars distalis adenohypophysis (Color section; Fig 1 and 3). At 
high magnification of the pars intermedia adenohypophysis a few cells were observed 
which stained positive for PRL and GH (not shown). 
The number of cells staining positive for LH and FSH varied greatly. In the two 
healthy neutered ferrets approximately 15% to 20% of all cells were immunopositive 
(Color section; Fig 1), whereas in the other two (intact, 1-year-old, male) ferrets only a few 
cells were positive. In the pars intermedia adenohypophysis of the neutered jills, a small 
Chapter 6 
 
 
 76
number of cells stained positive for LH and FSH at the junction of the pituitary stalk and 
the lobus nervosus neurohypophysis (Color section; Fig 4). 
 
Clinical cases 
Two pituitary glands had evidence of neoplasia and 8 had no abnormalities. The 
pituitary neoplasias in the two 5-year-old male neutered ferrets (No 3 and 10) were round 
chromophobic, PAS-negative adenohypophyseal adenomas. These neoplasias were not 
surrounded by a capsule and contained mainly poorly differentiated cells with a low 
cytoplasm-to-nucleus ratio. Some normal pituitary cells were seen between the 
adenomatous cells. There was no necrosis and few mitotic figures were seen.  
On immunohistochemical examination of the pars distalis adenohypophysis, in 5 of 
the 8 non-tumorous pituitaries only a few cells were positive for ACTH1-24 (number 1, 6, 7, 
8 and 9), while in the other three the number of cells positive for ACTH1-24 was similar to 
that in the healthy ferrets. In three ferrets the number of cells positive for LH and FSH were 
similar to those in the neutered control ferrets. In five ferrets (numbers 1, 3, 4, 6 and 7) only 
a few cells were positive for these hormones. The distribution of the cells staining positive 
for other hormones did not differ from that in the healthy ferrets. 
In the adenomas immunohistochemical staining for ACTH1-24, α-MSH, TSH, GH, 
PRL, LH, and FSH was negative. Positive staining of some normal cells associated with the 
adenomas was observed. The cells of the non-affected part of the adenohypophysis stained 
positive for ACTH, α-MSH, TSH, GH, and PRL in ferret 3 (Color section; Fig 5) and 
positive for TSH, GH, LH, FSH, and PRL in ferret 10. In ferret 3 only a few LH- and FSH-
positive cells were found while in ferret 10 very few ACTH- and α-MSH-positive cells 
were found in the surrounding tissue. 
 
 
Discussion 
 
As in other species, the cells of the ferret adenohypophysis are classified according to 
their specific secretory products: somatotropes (secreting GH), lactotropes (secreting PRL), 
thyrotropes (secreting TSH), gonadotropes (secreting LH and FSH), corticotropes 
(secreting ACTH) and melanotropes (secreting α-MSH). 
Immunopositivity for ACTH was predominantly located in the anterior and ventral 
region of the pars distalis adenohypophysis, as has been described in humans and 
dogs.7,17,38 Previous studies of ferrets did not describe the distribution of the cells in the 
pituitary gland.20,21 The intense staining of the pars intermedia adenohypophysis for ACTH, 
as found with the antibody to ACTH1-24, must be attributed to cross-reaction with α-MSH, 
as has previously been reported for dogs with the same antibody.17 With the cACTH10-23 
antibody a few immuno-positive cells in the pars intermedia adenohypophysis were 
detected, but with the hACTH18-39 antibody positive cells were not found in the pars 
intermedia adenohypophysis. Thus in ferrets, as in dogs,11,27 the most abundant cell type of 
the pars intermedia adenohypophysis is the melanotrope. The staining with the cACTH10-23 
antibody and the observations of Mohanty et al. indicate that some corticotropic cells exist 
in the pars intermedia adenohypophysis.20,21 Although Mohanty and co-workers attributed 
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this to cross-reaction with α-MSH, this is not possible with the cACTH10-23 antibody, since 
these two hormone fragments do not have similar epitopes. 
Mohanty et al. reported on the occurrence of corticotropes and gonadotropes in the 
pars tuberalis adenohypophysis.20,21 However, comparison of their pictures with our 
sections of the pituitary gland within the sella turcica suggests that the area they described 
as pars tuberalis adenohypophysis may either be a transitional zone or the pars intermedia 
adenohypophysis. In this region, we not only found gonadotropes but also thyrotropes and 
somatotropes. By contrast, Mohanty et al. found somatotropes to be confined to the pars 
distalis adenohypophysis.21 
In the present study, gonadotropes were well represented in the pars distalis 
adenohypophysis in the neutered ferrets whereas only a few gonadotropes were detected in 
the pituitary glands of the intact male ferrets. This is in agreement with observations in rats, 
in which castration leads to a 2-fold increase in the number of gonadotropes within 6 
months due to loss of feedback by sex steroids.12 Although Mohanty et al. detected 
gonadotropes in the pars distalis adenohypophysis of male ferrets, they did not specify 
whether the animals were castrated.21 
In four of the neutered ferrets with hyperadrenocorticism the number of gonadotropes 
was similar to that found in the neutered healthy ferrets. In the other 6 ferrets only a few 
gonadotropes were found. A possible explanation for the low number of gonadotropes in 
some of these ferrets may be that hormones by adrenal tumors, such as oestradiol,31 exert a 
negative feedback on the gonadotropes. 
In the pituitary glands of 5 of 8 ferrets with hyperadrenocorticism, only a few 
corticotropes were found. In healthy humans corticotropes are mainly distributed in the 
anteriomedian part of the anterior lobe.38 In the pituitary gland of a healthy neutered ferret, 
we examined multiple consecutive sections and found that the number of corticotropes 
diminished with lateralization of the sections. Thus sections with only low numbers of 
corticotropes may not have been taken from the median part of the pituitary gland. Another 
explanation, however, is that the adrenocortical neoplasia in some ferrets may have 
produced an excess of cortisol, which suppressed the ACTH synthesis in corticotrophs.19 
Although Rosenthal et al. have reported that hypercortisolism is unusual in 
hyperadrenocorticoid ferrets,31,32 they also found elevated plasma cortisol concentrations in 
some cases.31 The fact that hyperadrenocorticism in ferrets seems to be independent of 
ACTH and α-MSH 33 makes the first explanation the more plausible. 
In the present study, blood samples for hormone measurements were collected when 
the animals were first presented. Since the time between first presentation and post-mortem 
examination ranged from several weeks to over 3 years, it is not possible to correlate the in 
vivo data with the number of corticotropes or gonadotropes found at post-mortem 
examination. Disease progression may have led to changes in the secretory pattern of 
adrenocortical hormones, which would affect the activity and distribution of pituitary 
gonadotropes and corticotropes. 
In dogs, somatotropes account for 50% or more of the adenohypophyseal cells, with 
the other cell types each representing 5% to 15% of the cells.27 The results of the present 
study confirm an earlier report that somatotropes are an abundant cell type in the ferret 
adenohypophysis.21 
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Up to 40% of the adenohypophyseal cells of healthy ferrets stained positively for 
prolactin. In cows, multihormonal cells have been found containing both GH and PRL,2 but 
this has not been found in ferrets.21 The cross-reaction of the PRL antibody with small 
protein fragments 17 might explain the high number of positive cells found in the present 
study. Cells staining positive for TSH also comprised up to 40% of the adenohypophyseal 
cells of ferrets. This percentage may also be an overestimation since the TSH antibody 
stained proteins of different molecular weights (23, 27 and 28 kDa).17 
Among the ten ferrets with hyperadrenocorticism, there were two with a pituitary 
tumor, which are the first ever described in ferrets. This is in contrast to the situation in 
humans, dogs and cats, in which there is general agreement that pituitary-dependent 
hyperadrenocorticism is secondary to a tumor originating from corticotropes or 
melanotrophs.5,9,24,28 The present pituitary tumors were immunonegative for all hormones 
tested. 
The classification of pituitary tumors in man is based on morphology, 
immunohistochemistry, and ultrastructure.14 Generally, tumors can be stained with an 
antibody raised against the hormone produced, i.e., the hormone of the cell of origin, the 
exception being the gonadotrope adenomas, which stain poorly or not at all for their 
respective hormones. These adenomas are usually chromophobic, have poorly developed 
cytoplasm, and are PAS negative.13 The pituitary tumors described in this study meet this 
description and can be categorized as gonadotrope adenomas. In vitro studies have revealed 
that gonadotrope adenomas may secrete gonadotropic hormones or their alpha-subunits.1 In 
the ferrets of this study, tumor development may have been initiated by the lack of negative 
gonadal feedback on hypothalamic GnRH as a result of neutering. This is in line with the 
hypothesis that persistent stimulation of the adrenal cortices by gonadotropic hormones 
plays a role in the pathogenesis of hyperadrenocorticism in ferrets.34 Persistent stimulation 
may lead to adrenocortical hyperplasia and finally to autonomous hypersecretion due to 
tumor formation. The negative feedback action of adrenal androgens, produced by an 
autonomously hyperfunctioning adrenal tumor, might explain why at the time of necropsy 
very few LH- and FSH-positive cells were found in the non-tumorous part of the 
adenohypophysis in one of these ferrets. 
Pituitary adenomas have been found at autopsy in approximately 11% (1.5 to 26.7%) 
of human beings not suspected of having pituitary disease while alive.22 In the cases in 
which immunohistochemistry was performed for prolactin, approximately 40% of these 
tumors stained positively. No information was given on the immunohistochemistry of other 
hormones. The large number of pituitary tumors found in seemingly healthy humans 
suggests an alternative explanation for our findings, namely, that the pituitary adenomas 
found in the two ferrets reported here were not related to the adrenal disease and was an 
incidental finding. 
In conclusion, our observations suggest that hyperadrenocorticism in ferrets is unlikely 
to be the result of persistent stimulation of the adrenal cortex as a result of a pituitary 
lesion. Instead, the decreased numbers of corticotropes and gonadotropes in the 
adenohypophysis seem to be a consequence, rather than a cause, of the adrenocortical 
hyperplasia and tumors. The non-staining pituitary adenomas found in two of the ten ferrets 
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with hyperadrenocorticism may be related to the disease, but may also be incidental 
findings unrelated to hyperadrenocorticism. 
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Summary 
 
Objective – To determine prevalence of hyperadrenocorticism in ferrets in The Netherlands 
and evaluate age, sex, and age at neutering in affected ferrets. 
Design – Prevalence survey and retrospective study. 
Animals – 50 ferrets with hyperadrenocorticism and 1,267 ferrets without 
hyperadrenocorticism. 
Procedure – A questionnaire was sent to 1,400 members of a ferret-owners organization in 
The Netherlands; 492 (35%) owners returned the questionnaire, providing usable 
data on 1,274 ferrets. Seven of these ferrets developed hyperadrenocorticism 
during the survey period; medical records for these ferrets and 43 ferrets with 
confirmed hyperadrenocorticism were reviewed. Hyperadrenocorticism was 
confirmed by histologic examination of an excised adrenal gland (92% of ferrets) 
or clinical improvement after excision. 
Results – Prevalence of hyperadrenocorticism in the survey population was 0.55%. Sex 
was not associated with prevalence of disease. Median time interval between 
neutering and diagnosis of hyperadrenocorticism was 3.5 years. A significant 
linear correlation between age at neutering and age at time of diagnosis was 
detected. 
Conclusions and Clinical Relevance – Age at neutering may be associated with age at 
development of hyperadrenocorticism in ferrets. 
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Introduction 
 
Hyperadrenocorticism is a common disease in pet ferrets.3,6,7,8,10 A review of this 
disease has been published; 6 to our knowledge, reports have been based on observations 
made in the United States, where it is common practice to neuter ferrets at 6 weeks of age.8 
Because hyperadrenocorticism is most often detected in neutered ferrets, it has been 
suggested that early neutering may contribute to the high prevalence of 
hyperadrenocorticism in ferrets.3,8 This theory is based on results of studies in certain 
strains of mice that develop nodular adrenocortical hyperplasia or adrenocortical tumors in 
1 or both adrenal glands after neutering at an early age.2,4,9 
Because many ferrets in the United States are neutered at an early age 8 and the 
population of sexually intact ferrets is relatively small, it is difficult to draw conclusions 
regarding a relation between hyperadrenocorticism and neutering at an early age. The 
objective of the study reported here was to determine the prevalence of 
hyperadrenocorticism in the Dutch ferret population, in which neutering at early age is not a 
common practice, and to determine influence of age, sex, and age at neutering for affected 
ferrets by review of medical records. 
 
 
Materials and Methods 
 
Owner survey 
A short questionnaire was sent to 1,400 members of a Dutch ferret foundation 
(Stichting “De Fret”) during April, May, and June 1997; the questionnaire solicited 
information on ferrets regarding age, sex, age at time of neutering, and whether members 
had ever owned a ferret with hyperadrenocorticism or presently owned a ferret with typical 
signs of hyperadrenocorticism, such as symmetric alopecia, swollen vulva (spayed females 
only), pruritus, and return of sexual behavior. 
 
Retrospective study  
Medical records of 50 ferrets with hyperadrenocorticism diagnosed at the Utrecht 
University Clinic for Companion Animals and several private veterinary practices in the 
Netherlands between January 1993 and September 1997 were reviewed; 7 of these ferrets 
were identified by results of the survey. Data regarding gross and microscopic pathologic 
findings, sex, age at neutering, age at time of diagnosis, and interval between neutering and 
time of diagnosis were recorded. 
 
Statistical analyses 
The Pearson coefficient of linear correlation was calculated to determine the 
relationship between age at neutering and age at diagnosis. Differences between groups 
were tested by use of χ2 analysis or Student’s t test. Prevalence of hyperadrenocorticism 
(percentage, confidence interval [CI]) in the survey population was calculated.11 
Differences were considered significant at P < 0.05. 
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Figure 1. Age at neutering and age at diagnosis of hyperadrenocorticism in 50 ferrets. 
 
 
Results 
 
Owner survey 
Of the 1,400 questionnaires sent, 492 (35%) were returned and provided data on 1,405 
ferrets (782 male, 623 female) that had never had a diagnosis of hyperadrenocorticism. 
Data on age or age at neutering were lacking for 131 ferrets (88 male, 43 female); thus, data 
on 1,274 ferrets (694 male, 580 female) were used for analysis. Median age of this 
population was 3 years (mean ± SD, 3.2 ± 1.7 years; range, 0.5 to 10 years). Median age of 
neutered ferrets was 3 years  (mean, 3.4 ± 1.7 years; range, 0.5 to 10 years). Most ferrets 
(91% of males, 82% of females) had been neutered between 0.5 and 1.5 years old; median 
age at time of neutering was 1 year (mean, 0.98 ± 0.65 years; range, 0.5 to 6 years). In 108 
ferrets, neutering had been performed after 1.5 years of age. Eighty-seven ferrets (25 male, 
62 female) had not been neutered. Of these, 27 ferrets (11 male, 16 female) were > 1.5 
years old. Median age of sexually intact ferrets was 1 year (mean, 1.6 ± 1.3 years; range, 
0.5 to 6 years). Within the total survey population of 1,274 ferrets, 7 cases of 
hyperadrenocorticism were confirmed during the survey period by histologic examination 
of adrenal glands after adrenalectomy. Seven suspected cases of hyperadrenocorticism were 
also identified, but the owners did not allow further studies. Thus, prevalence of confirmed 
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cases of hyperadrenocorticism in the survey population was 0.55% (95% confidence 
interval, 0.2 to 1.1%). 
 
 
 
 
Figure 2. Interval between age at neutering and age at diagnosis of hyperadrenocorticism in 50 
ferrets. 
 
Retrospective study  
For 46 of 50 ferrets with hyperadrenocorticism, the diagnosis was confirmed by 
histologic examination of surgical specimens obtained during unilateral adrenalectomy. 
Histologic diagnoses included intra- and extra-capsular hyperplasia, adenoma, and 
adenocarcinoma; distinctions between these differential diagnoses were difficult to 
determine, because adrenal tumors in ferrets seldom metastasize and microscopic 
characteristics overlap. For 4 ferrets, diagnosis was made on the basis of macroscopic 
appearance of adrenal glands and clinical improvement after adrenalectomy. All 50 ferrets 
(33 male, 17 female) with hyperadrenocorticism had been neutered. A significant difference 
in frequency distribution of sex between ferrets with hyperadrenocorticism and ferrets 
without hyperadrenocorticism was not detected. Median age at time of neutering was 1 year 
(mean, 1.4 ± 1.2 years; range, 0.5 to 6 years; Fig 1). Median age at diagnosis of 
hyperadrenocorticism was 5 years (mean, 5.1 ± 1.9 years; range, 1 to 10 years; Fig 1). 
Median interval between neutering and diagnosis of hyperadrenocorticism was 3.5 years  
(mean, 3.5 ± 1.8 years; range, 0.5 to 8 years; Fig 2). A significant linear correlation was 
found between age at neutering and age at diagnosis (Fig 3). Data on plasma estradiol and 
androgen concentrations were not available. 
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Figure 3. Scatterplot of age at neutering and age at diagnosis of hyperadrenocorticism in 50 ferrets 
(y= – 0.064 + 0.285x; r = 0.437; P < 0.01) 
 
 
Discussion 
 
To our knowledge, this is the first report of the prevalence of hyperadrenocorticism in 
ferrets. Weiss and Scott 10 reported that 20 to 25% of ferrets examined in their practice had 
hyperadrenocorticism, but this may not be a reliable indication of prevalence because it was 
based on a selected population. In our study of a Dutch ferret population, prevalence was 
estimated to be 0.55% (95% CI, 0.2 to 1.1%); 7 other ferrets were reported with typical 
clinical signs, but owners refused further diagnostic efforts. The fact that ferrets with 
hyperadrenocorticism seldom have increased plasma cortisol concentrations 7 prevents 
useful comparisons between hyperadrenocorticism in ferrets and hyperadrenocorticism in 
dogs, cats, or humans. Nevertheless, a prevalence of 0.55% must be considered high. 
A significant correlation was found between age at neutering and age at diagnosis, 
suggesting that age at neutering may influence age of onset of this condition; however, the 
disease has also been reported in 7 sexually intact ferrets.7,8,10 Many more cases in sexually 
intact ferrets may have gone unnoticed, because sexual behavior – a common clinical sign 
of the disease – may not be regarded as abnormal in a sexually intact ferret, whereas it is 
considered abnormal in a neutered ferret and may cause the owner to seek veterinary 
assistance. 
Results reported from some institutions indicate almost twice as many female as male 
ferrets with adrenal tumors, but selection bias, rather than actual difference in prevalence, 
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was given as a possible explanation.6 In the population described by Weiss and Scott,10 the 
distribution between sexes was equal. Although two-thirds of the ferrets with 
hyperadrenocorticism in the study reported here were male, differences in the proportions 
of males and females among ferrets with and without hyperadrenocorticism were not 
significant; sex did not affect prevalence of the disease. 
In our study, mean age of ferrets with hyperadrenocorticism was 5.1 ± 1.9 years; 
significantly older than affected ferrets (mean age, 3.4 ± 1.4 years; n = 50) reported by 
Rosenthal et al.8 In the Netherlands, ferrets are neutered at 0.98 ± 0.65 years of age; 
American ferrets are commonly neutered at 4 to 6 weeks of age.8 The interval between age 
at neutering and age at diagnosis in the Dutch ferret population (3.5 ± 1.8 years) was, 
however, similar to that in the population studied by Rosenthal et al. (3.3 ± 1.4 years),8 
assuming that those ferrets were neutered at 6 weeks of age. Although a significant 
correlation between age at neutering and age at development of hyperadrenocorticism is 
apparent, an explanation for this relationship has yet to be found. It has been speculated 
that, after neutering, the adrenal cortices are persistently stimulated by luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH) as a result of the loss of negative gonadal 
feedback on hypothalamic gonadotropin releasing hormone (GnRH), and this results in 
adrenocortical hyperplasia or tumorigenesis 3,8; Donovan and ter Haar 1 detected increased 
plasma concentrations of LH and FSH in spayed female ferrets. Luteinizing hormone 
receptors have been found in the adrenal glands of humans,5 suggesting that increased LH 
concentrations in plasma could be a triggering factor for development of adrenal tumors. 
The successful use of the GnRH agonist leuprolide for medical control of 
hyperadrenocorticism strengthens the hypothesis that neutering plays a role in the 
development of hyperadrenocorticism in ferrets (Johnson-Delaney CA, personal 
communication, 1999).
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Summary 
 
Four studies were performed to test the hypothesis that gonadotropic hormones, and 
particularly luteinizing hormone (LH), play a role in the pathogenesis of 
hyperadrenocorticism in ferrets: (I) adrenal glands of ferrets with hyperadrenocorticism 
were studied immunohistochemically to detect LH receptors; (II) gonadotropin-releasing 
hormone (GnRH) stimulation tests were performed in 10 neutered ferrets, with 
measurement of androstenedione, 17α-hydroxyprogesterone and cortisol as endpoints; (III) 
GnRH stimulation tests were performed in 15 ferrets of which 8 had hyperadrenocorticism, 
via puncture of the vena cava under anesthesia; and (IV) urinary corticoid/creatinine ratios 
were measured at 2-week intervals for 1 year in the same ferrets as used in study II. 
Clear cells in hyperplastic or neoplastic adrenal glands of hyperadrenocorticoid ferrets 
stained positive with the LH receptor antibody. Plasma androstenedione and 17α-
hydroxyprogesterone concentrations increased after stimulation with GnRH in 7 out of 8 
hyperadrenocorticoid ferrets but in only 1 out of 7 healthy ferrets. Hyperadrenocorticoid 
ferrets had elevated urinary C/C ratios during the breeding season. 
The observations support the hypothesis that gonadotropic hormones play a role in the 
pathogenesis of hyperadrenocorticism in ferrets. This condition may be defined as a disease 
resulting from the expression of LH receptors on sex steroid-producing adrenocortical cells. 
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Introduction 
 
The most prominent, and initially seasonal, symptoms of hyperadrenocorticism in 
ferrets are symmetrical alopecia (Fig. 1), vulvar swelling in neutered jills, and recurrence of 
sexual behavior in neutered males.15 There is no sex predilection.18 The diagnosis is based 
upon increased plasma concentrations of androstenedione, 17α-hydroxyprogesterone, 
dehydroepiandrosterone sulfate, and/or estradiol. In contrast plasma concentrations of 
cortisol are increased in a minority of cases.16 Measurement of urinary corticoid/creatinine 
ratios 4 and ultrasonography of the adrenals 15 may contribute to the diagnosis. In 
approximately 85% of ferrets with hyperadrenocorticism only one adrenal gland is 
enlarged, without atrophy of the contralateral adrenal gland, and in the remaining 15% there 
is bilateral involvement.17,24 After unilateral adrenalectomy there may be recurrence of the 
disease due to enlargement of the contralateral adrenal gland.24 The histologic changes of 
the adrenals range from (nodular) hyperplasia to adenoma and adenocarcinoma.17,24 
 
 
Figure 1. Symmetrical alopecia in a ferret with hyperadrenocorticism 
 
These characteristics of hyperadrenocorticism in ferrets resemble those seen in some 
strains of mice in which nodular adrenocortical hyperplasia and adrenocortical tumors 
occur after neutering at an early age.3,11,19 In recent years, independent observations have 
provided suggestive evidence that castration is an important risk factor in the development 
of hyperadrenocorticism in ferrets. First, in the USA and in The Netherlands 
hyperadrenocorticism is a common disease in ferrets,15,18 whereas in the United Kingdom 
the condition is seldom diagnosed. This difference in incidence may be ascribed to the fact 
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that ferrets are usually not neutered in the United Kingdom,10 whereas this is common 
practice in the USA and in the Netherlands. Second, a significant correlation has been 
found between the age at neutering and age at onset of hyperadrenocorticism in ferrets.18 
The observation that initially signs of hyperadrenocorticism occur only during the breeding 
season,15 when plasma concentrations of gonadotropic hormones are high,6 and the recently 
reported beneficial effects of treatment with leuprolide acetate 23 have led to the hypothesis 
that hyperadrenocorticism in ferrets is mediated by gonadotropic influences, for which 
castration may play a precipitating role.9,17,18 
To test this hypothesis four studies were performed: (I) adrenal glands of ferrets with 
hyperadrenocorticism were studied immunohistochemically to detect luteinizing hormone 
receptors (LH-R); (II) a gonadotropin-releasing hormone (GnRH) stimulation test was 
performed in neutered ferrets via implanted venous catheters; (III) a GnRH stimulation test 
was performed in neutered ferrets via puncture of the vena cava under anesthesia; and (IV) 
urinary corticoid/creatinine (C/C) ratios were measured at 2-week intervals for 1 year in the 
ferrets of study II to investigate possible seasonal fluctuations. 
 
 
Materials and Methods 
 
(I) Immunohistochemical staining for the presence of LH receptors 
Tissues 
Adrenal glands of 6 neutered ferrets with signs of hyperadrenocorticism, and 
histologically diagnosed hyperplasia or adenoma, were examined for the presence of LH 
receptors. The adrenal glands were obtained during surgery. In all cases the contralateral 
adrenal gland appeared to be unaffected. Signs of hyperadrenocorticism disappeared after 
surgery in all cases. Two histologically normal adrenal glands of 2 intact ferrets without 
signs of hyperadrenocorticism were also examined for the presence of LH receptors. 
Ovaries and testes of healthy 6 to 9-month-old ferrets were used as positive controls. 
 
Antibody and immunohistochemical staining 
The murine LH-R monoclonal antibody (P1B4) was a gift from Dr. Wimalasena (Dept. 
Obstetrics and Gynecology, University of Tennessee, Knoxville, TN). The antibody had 
been raised against purified rat LH receptors, as described by Indrapichate et al..5 The 
antibody binds specifically to LH receptors in various tissues of different species.1,13 
All tissues were fixed in 4% buffered formalin. After at least 24 h of fixation the 
tissues were embedded in paraffin and cut into 4-µm sections. One section was routinely 
stained with hematoxylin and eosin. For immunohistochemical staining, sections were 
deparaffinized and endogenous peroxidase was blocked with 1% H2O2 in methanol for 30 
min. The slides were washed in 0.01 M Tris-buffered saline (TBS, pH 7.4), incubated with 
0.75% glycine in TBS for 30 min, and rinsed with TBS. The sections were blocked with 
10% normal goat serum in TBS for 30 min, and then incubated overnight at 4 °C with the 
LH-R P1B4 monoclonal antibody at a 1:5000 dilution in TBS to which 0.05% acetylated 
BSA (BSA-c) was added (Aurion, Wageningen, The Netherlands). The next day the slides 
were rinsed with TBS and incubated for 60 min with a biotinylated goat-anti-mouse 
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antibody (Vector Laboratories, Burlingame, CA) [1:200 dilution in TBS with 0.05% BSA-
c] at room temperature. Again, the slides were rinsed in TBS and subsequently incubated 
with the avidin (A) biotin (B) complex of the ABC staining kit (Vector Laboratories) for 60 
min in a dilution of 1:1500 in TBS with 0.05% BSA-c. The ABC solution was prepared at 
least 15 min prior to use, to allow complex formation. Slides were rinsed again in TBS 
followed by Tris-HCl (0.05M, pH 7.6). Bound antibody was visualized using a 0.6 mg/ml 
solution of 3,3' - Diaminobenzidine tetrachloride (DAB, Sigma Chemical Co., St. Louis, 
MO) in Tris-HCl, to which 0.03% H2O2 was added. Sections were incubated with the DAB 
solution for approximately 50 sec and counterstained with Mayer’s hematoxylin. 
In control experiments the primary antibody was replaced by normal mouse serum. 
 
(II) GnRH stimulation test in catheterized ferrets 
Animals 
For this study, which was approved by the Ethics Committee of the Faculty of 
Veterinary Medicine, Utrecht University, 5 male and 5 female healthy ferrets were used in 
July and August 1999. All but one ferret were 2 years of age and had been gonadectomized 
at 6 weeks of age. One ferret, a 1-year-old male, had been gonadectomized at 9 months of 
age. The ferrets were either purchased at 6 weeks of age from a breeder or born and raised 
at the Department of Clinical Sciences of Companion Animals. The ferrets were 
individually housed in outdoor suspended cages with a night box. Both water and ferret 
pellets (FerRet, Hope Farms, Woerden, The Netherlands) were available ad libitum.  
Unexpectedly, in two ferrets elevated basal plasma androstenedione and 17α-
hydroxyprogesterone concentrations, as well as unilaterally enlarged adrenal glands 
visualized on ultrasonographic examination, indicated the presence of 
hyperadrenocorticism. 
 
Catheterization 
A jugular catheter was placed under isoflurane anesthesia in all ferrets. The catheters 
were tunneled subcutaneously to the base of the scull and connected to a 20-gauge cannula 
with an injection port (Vasofix® Braunüle®, Braun, Melsungen, Germany). The injection 
port was attached to the skin with polyglactin 910 (Vicryl®, Ethicon, Norderstedt, 
Germany) 2-0 USP sutures. The catheters (Silastic® Medical Grade Tubing [602-155], 
Down Corning Co. Midland, Michigan, U.S.A) had an inner diameter of 0.025 inch (0.64 
mm) and an outer diameter of 0.047 inch (1.19 mm). The catheter was filled with a 
polyvinyl pyrrolidone (PVP) and heparin mixture (60 g PVP / 54 ml 0.9% NaCl + 6 ml 
heparin [5,000 IU/ml]) to keep it patent. 
 
Sampling 
Blood samples were collected 2 days after placement of the jugular catheter at –5, 0, 
30, 60, 90, 120, 240, and 480 min after intravenous injection of 10 µg of a synthetic GnRH 
analogue (Fertagyl®, Intervet Nederland B.V., Boxmeer, The Netherlands), placed in pre-
chilled EDTA-coated tubes and centrifuged. Plasma was divided into two portions and 
stored at – 20 ºC pending analysis. After the collection of each blood sample the catheter 
was flushed with 0.3 ml heparin solution (50 IU/ml). 
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(III) GnRH stimulation test with blood collection under anesthesia 
We used a modified GnRH stimulation test for privately owned ferrets thought to have 
hyperadrenocorticism. Blood samples were collected under isoflurane anesthesia by 
puncture of the cranial vena cava, immediately before and 30 min after intravenous 
injection of 10 µg Fertagyl®. In between blood collections the ferrets were allowed to 
recover from anesthesia, which usually occurred within 5 minutes. Blood samples were 
placed in pre-chilled EDTA-coated tubes and centrifuged. Plasma was stored at – 20 ºC 
pending analysis. 
 
Animals 
GnRH stimulation tests with blood collection under isoflurane anesthesia were 
performed in 9 of the gonadectomized ferrets of study II (5 male and 4 female), including 
the 2 ferrets with hyperadrenocorticism, and in 6 privately owned neutered ferrets (4 male 
and 2 female; 3 – 7 years of age) with hyperadrenocorticism. The diagnosis of 
hyperadrenocorticism in the latter cases was based upon history, physical changes, and 
ultrasonographic examination of the adrenal glands. In the privately owned ferrets only 
plasma concentrations of androstenedione were measured because blood was needed for 
routine laboratory tests and the animals had to undergo surgery.  
 
Reference plasma concentrations of androstenedione and 17α-hydroxyprogesterone 
For the determination of reference values for basal plasma concentrations of 
androstenedione and 17α-hydroxyprogesterone, blood was collected between March 15 and 
September 29, 2000, from 18 healthy, privately owned ferrets, and 14 healthy ferrets kept 
under laboratory conditions. All ferrets (20 female and 12 male) had been neutered and 
were between 1.5 and 8 years old (median 3 years). 
 
Hormone determinations 
Androstenedione concentrations were measured by radioimmunoassay (RIA) as 
described previously.22  The lower limit of detection was 0.1 nmol/l and the interassay 
coefficients of variation were 10.5%, 9.3%, and 11.6% at 1.43, 4.82, and 11.76 nmol/l, 
respectively. Steroids cross-reacted in this assay as follows: 0.4 % for testosterone, 0.3 % 
for dihydrotestosterone, 3.6 % for 11β-OH-androstenedione, 2.2 % for adrenosterone (11-
keto-androstenedione), 5.5 % for 5α-andostanedione, and 2.2 % for 5β-andostanedione. 
17α-Hydroxyprogesterone concentrations were measured after toluene extraction using 
a competitive RIA and a polyclonal anti-17α-hydroxyprogesterone-antibody (UCB i903, 
UCB Bioproducts, Brussels, Belgium). 17α-Hydroxy[1,2,6,7-3H]-progesterone (TRK 611, 
Amersham Pharmacia Biotech Benelux, Roosendaal, The Netherlands) was used as a tracer 
after chromatographic purification. The lower limit of detection was 0.2 nmol/l and 
interassay coefficients of variation were 9.0%, 7.4%, and 9.9% at 0.89, 5.13, and 26.02 
nmol/l, respectively. Steroids cross-reacted in this assay as follows: 0.4 % for progesterone, 
0.3 % for pregnenolone and 20 % for 17α-OH-pregnenolone. 
Cortisol concentrations were measured by RIA (Coat-A-Count® Cortisol, Diagnostic 
Products Corporation, Los Angeles, USA). The lower limit of detection was 1 nmol/l and 
the interassay coefficient of variation was between 4.0% and 6.4%. 
Chapter 8 
 
 
 100
(IV) Serial measurements of urinary corticoid/creatinine (C/C) ratios 
Animals 
One year after the GnRH stimulation test, 9 of the gonadectomized ferrets of study II 
(5 male and 4 female), including the 2 ferrets with hyperadrenocorticism, were used to 
monitor the urinary C/C ratios for 1 year. One of the ferrets with hyperadrenocorticism died 
7 months after the last urine sample was collected. On postmortem examination a large 
(metastasized) adrenocortical tumor was found. 
 
Sampling 
Propylene litter boxes with Macrolon plates were placed underneath the cages for 
collection of overnight urine samples at 2-week intervals for a period of 1 year. A 2-mm 
space between the plate and the wall of the litter box allowed urine to drain away from the 
feces.12 The litter boxes were underneath the cages from 17:00 – 8:00 hours. Urine was 
transferred to tubes and stored at 4 ºC pending analysis, which was performed within 5 days 
after collection of the sample. 
 
Hormone determination 
Urinary corticoid concentrations were measured by RIA for cortisol as described 
previously.14 The cortisol antiserum was raised in rabbits against a cortisol-21-
hemisuccinate-bovine serum albumin conjugate. This antiserum is known to cross-react 
with other endogenous corticosteroids such as 21-deoxycortisol (62%), corticosterone 
(11%), cortisone (2%), 11-deoxycortisol (1.3%), deoxycorticosterone (1.3%), and 17α-
hydroxyprogesterone (0.1%).21 The urinary corticoid concentration was related to the 
urinary creatinine concentration (Jaffé kinetic method, initial rate reaction) by calculation 
of its quotient (x 10-6).20 
 
Statistics 
The increase in plasma androstenedione concentrations in the GnRH stimulation test in 
the two hyperadrenocorticoid ferrets was compared with the (mean + 2sd) increase in 
plasma androstenedione concentrations in the 8 ferrets with normal basal plasma 
androstenedione concentrations (study II). Significance at P<0.025 was assumed when the 
increase in plasma androstenedione concentrations in one of the hyperadrenocorticoid 
ferrets was higher than the mean increase + 2sd in the 8 other ferrets. 
The reference values for plasma androstenedione and 17α-hydroxyprogesterone 
concentrations were established in percentiles.2 The inner limits of the percentiles P2.5 and 
P97.5 are presented with a probability of 95%. 
Student’s t-test was used to compare the mean corticoid/creatinine ratio of the 2 ferrets 
with hyperadrenocorticism with the mean ratio for the 7 healthy ferrets during both the 
breeding and the non-breeding season. Statistical significance was assumed at P < 0.05. 
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Results 
 
(I) Immunohistochemical staining for the presence of LH receptors 
Thecal cells in the ovaries and Leydig cells in the testes of healthy control animals 
stained positively with the LH-R antibody. In the adrenal glands of the healthy ferrets there 
was positive staining for LH-R in the zona glomerulosa and a slightly less clear staining in 
the zona fasciculata (not shown). 
The adrenal glands of ferrets with hyperadrenocorticism had a heterogeneous 
appearance on histology. Cells were either small with pyknotic nuclei or large with a clear 
cytoplasm. The latter cells are referred to as clear cells. Spindle-shaped cells were also 
observed in the adenomas. Cells staining positive for the LH receptor were seen in the 
hyperplastic and neoplastic adrenal glands of the ferrets with hyperadrenocorticism. These 
cells were mostly clear cells (Color section; Fig. 6). 
 
(II) GnRH stimulation test in catheterized ferrets 
No significant response was seen after the administration of GnRH to the 8 healthy 
ferrets. In the 2 ferrets with hyperadrenocorticism basal plasma concentrations of 
androstenedione (1.5 and 3.8 nmol/l) and 17α-hydroxyprogesterone (1.7 and 1.9 nmol/l) 
were significantly higher than those of the healthy ferrets. Moreover, the plasma 
concentrations of these hormones rose significantly (P<0.025) 30 min after GnRH 
administration, and returned to basal concentrations within 60 – 90 min. In all ferrets, 
including the ferrets with hyperadrenocorticism, plasma cortisol concentrations did not 
change significantly after GnRH stimulation (Fig. 2). 
 
(III) GnRH stimulation test with blood collection under anesthesia  
Reference plasma concentrations 
Basal plasma androstenedione concentrations in 32 healthy neutered ferrets ranged 
from 0.1 to 0.5 nmol/l (median 0.2 nmol/l; P2.5 - P97.5: 0.1 – 0.4 nmol/l). Basal plasma 17α-
hydroxyprogesterone concentrations in the same ferrets ranged from 0.3 to 1.2 nmol/l 
(median 0.4 nmol/l; P2.5 - P97.5: 0.3 – 0.7 nmol/l). 
 
Ferrets used in study II 
Basal plasma androstenedione and 17α-hydroxyprogesterone concentrations of the two 
ferrets with hyperadrenocorticism (number 4 and 7) were higher than the respective 
reference range. Concentrations of these hormones were significantly higher at 30 min after 
stimulation with GnRH. In the other 7 ferrets, basal plasma androstenedione and 17α-
hydroxyprogesterone concentrations were all within the reference range (Table 1). The 
plasma androstenedione concentration was unchanged 30 min after stimulation with GnRH 
in 3 of the ferrets; it increased slightly, but remained within the reference range in 3 ferrets; 
and in 1 ferret it rose above the reference range (Table 1). The plasma 17α-
hydroxyprogesterone concentration remained unchanged 30 min after stimulation with 
GnRH in 4 ferrets; it increased slightly, but remained within the reference range, in 1 ferret; 
and it rose above the reference range in 2 ferrets (Table 1). 
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Figure 2. Mean (± sd) plasma concentrations of androstenedione (A), 17α-hydroxyprogesterone (B), 
and cortisol (C) before and after stimulation with 10 µg Fertagyl® (GnRH analogue) in 8 
healthy neutered ferrets (z) and in 2 neutered ferrets (, x) with hyperadrenocorticism. 
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Table 1. Plasma concentrations of androstenedione and 17α-hydroxyprogesterone (nmol/l) in 9 
ferrets used in study II (1 – 9) and 6 privately owned ferrets with hyperadrenocorticism  
(C1 – C6) before and 30 min after and intravenous injection with 10 µg Fertagyl® (GnRH 
analogue). Blood samples were collected under isoflurane anesthesia. The same 2 ferrets 
which responded to GnRH stimulation when catheterized (number 4 and 7) responded in 
this modified stimulation test. 
 
androstenedione 17 OH prog Ferret 
number t = 0 t = 30 t = 0 t = 30 
1 0.2 0.2 0.4 0.4 
2 0.2 0.3 0.4 0.3 
3 0.2 0.2 0.4 0.4 
4 8.5 13.8 5.1 10.5 
5 0.2 0.2 0.4 0.4 
6 0.3 0.4 0.4 0.5 
7 4.2 16.9 7.5 35.0 
8 0.3 0.4 0.5 0.8 
9 0.4 1.3 0.6 1.0 
C1 0.1 1.3   
C2 0.3 0.4   
C3 11.7 33.3   
C4 0.7 5.4   
C5 0.3 0.6   
C6 0.5 0.7   
 
Privately owned ferrets 
In 3 of the 6 privately owned hyperadrenocorticoid ferrets, basal plasma concentrations 
of androstenedione were within the reference range. The plasma androstenedione 
concentration was within the reference range 30 min after stimulation with GnRH in 1 
ferret; it was higher than the reference range in 2 ferrets (Table 1); and it was higher than 
the reference range at baseline and increased further after stimulation with GnRH in 3 
ferrets (Table 1). 
 
(IV) Serial measurements of urinary corticoid/creatinine ratios  
During the breeding season (March to August) and the non-breeding season 
(September to February), the urinary corticoid/creatinine (C/C) ratio was measured on 12 
occasions (Fig. 3). During the breeding season the mean (± sd) C/C ratio of the 2 ferrets 
with hyperadrenocorticism (both 3.5 ± 1.1 x 10-6) was significantly higher than that of the 
neutered control animals (1.4 ± 0.5 x 10-6); however, during the non-breeding season the 
mean C/C ratio of only one ferret was significantly higher (3.0 ± 1.3 x 10-6 and 1.8 ± 0.3 x 
10-6 versus 1.8 ± 0.7 x 10-6 in the healthy control animals). The urinary C/C ratio of the 
latter ferret decreased at the end of October, after which the mean C/C ratio was no longer 
significantly higher than that of other animals (2.5 ± 1.1 x 10-6 versus 1.9 ± 0.7 x 10-6). 
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Figure 3. The mean (± sd) urinary corticoid/creatinine (C/C) ratio (x 10-6) of 7 healthy neutered 
control ferrets (z) and the urinary C/C ratios of 2 neutered ferrets (, x) with 
hyperadrenocorticism.  
During the breeding season (March to August) the mean C/C ratio in both ferrets with 
hyperadrenocorticism was significantly higher than the mean C/C ratio in the 7 control 
ferrets (P<0.025) 
 
 
Discussion 
 
The detection of LH receptors in hyperplastic and/or neoplastic adrenal glands of 
ferrets with hyperadrenocorticism supports the hypothesis that LH plays a role in the 
pathogenesis of hyperadrenocorticism in these animals, and that this hormone is involved in 
the production of androstenedione and 17α-hydroxyprogesterone. The adrenal cortices of 
young intact healthy ferrets also stained positively for LH-R proteins. Since the LH-R 
antibody used in this study reacts with both intact LH-R protein and LH-R protein 
fragments,5 it cannot be excluded that the immunohistochemical reactivity was due to 
staining of LH-R fragments, i.e. truncated forms of the receptor that are not functional. To 
investigate the functionality of this receptor, GnRH or LH stimulation tests should be 
performed either in vivo or in tissue culture. 
Human chorionic gonadotropin (hCG) has been used for stimulation tests in women 
with endocrine tumors. In a woman with a virilizing adrenal adenoma testosterone levels 
increased after hCG,8 and in a woman with LH-dependent Cushing’s syndrome plasma 
cortisol levels increased after hCG.7 However, we used GnRH as stimulating hormone, 
because it is not known which gonadotropic hormone stimulates the adrenal cortex in 
ferrets. Only the two ferrets (study II) with high basal androgen levels responded to 
stimulation with GnRH. Plasma concentrations of androstenedione and 17α-
hydroxyprogesterone increased upon stimulation, whereas plasma cortisol concentrations 
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remained unchanged. The observation that the healthy ferrets did not have a response to 
GnRH stimulation indicates that the LH-R protein found in healthy ferrets is not functional.  
In the modified GnRH stimulation test, 5 of the 6 privately owned ferrets with 
hyperadrenocorticism responded to stimulation. The increase in plasma androstenedione 
concentrations cannot be ascribed to isoflurane anesthesia because the increase in 
androstenedione concentrations did not occur in the healthy ferrets. The non-elevated basal 
androstenedione concentrations in 3 diseased ferrets were in accordance with the findings 
of Rosenthal and Peterson,16 who observed that basal plasma androstenedione 
concentrations are not increased in approximately 25% of ferrets with 
hyperadrenocorticism. 
Based on our findings, it would appear that the neoplastic transformation of the adrenal 
cortex is associated with activation of pre-existent receptor protein. It is not clear whether 
this activation is a prerequisite for hyperplasia and/or neoplasia or a consequence of cell 
transformation. The positive correlation between disease incidence and time elapsed since 
castration 18 makes it tempting to speculate that a persistent elevation of plasma 
gonadotropin concentrations plays a crucial role in both receptor activation and cell 
multiplication. 
During the breeding season, the 2 ferrets with hyperadrenocorticism had a significantly 
higher C/C ratio than the other neutered ferrets. Earlier Gould et al. 4 had found that the C/C 
ratio in ferrets with hyperadrenocorticism was significantly higher than the C/C ratio in 
healthy ferrets. In the non-breeding season, when gonadotropic hormones are low,6 the 
urinary C/C ratio of the 2 control ferrets with hyperadrenocorticism was no longer elevated. 
This finding further supports the hypothesis that hyperadrenocorticism in ferrets arises 
under the influence of gonadotropic hormones. 
The use of the urinary C/C ratio as tool to aid the diagnosis of hyperadrenocorticism in 
ferrets has been questioned by Rosenthal,15 because cortisol is not considered to play an 
important role in the development of the signs and symptoms of hyperadrenocorticism in 
ferrets.16 The 2 ferrets with hyperadrenocorticism in study II also did not have increased 
plasma cortisol concentrations, whereas the C/C ratio was increased. This may be because 
the cortisol assay measures other steroids in urine because the antibody used cross-reacts 
with other steroid hormones.21 Although it is uncertain whether the increased C/C ratio was 
due to an increased secretion of cortisol, we found that urinary steroid hormone excretion is 
increased during the breeding season in ferrets with hyperadrenocorticism, an increase 
which coincides with the reported increase in plasma LH concentrations.6 
LH-dependent Cushing’s syndrome and LH-dependent adrenal androgen secreting 
tumors have been described in humans.7,8 Patients with LH-dependent Cushing’s syndrome 
have bilateral macronodular adrenal hyperplasia with high plasma concentrations of cortisol 
and suppressed concentrations of ACTH.7 Patients with LH-dependent adrenal androgen 
secreting tumors may have unilateral adrenal neoplasia and unaltered cortisol and ACTH 
concentrations.8 
The results of the present study support the hypothesis that gonadotropic hormones, 
and particularly LH, play a role in the pathogenesis of hyperadrenocorticism in ferrets. This 
disease is not a counterpart of LH-dependent Cushing’s disease in humans because GnRH 
does not elicit cortisol secretion in ferrets. There are similarities between 
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hyperadrenocorticism in ferrets and LH-dependent adrenal androgen-secreting tumors in 
humans, although the adrenal glands of diseased ferrets can also secrete estradiol.16 Thus at 
this stage hyperadrenocorticism in ferrets is without a clear counter part in humans, and 
may probably be best defined as a disease resulting from LH-R expression by sex steroid-
producing adrenocortical cells. 
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Summary 
 
Hyperadrenocorticism is a common disease in ferrets and is characterized by 
excessive production of sex steroids, which gives rise to vulvar swelling in neutered 
females, recurrence of sexual behavior in neutered males, and alopecia in both sexes. It is 
thought to be caused by increased gonadotropin secretion as a result of neutering. In this 
study the presence and function of gonadotropin receptors in the adrenal glands of healthy 
ferrets and ferrets with hyperadrenocorticism was investigated.  
The adrenal cortices of healthy ferrets stained positively with an antibody against the 
LH receptor (LH-R). Fifty-five hyperplastic and/or tumorous adrenal glands from 46 
hyperadrenocorticoid ferrets also stained for the LH-R, with the exception of two 
metastasized carcinomas. RT-PCR analysis of 6 adrenal adenomas revealed the expression 
of the genes for LH-R and FSH-R. 
Stimulation in vitro with ACTH and hCG of adrenal tissue from a healthy ferret led to 
significant increases in the concentrations of 17α-hydroxyprogesterone and cortisol in the 
culture medium, whereas the androstenedione concentration remained unchanged. FSH had 
no effect on steroid concentrations. In contrast, incubation of tumorous adrenocortical cells 
with hCG caused a sharp increase in androstenedione production in two of the three tumors 
investigated. FSH increased the production of 17α-hydroxyprogesterone and cortisol in the 
cells of one tumor, without having an effect on androstenedione release. 
In vivo the plasma concentrations of 17α-hydroxyprogesterone, cortisol, and 
androstenedione of healthy ferrets did not change after stimulation with either FSH or hCG. 
In one of the two hyperadrenocorticoid ferrets studied, hCG but not FSH, increased the 
plasma concentrations of 17α-hydroxyprogesterone, cortisol and androstenedione. Plasma 
concentrations of 17α-hydroxyprogesterone and androstenedione increased after GnRH 
administration in 10 of 12 ferrets with hyperadrenocorticism, with concomitant increases in 
the concentrations of LH in 11 ferrets and FSH in 8 ferrets. 
We conclude that, in healthy neutered ferrets, adrenocortical LH-Rs are not, or hardly, 
functional in vivo. In contrast, these receptors are functional in most neutered ferrets with 
hyperadrenocorticism. Although FSH-R mRNA is expressed in adrenal adenomas, FSH 
appears to have a less prominent pathogenetic role than LH. 
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Introduction 
 
Hyperadrenocorticism is a common disease in neutered pet ferrets (Mustela putorius 
furo). The syndrome differs from hyperadrenocorticism in other species, such as humans, 
dogs, cats, and horses, in that glucocorticoid excess is much less pronounced in ferrets.30 
Instead, in ferrets the disease is characterized by excessive production of sex steroids, 
giving rise to vulvar swelling in neutered female ferrets (jills), recurrence of sexual 
behavior in neutered male ferrets (hobs), and alopecia.19,29,30,31,34,46 In line with these 
physical and behavioral changes, plasma concentrations of androstenedione, 17α-
hydroxyprogesterone, dehydroepiandrosterone sulfate, and estradiol are often increased, 
whereas plasma cortisol concentrations only rarely exceed the upper limit of the reference 
range.30 In approximately 85% of ferrets with hyperadrenocorticism there is unilateral 
adrenocortical enlargement without atrophy of the contralateral adrenal gland, while in the 
other 15% of cases bilateral enlargement is seen.31,46 The disease may recur after unilateral 
adrenalectomy due to enlargement of the contralateral adrenal gland.46 The histological 
changes of the adrenals range from (nodular) hyperplasia to adenoma and 
adenocarcinoma.31  
There are several reasons to suggest a relationship between gonadotropic hormones 
and hyperadrenocorticism in ferrets. First, some symptoms of hyperadrenocorticism, such 
as alopecia and swelling of the vulva, initially occur only during the breeding season, when 
plasma concentrations of gonadotropic hormones are high.13 Melatonin, which is released 
from the pineal gland during the dark period of the day, suppresses the release of 
gonadotropin-releasing hormone (GnRH). With increasing daylight melatonin release 
decreases accordingly, and when daylight exceeds 12 hours, melatonin exposure is 
insufficient to suppress the release of GnRH, leading to the start of the breeding season.1 
Second, as in some strains of mice 8,21,38 in ferrets the age of neutering is related to the age 
at which hyperadrenocorticism develops.34 Thirdly, the similar plasma adrenocorticotropic 
hormone (ACTH) concentrations in ferrets with hyperadrenocorticism and in healthy ferrets 
makes it unlikely that the increased production of sex steroids is ACTH-dependent.33 
Fourthly, the depot GnRH agonist, leuprolide acetate, can be used successfully to treat 
ferrets with hyperadrenocorticism.45 Finally, luteinizing hormone receptors (LH-R) have 
been detected in the adrenal glands of ferrets with hyperadrenocorticism. These receptors 
were considered to be functional because plasma concentrations of adrenal androgens 
increased after intravenous injection of a GnRH agonist.35 These observations support the 
hypothesis that neutering leads to the persistent stimulation of the adrenal cortices, due to 
the loss of negative feedback, which may result in adrenocortical hyperplasia and tumor 
formation.34 Daylight periods exceeding 12 h seem to promote this phenomenon. 
The present study was designed to investigate the presence and functioning of LH and 
FSH receptors in healthy ferrets and in ferrets with hyperadrenocorticism by means of 
immunohistochemistry, RT-PCR, in vitro and in vivo stimulation tests. 
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Materials and Methods 
 
1. Immunohistochemical staining for LH receptors 
1.1 Tissues 
Ovaries and testes from healthy, 6- to 9-month-old ferrets were used as positive 
controls. Adrenocortical control tissue was obtained from six intact (4 male, 2 female), 6- 
to 15-month-old ferrets that had died of diseases unrelated to hyperadrenocorticism. 
Affected adrenal glands were obtained from 46 ferrets that had been presented with 
signs of hyperadrenocorticism. Most adrenal glands were obtained during adrenal surgery 
(n=31); the others were obtained post mortem (24 adrenal glands from 19 ferrets). From 
four ferrets, first an adrenal gland was obtained at surgery and later the contralateral adrenal 
gland was obtained post mortem. In total 55 affected adrenal glands were examined (39 left 
and 16 right). 
For histological examination, all tissues were fixed for at least 24 hours in 4% 
phosphate-buffered formalin and then embedded in paraffin. Four-micrometer sections 
were cut: one section was routinely stained with hematoxylin and eosin (H&E) and the 
others were used for immunohistochemistry. 
On the basis of the guidelines of Williams and co-workers, 48 the following criteria 
were used to categorize the adrenal cortices of diseased ferrets into hyperplasia, adenoma, 
or adenocarcinoma. Hyperplasia was defined as an increased tissue mass with maintenance 
of the normal cortical structure, with extra-capsular tissue or areas with ballooning cells 
(clear cells) within the cortex. Adenoma was defined as an increased tissue mass without 
the normal cortical structure; lesions usually contained a mixture of cell types ranging form 
clear cells to small cells with picnotic nuclei and spindle shaped cells. Adenocarcinoma was 
defined as infiltration of tumor cells into blood vessels and/or when metastases were found. 
Mitotic figures were not used as a selection criterion since they were absent in all slides 
examined. 
Sixteen adrenal glands from 15 clinical cases were categorized as hyperplasia, 28 
adrenal glands from 26 clinical cases were categorized as adenoma, and 11 adrenal glands 
from 10 clinical cases were categorized as adenocarcinoma. In three of the latter cases the 
tumor had metastasized. 
 
1.2 Immunohistochemical Staining 
Immunohistochemical staining for LH-Rs was performed as described previously.35 
The LH-R monoclonal antibody (P1B4), a gift from Dr. Wimalasena (Dept. Obstetrics and 
Gynecology, University of Tennessee, Knoxville, TN, USA), had been raised against 
purified rat LH-Rs, as described by Indrapichate et al..12 The antibody binds specifically to 
LH-Rs in various tissues of different species.4,25,41,42 
 
2. In vivo stimulation tests 
2.1 Stimulation tests in catheterized ferrets 
In a first study, which was approved by the Ethics Committee of the Faculty of 
Veterinary Medicine, Utrecht University, four stimulation tests were performed with 
catheterized ferrets. The order of the first three tests (ACTH, hCG, and FSH) was 
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determined by Latin square. The GnRH stimulation test was performed last as this test 
required twice the number of blood collections in comparison to the other tests. The tests 
were performed over two weeks with at least one day in between tests. The jugular catheter 
was placed 2 days before the first stimulation test. For the ACTH, hCG, and FSH 
stimulation tests, plasma concentrations of androstenedione, 17α-hydroxyprogesterone and 
cortisol were measured. For the GnRH stimulation test, plasma concentrations of LH and 
FSH were measured; the corresponding concentrations of androstenedione, 17α-
hydroxyprogesterone, and cortisol are reported elsewhere.35 
 
2.1.1 Animals 
Twelve ferrets (6 male and 6 female) were used in July and August 1999. Eleven 2-
year-old ferrets had been gonadectomized at 6 weeks of age. The twelfth ferret, a 1-year-
old male, had been gonadectomized at 9 months of age. The ferrets were either purchased at 
6 weeks of age from a breeder or born and raised in our department. The ferrets were 
individually housed in outdoor suspended cages with a night box. Water and ferret pellets 
(FerRet, Hope Farms, Woerden, The Netherlands) were available ad libitum.  
Unexpectedly, two ferrets had increased basal plasma androstenedione and 17α-
hydroxyprogesterone concentrations. This, together with ultrasonographically visualized 
unilateral adrenal gland enlargement, indicated the presence of hyperadrenocorticism, 
which was later confirmed by histological examination of the adrenal glands. 
 
2.1.2. Catheterization and sampling 
Jugular catheters were introduced, via vena section under isoflurane anesthesia, as 
described previously.35 To keep the catheters patent they were filled with a mixture of 
polyvinyl pyrrolidone (PVP) and heparin (60 g PVP / 54 ml 0.9% sodium chloride + 6 ml 
heparin [5000 IU/ml]). Anesthesia was used only for catheter placement. 
All blood samples were collected from the jugular catheter into pre-chilled EDTA-
coated tubes and centrifuged. Plasma was stored in aliquots at – 20 ºC pending analysis. 
After collection of each blood sample the catheter was flushed with 0.3 ml heparin solution 
(50 IU/ml). 
 
2.1.3 Stimulation tests 
For the ACTH-stimulation test blood samples were collected at -5, 0, 30, 60, 120 and 
180 min after an intravenous injection with 1 µg of synthetic ACTH1-24 (corticotropin, 
Synacten®, Novartis Pharma B.V., Arnhem, The Netherlands). For the FSH-stimulation 
test blood samples were collected at -5, 0, 60, 120, 240, 480 and 1440 min after a 
subcutaneous injection of 5 IU follitropin alfa (Gonal-F® 75, Serono Pharma S.P.A., Bari, 
Italy). For the hCG stimulation test blood samples were collected at -5, 0 30, 60, 120 and 
240 min after an intramuscular injection of 100 IU of the LH-R agonist hCG (Pregnyl®, 
Organon, Oss, The Netherlands). For the GnRH stimulation test blood samples were 
collected at -5, 0, 5, 10, 15, 30, 45, 60, 90 and 120 min after an intravenous injection of 10 
µg of the GnRH agonist gonadorelin (Fertagyl®, Intervet Nederland B.V., Boxmeer, The 
Netherlands). 
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2.2 GnRH stimulation test with blood collection under anesthesia 
In a second study a GnRH stimulation test was performed in 10 privately owned 
neutered ferrets (5 male and 5 female; 3 – 7 years of age) with hyperadrenocorticism. The 
diagnosis of hyperadrenocorticism was based upon history, physical changes, and 
ultrasonography of the adrenal glands. 
Blood samples were collected under isoflurane anesthesia by puncture of the cranial 
vena cava, immediately before and 30 min after an intravenous injection of 10 µg 
Fertagyl®, as described previously.35 Plasma concentrations of androstenedione, 17α-
hydroxyprogesterone, LH, and FSH were measured. 
 
2.3 Hormone determinations 
Androstenedione concentrations were measured by radioimmunoassay (RIA) as 
described previously.44 The lower limit of detection was 0.1 nmol/l and the interassay 
coefficients of variation were 10.5%, 9.3%, and 11.6% at 1.4, 4.8, and 11.8 nmol/l, 
respectively. 17α-Hydroxyprogesterone concentrations were measured after toluene 
extraction by RIA as described previously.35 The lower limit of detection was 0.2 nmol/l 
and interassay coefficients of variation were 9.0%, 7.4%, and 9.9% at 0.9, 5.1, and 26.0 
nmol/l, respectively. Cortisol concentrations were measured by RIA (Coat-A-Count® 
Cortisol, Diagnostic Products Corporation, Los Angeles, USA). The lower limit of 
detection was 1 nmol/l and the interassay coefficient of variation was between 4.0% and 
6.4%. FSH concentrations were measured by RIA as described previously.47 This RIA has 
been validated for use in ferrets.6 Rat FSH-RP2 (NIAMD, Bethesda, MD) was used as a 
standard. The lower limit of detection was 0.8 µg/l and the intra-assay coefficient of 
variation was 7.2%. LH concentrations were measured in duplicate 100-µl samples of 
plasma in one run with a heterologous RIA method as described before 5 with slight 
modifications. Anti-rat LH (1:11,200 CSU120; generously donated by Dr. G.D. Niswender, 
Colorado State University, Fort Collins, CO, USA), which recognizes ferret LH, was used. 
Radioiodinated rat LH (kindly donated by F.H. de Jong, Erasmus Medical Center, 
Rotterdam, The Netherlands) and canine LH LER 1685-1 (kindly donated by Dr. L.E. 
Reichert, Tucker Endocrine Research Institute LLC, Atlanta, GA, USA) were used as tracer 
and standard, respectively. The range was 0.39 to 50 µg/l at 94.6 to 6.5% relative bound 
with a maximum binding of 41%. Parallelism was tested by comparing the results of 50- 
and 100-µl samples of plasma from 5 ferrets (Fig 1). In four ferrets the difference between 
the 2 samples was 7.5%. In one ferret the results deviated by 43%. The intra- and interassay 
coefficients of variation were 5 and 10.5%, respectively. The limit of quantitation was 0.4 
µg/l. 
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Figure 1. Ferret LH in plasma samples (n=5) of 50 and 100 µl plotted vs. canine LH (LER 1685-1) 
standards in a radioimmunoassay with iodinated rat LH and anti-rat LH antibody 
(CSU120). 
 
3. In vitro stimulation test 
3.1 Adrenal tissue 
Adrenal tissue was obtained at surgery or within 30 min of death from a healthy intact 
male ferret, which died of a disease unrelated to hyperadrenocorticism, and three neutered 
ferrets with signs of hyperadrenocorticism. The adrenal glands of the healthy ferret (a 5-
year-old male) had no macroscopic alterations. To be able to obtain sufficient adrenal cells 
no histological examination was performed on the latter glands. Histological examination 
of parts of the adrenal glands of the hyperadrenocorticoid ferrets (1 male, 2 female; aged 4 
to 6 years) revealed two adenomas and one carcinoma. 
 
3.2 Tissue preparation 
The adrenal glands were collected in Hanks’ balanced salt solution (Life technologies, 
Breda, The Netherlands) and placed on ice. Within 30 min of collection the adrenals were 
cut into pieces and incubated with 3 mg/ml collagenase (type 1, Sigma-Aldrich, St. Louis, 
USA) in Hank’s solution at 37°C for 60 min under gentle agitation. Cells were collected by 
centrifugation at 250 g for 3 min and resuspended in DMEM (Sigma-Aldrich, St. Louis, 
USA) with 0.2% BSA before plating into 24-well culture dishes at a density of 500,000 
cells/ml/well. The cells were incubated in medium without or with ACTH1-24 (Synacten®) 
in a final concentration ranging from 10-6 to 10-9 M, GnRH (gonadorelin, Fertagyl®) at 10-6 
to 10-9 M, FSH (follitropin alfa, Gonal-F® 75) at 2 and 20 IU/ml, and hCG (Pregnyl®) at 5 
and 100 IU/ml. Incubations were performed in triplicate during 2 h at 37°C. Supernatants 
were collected and stored at – 20°C until measurement of cortisol, androstenedione, and 
17α-hydroxyprogesterone concentrations as described above. 
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4. RT-PCR 
4.1 Primer design 
The primers for the LH receptor and FSH receptor (Table 1) were based on sequences 
with a high degree of homology among other animals and came from Invitrogen (Breda, 
The Netherlands) and Isogen (Maarsen, The Netherlands), respectively. 
 
Table 1. Sequences of primers used for PCR amplification of ferret LH-R and FSH-R cDNA 
 
Name Sequence Expected product size 
LH-Forward 5’ ctaatgcctttgacaacctcctc 3’ 
LH-Reversed 5’ tgtaagttatcacaaatttccagaatg 3’ 
 
208 bp 
FSH-Forward 5’ ttggggacctggagaaaatagagatc 3’ 
FSH-Reversed 5’ aggctccgtggaaaacatcattagg 3’ 
 
447 bp 
 
4.2 Tissues 
Nine surgically removed adrenal glands of ferrets with hyperadrenocorticism were 
divided in two. One part was immediately frozen in liquid nitrogen and stored at – 70°C, 
and the other part was fixed in 4% buffered formalin and submitted for histological 
examination, which revealed adrenocortical hyperplasia (n=2) and adenoma (n=7). All nine 
adrenal gland samples were examined for the presence of LH-R mRNA, while 6 adenomas 
were examined for the presence of FSH-receptor (FSH-R) mRNA. Ferret testes tissue, 
obtained during an elective castration and frozen in liquid nitrogen and stored at – 70°C, 
served as a positive control. 
 
4.3 RNA isolation and cDNA synthesis 
Total RNA was extracted from tissue using the RNAeasy mini kit (Qiagen, Valencia, 
CA), and 1 µg was reverse transcribed in 20 µl at 42°C for 60 min using the Reverse 
Transcription System (Promega, Leiden, The Netherlands). Each reaction contained 5 mM 
MgCl2 , 1x Reverse Transcription Buffer (10 mM Tris-HCl [pH 9.0], 50 mM KCl, 0.1% 
Triton X-100), 1 mM each dNTP, 1 U RNasin, 15 U AMV Reverse Transcriptase, and 0.5 
µg Oligo(dT)15 primer. 
 
4.4 PCR 
PCR to detect LH-R and FSH-R mRNA was performed on 1 µl cDNA in a 50-µl 
reaction mixture containing 2 mM MgCl2, 1x reaction buffer (50 mM KCl, 10 mM Tris-
HCl [pH9.0], 1% Triton X-100), 0.2 mM of each dNTP, and 1.25 U of Taq DNA 
polymerase. 
Amplification was performed using the following thermo cycle parameters: 96°C for 4 
min followed by 35 cycles of 30 sec at 96°C, 30 sec at 58°C and 1 min at 72°C. Final 
extension was performed at 72°C for 10 min. PCR products were analyzed on a 1% agarose 
gel. PCR products were also purified and sequenced for product verification. 
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Results 
 
1. Immunohistochemical staining for LH receptors 
Thecal cells in the ovary and Leydig cells in the testis of healthy ferrets (Color 
section; Fig 7) stained positive with the LH-R antibody. In the adrenal glands of healthy 
ferrets, the zona glomerulosa stained positively for LH-R, as did the zona fasciculata, but 
less intensely (Color section; Fig 8). 
All adrenal glands from the clinical cases, except two adrenocortical tumors and their 
metastasis, stained positively for the LH-R. In another clinical case with a metastasizing 
adenocarcinoma, the primary tumor contained LH-R positive cells while the metastasis did 
not. Besides staining of the zona glomerulosa and zona fasciculata, clusters of clear cells in 
hyperplastic adrenal cortices stained for LH-R. Clusters of positively staining cells were 
found throughout the adenomas and adenocarcinomas (Color section; Fig 9). 
 
2. In vivo stimulation tests 
2.1 Stimulation tests in catheterized ferrets 
Thirty minutes after intravenous administration of ACTH1-24, plasma concentrations of 
cortisol and 17α-hydroxyprogesterone had increased in all healthy ferrets. In one of the 
ferrets with hyperadrenocorticism the cortisol response was in the range. The other 
hyperadrenocorticoid ferret had a low basal cortisol concentration and only a moderate 
response to stimulation with ACTH. In the healthy ferrets plasma androstenedione 
concentrations remained unchanged after stimulation with ACTH, whereas they increased 
in both hyperadrenocorticoid ferrets (Fig 2). 
In the healthy ferrets, plasma concentrations of cortisol, androstenedione, and 17α-
hydroxyprogesterone did not change after stimulation with recombinant FSH or hCG. In 
one hyperadrenocorticoid ferret, plasma concentrations of cortisol, androstenedione, and 
17α-hydroxyprogesterone increased 60 minutes after administration of FSH and returned to 
baseline 60 minutes later. In the other ferret with hyperadrenocorticism hormone levels did 
not change after stimulation with FSH. Plasma concentrations of androstenedione and 17α-
hydroxyprogesterone gradually increased after stimulation with hCG in the latter 
hyperadrenocorticoid ferret, but did not change in the former (Fig 3). 
Within 10 minutes of intramuscular administration of GnRH, plasma LH 
concentrations increased in all ferrets and returned to baseline values after approximately 1 
hour (Fig 4A), whereas plasma FSH concentrations did not change. In the two ferrets with 
hyperadrenocorticism plasma FSH concentrations increased slightly between 5 and 20 min 
after administration of GnRH (Fig 4B). 
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Figure 2. Mean (± SEM) plasma concentrations of androstenedione (A), 17α-hydroxyprogesterone 
(B), and cortisol (C) before and after the intravenous administration of ACTH1-24 at t=0 min 
in 10 healthy neutered ferrets (z) and in 2 neutered ferrets (, ▲) with 
hyperadrenocorticism. 
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Figure 3. Mean (± SEM) plasma concentrations of androstenedione (A), 17α-hydroxyprogesterone 
(B), and cortisol (C) before and after the subcutaneous administration of recombinant 
FSH, and mean (± SEM) plasma concentrations of androstenedione (D), 17α-
hydroxyprogesterone (E), and cortisol (F) before and after the intramuscular 
administration of hCG at t=0 min in 10 healthy neutered ferrets (z) and in 2 neutered 
ferrets (, ▲) with hyperadrenocorticism. Note difference with figure 5 with regard to 
scale for cortisol. 
 
2.2 GnRH stimulation test with blood collection under anesthesia 
Intravenous injection of GnRH in 10 ferrets with hyperadrenocorticism increased the 
median plasma LH concentration from 1.6 µg/l (range, 0.7 – 2.2 µg/l) to 3.2 µg/l (range, 1.2 
– 3.7 µg/l), and the median plasma FSH concentration from 23.8 µg/l (range, < 0.8 – 67.2 
µg/l) to 34.8 µg/l (range, < 0.8 – 93.5 µg/l). In one ferrets the plasma LH concentration did 
not increase and in four ferrets the plasma FSH concentrations did not increase after GnRH 
administration. The median plasma androstenedione concentration increased from 1.1 
nmol/l (range, 0.1 – 9.1 nmol/l) to 4.0 nmol/l (range, 0.1 – 22 nmol/l), and the median 
plasma 17α-hydroxyprogesterone concentration increased from 1.9 nmol/l (range, < 0.5 – 
29 nmol/l) to 2.8 nmol/l (range, < 0.5 – 62 nmol/l). In 7 of the 10 hyperadrenocorticoid 
ferrets, basal plasma concentrations of androstenedione exceeded the reference range (0.1 – 
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0.4 nmol/l)35. In two of the ferrets with normal basal plasma concentrations of 
androstenedione, concentrations exceeded the reference range 30 min after stimulation with 
GnRH. In 6 of the 10 hyperadrenocorticoid ferrets basal plasma concentrations of 17α-
hydroxyprogesterone exceeded the reference range (0.3 – 0.7 nmol/l)35. In three of the 
ferrets with normal basal concentrations, plasma 17α-hydroxyprogesterone concentrations 
exceeded the reference range 30 min after stimulation with GnRH. 
 
Figure 4. Mean (± SEM) plasma concentrations of LH (A), and FSH (B) before and after the 
intramuscular administration of a GnRH agonist at t=0 min in 8 healthy neutered ferrets 
(z) and in 2 neutered ferrets with hyperadrenocorticism (, ▲). 
 
3. In vitro stimulation tests 
ACTH and hCG significantly stimulated the release of cortisol and 17α-
hydroxyprogesterone from normal adrenal cells in culture medium as compared to the 
control incubations. This was also true for the dispersed cells from the adrenal adenoma A 
and carcinoma B. In the medium of cells obtained from adrenal adenoma C cortisol and 
17α-hydroxyprogesterone concentrations only increased after incubation with hCG. The 
cells had been incubated with a far lower concentration of ACTH (10-11 M). Incubation 
with FSH only caused significant increases in cortisol and 17α-hydroxyprogesterone 
concentrations in adrenal cells from carcinoma B (Fig 5). 
None of the hormones used stimulated the release of androstenedione from normal 
adrenal cells in culture medium as compared to the control incubations, whereas ACTH 
(10-6 M) significantly increased androstenedione concentrations in culture medium of cells 
from adenoma A and carcinoma B. Incubation with hCG led to a significant increase in 
androstenedione concentrations in culture medium with carcinoma B and adenoma C cells 
(Fig 5). GnRH did not stimulate the release of any of the hormones measured. 
 
4. RT-PCR 
RT-PCR analysis showed that LH-R and FSH-R mRNA is expressed in the ferret 
adrenal gland (Fig 6). Sequence analysis of the partially amplified LH-R mRNA revealed 
high sequence homology to the corresponding regions of the mRNA encoding LH-R in the 
polar bear (98%), pig (96%), cow (95%), human (92%), and rat (92%). Part of the ferret 
FSH-R mRNA was homologous to the published sequences of the polar bear (85%), cow 
(84%), pig (83%), human (80%), and rat (78%). 
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Figure 5. Concentrations of cortisol (I), androstenedione (II), and 17α-hydroxyprogesterone (III) in 
culture medium after a 2-h incubation of dispersed cells from 1 normal adrenal gland (H),          
2 adrenal adenomas (A, C) and 1 adrenal carcinoma (B) with ACTH (10-6 M), GnRH      
(10-6 M), hCG (100 IU/ml), and FSH (20 IU/ml). The dispersed cells of adenoma C were 
incubated with ACTH in a concentration of 10-11 M. An asterisk indicates a significantly  (P 
< 0.05) higher concentration than the control 
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Discussion 
 
The present data provide further support for the concept that gonadotropic hormones 
play an important role in the development of hyperadrenocorticism in ferrets. The results of 
immunocytochemical studies, in vivo and in vitro stimulation tests, and RT-PCR studies 
point to the importance of the expression of receptors for gonadotropic hormones, and 
particularly LH-Rs, in adrenocortical cells. The results are discussed below according to the 
experimental approach used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. PCR-products obtained from 6 ferret adrenal adenomas (lanes 1-6) showing bands 
corresponding with the expected size for LH- and FSH-receptors. M = marker, T = 
testes as positive control. RT – = PCR reaction without the addition of reverse 
transcriptase. 
 
Immunohistochemistry revealed the presence of LH-R protein in the adrenal cortices 
of intact 6- to 15-month-old ferrets. Thus, LH-R protein is already present in adrenal 
cortices of young, intact ferrets. The presence of LH-R protein in the zona glomerulosa and 
zona fasciculata is unexpected because LH-Rs are found in the zona reticularis and the 
distal zona fasciculata of the human adrenal gland.23 These zones produce androgens, 
whereas the zona glomerulosa lacks the enzyme 17α-hydroxylase, which is essential to 
androgen synthesis.40 The presence of LH-Rs in the zona glomerulosa, however, is not 
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unique to ferrets, and these receptors have been found throughout the adrenal cortex 
including the zona glomerulosa in mice with chronically elevated serum LH 
concentrations.15 Hämäläinen et al. 11 detected positive β-galactosidase staining in the zona 
glomerulosa and zona fasciculata in transgenic mice carrying an LH-R promoter (7.4 kb) 
fused with β-galactosidase. 
LH-R immunopositive cells were found in the adrenocortical lesions of 44 of the 46 
ferrets with hyperadrenocorticism. Of the three ferrets with metastasizing adrenocortical 
adenocarcinomas only one had LH-Rs in the primary tumor but not in the metastases. 
These three ferrets had only minor signs of hyperadrenocorticism. In these animals LH-Rs 
may have been lost during dedifferentiation of the neoplastically transformed cells, as has 
been observed for steroid hormone receptors in malignant mammary tumors.32 
The detection of LH-R mRNA by RT-PCR further confirms the local expression of 
LH-Rs in the ferret adrenal gland. However, the mRNA transcript and the locally produced 
protein may not be functional because the transcript may comprise truncated (iso)forms of 
the receptor.11,12 In a previous study we demonstrated that plasma concentrations of 
androstenedione and 17α-hydroxyprogesterone increased in neutered ferrets with 
hyperadrenocorticism in response to intravenous administration of a GnRH agonist. 
However, no such rise occurs in healthy ferrets,35 suggesting that LH-Rs may become 
functional only after form of metabolic/hormonal derangement. 
In all eight healthy neutered ferrets plasma LH concentrations, but not FSH 
concentrations, clearly increased after intravenous administration of GnRH. In 11 of the 12 
neutered ferrets with hyperadrenocorticism plasma LH concentrations increased after 
intravenous administration of GnRH, whereas plasma FSH concentrations increased in only 
8 of the 12 ferrets. In the two ferrets with hyperadrenocorticism in which hCG was 
administered intramuscularly, one responded with increased plasma concentrations of 
androstenedione and 17α-hydroxyprogesterone. The other ferret appeared to respond only 
to subcutaneous administration of FSH. In the latter ferret, however, the response was seen 
only 60 min after administration, and then only after 60 min. Because ACTH can increase 
the plasma concentrations of these three hormones, this increase may well be due to the 
stress of handling before blood collection, rather than a direct effect of FSH administration. 
None of the healthy neutered ferrets responded to stimulation with either hCG or FSH, 
consistent with observations in healthy humans.24,26 In a young woman with an 
adrenocortical adenoma testosterone secretion could only be stimulated with hCG before 
resection of the adrenal tumor.2 Thus in humans23 and ferrets, LH-Rs may become 
functional only under pathophysiological conditions. 
ACTH has been implicated as an important factor controlling the adrenal androgen 
secretion.9,24,27 In our study, however, only ferrets with hyperadrenocorticism responded to 
ACTH with an increased secretion of androstenedione; healthy ferrets showed no response. 
Adrenocortical cells can be categorized on the basis of their lipid content,49 with lipid-rich 
cells producing more cortisol than androstenedione, and the reverse in lipid-poor cells. It is 
possible that the adrenal glands of ferrets with hyperadrenocorticism contain relatively 
more lipid-poor cells. However, in our ferrets the LH-R-positive cells seemed to be lipid-
rich (clear cells). It is more likely that an alternative stimulatory pathway for the synthesis 
of androstenedione is activated in the hyperplastic or tumorous cells. 
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The in vitro stimulation tests gave the most cogent evidence for the existence of 
functional LH-Rs in the ferret adrenal glands. In the four adrenal glands, including a normal 
adrenal gland from an intact male ferret, cortisol secretion increased after incubation with 
hCG. In an adenoma and a carcinoma androstenedione concentrations increased after 
incubation with this hormone. Similar results have been reported for isolated guinea-pig 
adrenal cells, where hCG stimulated the production of cortisol and androstenedione.22 The 
increase in cortisol concentrations after incubation of ferret adrenal glands with hCG may 
explain why the urinary corticoid/creatinine ratio is increased in ferrets with 
hyperadrenocorticism.10, Schoemaker et al. submitted However, in vivo this increase in cortisol 
secretion must be limited because plasma ACTH concentrations are not decreased in ferrets 
with hyperadrenocorticism.33 An earlier study did not report an increase in cortisol after in 
vivo stimulation with hCG or GnRH in two ferrets with hyperadrenocorticism.35 
The LH-R belongs to the group of G protein-coupled receptors (GPCRs). While the 
precise mechanism for GPCR activation after agonist binding remains to be defined, it is 
generally postulated that GPCRs are in equilibrium between an activated state and an 
inactive state. These states presumably differ in the disposition of the transmembrane 
helices and, in turn, the cytoplasmic domains that determine G protein coupling. Since 
continued exposure to an agonist leads to desensitization,39 the adrenocortical LH-Rs may 
have become desensitized in the healthy neutered ferrets, as a result of continuous exposure 
to high LH concentrations. 
Some mutations in GPCRs can cause loss of function, while others lead to a gain of 
function. Activating missense mutations are thought to disrupt normal inhibitory constraints 
that maintain the receptor in its inactive conformation,14 shifting the equilibrium toward the 
activated state of the receptor. Some gain-of-function mutations are associated with 
increased sensitivity to the agonist.50 As in mice, the tumorigenic consequences of the high 
LH levels 20,28 may be associated with or mediated by activated LH-Rs, which may be due 
to a mutation in either the receptor protein or the G protein.3,43 In addition, receptor 
expression may be further increased after hormonal stimulation,37 a supposition supported 
by studies in mice. In healthy intact mice LH-R mRNA is not expressed in the adrenal 
cortex. Increased LH concentrations following gonadectomy, however, resulted within 4 
months in the expression of adrenal LH-R mRNA,15 indicating that prolonged elevation of 
LH levels may result in the expression of LH-Rs in adrenal cortex. 
Both LH-dependent hypercortisolism and LH-dependent adrenal androgen secreting 
tumors have been described in humans.17 Patients with LH-dependent Cushing’s syndrome 
usually have bilateral macronodular adrenal hyperplasia with high plasma concentrations of 
cortisol and suppressed concentrations of ACTH.7,16 Hyperadrenocorticism in ferrets is 
usually associated with unilateral adrenal pathology. However, the contralateral adrenal 
cortex is not atrophic and plasma ACTH concentrations are not significantly different from 
those of healthy ferrets.33 Thus hyperadrenocorticism in ferrets is not identical to LH-
dependent Cushing’s syndrome in humans. Hyperadrenocorticism in ferrets may, however, 
be comparable with LH-dependent adrenal androgen-secreting tumors in women, in whom, 
as in ferrets, usually only one adrenal gland is involved without alterations in plasma 
ACTH concentrations.2,18 
Chapter 9 
 
 
 126
To our knowledge, the presence of FSH-Rs in adrenal tissue has thus far only been 
reported in adrenocortical carcinoma cells from a rat.36 Here we detected FSH-R mRNA in 
ferret adrenal adenomas by RT-PCR. We also observed a significant increase in cortisol 
and 17α-hydroxyprogesterone in response to FSH stimulation. However, since this 
response to FSH stimulation was demonstrated in only one of the three tumors examined, 
the response to an in vivo stimulation test was questionable, and plasma FSH concentrations 
did not increase during the GnRH stimulation test in 4 out of 12 ferrets, we speculate that 
the FSH-R plays a less prominent role than the LH-R in the development of 
hyperadrenocorticism in ferrets. 
We conclude that the LH-Rs detected in the adrenal cortex of healthy neutered ferrets 
are hardly, or not, functional in vivo. In contrast, these receptors appear to be functional in 
neutered ferrets with hyperadrenocorticism. Although FSH-R mRNA is expressed in 
adrenal adenomas, these receptors appear to play a less prominent pathogenetic role than 
LH-Rs. 
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Summary 
 
Female ferrets (jills) are commonly ovariectomized to prevent estrus-induced bone 
marrow suppression, and male ferrets (hobs) are castrated to reduce intraspecies aggression 
and skin odor. There is increasing evidence, however, that castration may precipitate the 
development of hyperadrenocorticism in ferrets. The detection of luteinizing hormone 
receptors in the adrenal cortex of ferrets with hyperadrenocorticism has strengthened this 
notion. Since surgical castration is a major risk factor for the development of 
hyperadrenocorticism in ferrets, this paper concentrates on the current and possible future 
options for neutering ferrets. Some of the alternatives, such as progestagen administration, 
seem very practical in jills but the effect in hobs is uncertain. Possible future alternatives 
may be the use of slow-release gonadotropin-releasing hormone (GnRH) implants, GnRH 
antagonists, or immunization against GnRH. 
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Introduction 
 
Surgical castration of ferrets (Mustela putorius furo) is common practice in the USA 
and various European countries. Female ferrets (jills) are induced ovulators and therefore 
remain in estrus until they are mated, or for as long as daylight lasts longer than 12 hours. 
In the early 1980s several publications appeared concerning estrogen-induced bone marrow 
suppression in jills with prolonged oestrus.8,36,43,66 Since then, preventive 
ovari(ohyster)ectomy of jills has been advised. In male pet ferrets (hobs) there is no 
medical need for castration. The main reason to castrate hobs is to reduce aggression so that 
they can be kept in groups, and to decrease the intensity of the musky odor produced by the 
sebaceous glands.51 In the USA it is common practice to castrate ferrets at 6 weeks of age, 
before their delivery to pet shops.58 
Hyperadrenocorticism is a common disease among pet ferrets and is characterized by 
signs of excessive production of sex steroids (androstenedione, 17α-hydroxyprogesterone, 
dehydroepiandrosterone sulfate and/or oestradiol), i.e., symmetrical alopecia, vulvar 
swelling in neutered jills, and recurrence of sexual behavior in neutered ferrets.40,57,58,63,71 In 
recent years, evidence has accumulated that hyperadrenocorticism in ferrets is mediated by 
an increased secretion of gonadotropic hormones after castration.40,58,63 First, the initial 
signs of hyperadrenocorticism occur only during the breeding season,56 when plasma 
concentrations of gonadotropic hormones are high.33 Second, in the USA and in The 
Netherlands, where the neutering of ferrets is common practice, hyperadrenocorticism is a 
common condition.56,63 In contrast, hyperadrenocorticism is seldom diagnosed in the United 
Kingdom, where ferrets often remain entire.41 Third, a significant correlation has been 
found between the age at neutering and age at onset of hyperadrenocorticism.63 Fourth, the 
gonadotropin-releasing hormone (GnRH)-analogue leuprolide acetate has recently been 
reported to have beneficial effects in the treatment of this disease.70 Finally, luteinizing 
hormone (LH) receptors have been detected in the adrenal cortex of ferrets.64 
Because several lines of evidence point to surgical castration as a major risk factor in 
the development of hyperadrenocorticism in ferrets, this paper concentrates on current and 
future options for the neutering of ferrets. 
 
Reproductive physiology 
Gonadal activity is seasonal in both male and female ferrets, and more than 12 hours of 
light per day promotes reproductive activity.10,25 The pineal hormone melatonin plays a 
central role in the regulation of these changes,27 and plasma and pineal gland concentrations 
of melatonin are significantly higher during the dark phase of the day (scotophase) than in 
the light phase (photophase).7 
Plasma concentrations of follicle-stimulating hormone (FSH) increased within a few 
days after male hamsters were transferred from a short to a long photoperiod. Plasma LH 
concentrations, however, increased only after exposure to a female hamster.2 The different 
regulation of LH and FSH secretion can be explained by the fact that there are at least two 
types of GnRH receptors 30 and several GnRH isotypes, some of which may have specific 
FSH-releasing activity.72 Anand et al. also found that both melatonin and a GnRH-
antagonist (antide) could prevent the release of LH in male hamsters exposed to a female.2 
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These findings indicate that melatonin suppresses the release of GnRH in seasonal 
breeders. 
During the breeding season, GnRH stimulates the production of the gonadotropic 
hormones LH and FSH, which stimulate the gonads to produce either oestradiol or 
testosterone. The latter two hormones exert a negative feedback on the hypothalamus and 
pituitary gland, thereby preventing excessive secretion of GnRH, LH, and FSH. 
 
Definitions 
In its classical definition, castration denotes the removal of gonads. Thus the term 
covers both the removal of the ovaries (ovariectomy or spaying) in females and the removal 
of the testes (orchiectomy) in males.3 In recent years, this definition has been extended by 
the introduction of new methods to create non-functional gonads, e.g., chemical castration 
and immunological castration.5 The term castration is controversial since it is sometimes 
used to indicate the removal of the gonads in male individuals only.16 A term that 
encompasses all means of eliminating gonadal function in both males and females is 
neutering,4 and this term is used in this article. 
There are methods of contraception that do not affect gonadal function. For example, 
fertilization of oocytes can be prevented by vaccination against zona pellucida proteins 
6,26,44 or vaccination against sperm proteins.39,53 Another option to prevent oocyte 
fertilization is surgical sterilization, by means of tubal ligation. Immunization of female rats 
and monkeys with riboflavin carrier protein caused termination of pregnancy around the 
pre-implantation stage, while immunization of male rats and monkeys resulted in a reduced 
fertilizing potential of their spermatozoa.1 Since these methods do not eliminate gonadal 
function and therefore do not prevent the resulting detrimental effects in ferrets, they are 
not discussed here. 
 
Progestagens 
Principle: Although not fully understood, the probable mode of action of progestagens is 
suppression of the secretion of gonadotropic hormones, thereby preventing ovarian 
cyclicity.15 
Method: Several progestagens are used in veterinary medicine: medroxyprogesterone 
acetate, megestrol acetate, and proligestone. Megestrol acetate (Ovaban; Schering 
Plough) can be given orally, medroxyprogesterone acetate (Depo-provera; Pharmacia) 
can be given orally or by injection and proligestone (14α, 17α propylidene-dioxy 
progesterone) (Delvosteron; Intervet) is given by depot injection. The latter is 
recommended in the United Kingdom for the prevention of estrus in ferrets at a dose of 
0.5 ml (100 mg/ml SC) just prior to the breeding season.35,52 Proligestone can also be 
used in jills in estrus. 
Effect: Return of estrus was reported in approximately 8% of ferrets 2 – 5 months after the 
initial dose of proligestone. In these cases, a second dose suppressed estrus for the rest 
of the breeding season.52 Megestrol acetate has been used in ferrets to prevent estrus 
but is not recommended because of the assumed risk of pyometra.19,60 However, this 
restriction is probably not justified because pyometra has not been described in ferrets 
after the use of megestrol acetate.17,29 
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Remarks: Reported side-effects associated with the use of progestagens in either dogs or 
cats are the development of cystic endometrial hyperplasia (CEH), prolonged 
pregnancy, hypersecretion of growth hormone (GH), diabetes mellitus, and increased 
risk of neoplastic transformation of mammary tissue.62 Of these side-effects, only 
prolonged pregnancy (gestation 51 days, normal 38 – 44 days) has been reported after 
the use of proligestone. Proligestone had been given to these two ferrets when they 
were in estrus and had been mated.35 
There is no information on the use of progestagens in hobs. In other species, 
including humans, progestagens have been used to suppress libido and fertility in 
males.23,47,67 Progestagens are rarely used for contraception of human males since they 
cause loss of libido and incomplete suppression of spermatogenesis.47 For this reason 
the combination of progestagens and androgens is often used: it provides a better 
contraceptive effect than progestagens alone and the libido is maintained.22,47 This 
combination would not be an option in ferrets, because libido is an undesirable 
characteristic in hobs. Delmadinone acetate (Tardak; Pfizer) is used to suppress libido 
in dogs.67 A recent study of Beagles, however, has revealed that this progestagen does 
not suppress plasma testosterone concentrations.38 Thus delmadinone acetate, when 
used in ferrets, may not suppress the musky odor produced by the sebaceous glands. In 
humans, cyproterone acetate (Androcur; Schering) and medroxyprogesterone acetate 
have been used to suppress libido in sex offenders.23 Both drugs suppress plasma 
testosterone concentrations. 
Studies with progestagens are needed to determine whether these drugs can be 
used to control libido and odor in hobs. In addition, the effect of progestagen 
administration on GH release should be studied in jills, because progestin-induced 
expression of the mammary GH gene has now been demonstrated in dogs, cats, and 
humans.49,50,65 
 
“Sham” mating 
Principle: Ferrets, rabbits, and cats are all induced ovulators. When ovulation is achieved 
without fertilization, pseudopregnancy will occur.19 
Method: In rabbit does, the proximity of an intact male, mechanical stimulation of the 
vagina, or mounting by a female rabbit can induce ovulation.24 In cats, stimulation of 
the vagina will result in ovulation.15,62 In ferrets, both vaginocervical stimulation and 
neck-gripping are necessary to induce ovulation.9 Because of this elaborate procedure, 
it is not practical for owners to try to induce ovulation in jills. As an alternative, 
vasectomized hobs are used in the UK to induce ovulation.32,60 One mating leads to 
cessation of estrus in about 75% of ferrets and two matings to cessation of estrus in 
85% of ferrets.60 
Effect: Termination of estrus followed by pseudopregnancy lasting about 42 days.19 
Remarks: During pseudopregnancy, jills may display nesting behavior and enlargement of 
the abdomen and mammary glands.19 The nesting behavior, which includes dragging 
cage mates around the cage and increased aggression towards the owners, does not 
make this an attractive option. 
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Vasectomized hobs remain aggressive and have a musky odor similar to that of 
intact hobs. 
 
hCG or GnRH administration 
Principle: After mating there is a preovulatory LH surge that may last to up to 12 hours.12 
This LH surge can be mimicked by the administration of either human chorionic 
gonadotropin (hCG) or indirectly by stimulating endogenous LH release with the 
hypothalamic releasing hormone GnRH. 
Method: Ten days after the onset of estrus, 20 µg GnRH or 100 IU hCG is given 
intramuscularly.19 
Effect: Approximately 35 hours after injection the ferrets ovulate, resulting in the formation 
of corpora lutea in 95% of the cases.45 Vulvar swelling will start to decrease within 1 
week of injection. Anoestrus (pseudopregnancy) will last for 40 – 60 days.8 
Remarks: Fox et al. found that multiple injections of GnRH may sensitize the ferret to the 
drug, resulting in anaphylactic reactions shortly after administration.19 Antihistamine 
administration ameliorates these reactions within minutes. The consequences of 
pseudopregnancy have been mentioned in the previous section and neutering ferrets 
with hCG or GnRH injections only applies to jills. 
 
Manipulation of photoperiod and administration of melatonin 
Principle: As described above, the ferret’s reproductive season starts when there is more 
than 12 hours of light per day. During the scotophase, melatonin concentrations in 
plasma are high.7,59 It has been speculated that keeping ferrets either under conditions 
with short photoperiods or giving them melatonin would suppress the pituitary-gonadal 
axis. 
Method: Provision of a maximum of 8 hours of light per day, or daily administration of 1 
mg melatonin 8 hours after the onset of light.13 
Effect: Ferrets kept under 8h light : 16 h darkness (8L : 16D) come into estrus only 7 weeks 
later than ferrets exposed to long photoperiods (14L : 10D). When ferrets kept under 
long photoperiods (14L : 10D) received melatonin (1 mg/day) 8 hours after the onset of 
light, they come into estrus only 7 weeks later than ferrets kept under similar 
conditions and receiving oil injections.13 Herbert et al. found that in the first year after 
ferrets were blinded they came into estrus at the expected time, but thereafter estrus 
synchrony was lost.28 Estrus periods in blinded ferrets lasted from just a few weeks to 
up to 60 weeks. 
Remarks: A limited light regimen and administration of melatonin are not effective in 
inhibiting the hypothalamus-pituitary-gonadal axis in ferrets. 
 
Immunization against GnRH 
Principle: There are several reports on the use of GnRH vaccines in mammals.21,37,46,73 
Depending on the species, these vaccines aim at contraception, the prevention of boar 
taint, or the control of hormone-dependent cancers, including breast and prostate 
cancers. In ferrets, use of a GnRH vaccine would serve two goals: inactive gonads in 
both sexes in combination with low plasma concentrations of gonadotropic hormones.  
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Method: Depending on the study inoculations were performed intramuscularly, 
subcutaneously or intranasally. 
Effect: Decreased plasma gonadotropic hormone concentrations have been reported in male 
rats after immunization against GnRH.37 Testosterone concentrations decreased in 
bulls, boars, male rats and dogs after immunisation,21,37,46 while in female mice a 
sterilizing effect was seen.73 Reduced testes size has also been reported in boars and 
rats after immunization against GnRH.37,46 
Remarks: In a pilot study conducted at Utrecht University, eight out of twelve ferrets 
immunized against GnRH had to be euthanased (Schoemaker and others, in 
preparation). Post mortem examination disclosed aspecific lympho-plasmacellular 
infiltrations in multiple organs (liver, kidney, lung and intestines) suggesting an a-
specific immune reaction. The background of these reactions has to be unraveled 
before GnRH immunization can be employed in ferrets. 
 
Immunization with LH 
Principle: Inhibition of LH secretion by immunization with heterologous LH.18,34,55 
Method: Heterologous LH is injected intramuscularly or subcutaneously. 
Effect: Injection of bovine LH causes a 90% reduction in the weight of rabbit testes, and 
genital atrophy in female rabbits and loss of receptiveness to males.18 In another study 
with male rabbits, LH and testosterone plasma concentrations decreased significantly 
after immunization against LH; however, FSH concentrations increased significantly.34 
Similar, but less consistent, effects of LH immunization were seen in dogs.42 In ewes 
estrus and pregnancy were prevented for 2 years after immunization against LH, 
although plasma LH concentrations were not lower than in control ewes.55 In these 
ewes FSH concentrations were also increased. 
Remarks: So far, there are no reports of LH vaccination in ferrets. Since not only LH but 
also FSH may influence the development of hyperadrenocorticism in ferrets, there is 
reason for caution with LH immunization in ferrets. 
 
Immunization with LH receptor 
Principle: Induction of LH receptor dysfunction by immunization with heterologous LH 
receptor. 
Method: Immunization of bitches with 0.5 mg bovine LH receptor (bLH-R) encapsulated in 
a silastic subdermal implant, followed by intramuscular booster injections.61 
Effect: In bitches immunization with bLH-R suppresses serum progesterone concentrations 
for approximately 1 year, while serum concentrations of oestradiol and LH are not 
affected. Although stimulation with GnRH in immunized dogs leads to a LH surge, 
serum progesterone concentrations do not increase. Thus bLH-R immunized bitches do 
not ovulate or do not produce active corpora lutea.61 
Remarks: The main drawback of this approach is that ferrets may fail to ovulate. Prolonged 
estrus can be expected, which may result in bone-marrow suppression. In male mice, 
immunization against LH-R caused reduces androgen production.54 In male ferrets, this 
might result in reduced aggressive behavior and decreased intensity of their musky 
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odor. Again some caution is warranted because high LH-R antibody titers in mice had 
an agonistic effect, resulting in hypertestosteronemia.54 
 
Depot GnRH agonist 
Principle: Depot GnRH agonists increase the levels of gonadotropic hormones, followed by 
a desensitization of gonadotroph receptors, resulting in decreased LH and FSH plasma 
concentrations.69 The exact mechanism of the desensitization is still not clear.30 
Method: Of the available formulations, leuprolide acetate (Lupron Depot 3.75 mg, TAP 
Pharmaceuticals Inc) is used to treat hyperadrenocorticism in ferrets.70 Ferrets 
weighing less than 1 kg receive an intramuscular dose of 100 µg at monthly intervals 
and ferrets heavier than 1 kg receive 200 µg per month. A similar treatment protocol 
might also be effective for contraceptive purposes. Slow-release implants have been 
described in humans 14 and dogs.68,69 
Effect: When leuprolide acetate is given to jills in estrus, ovulation will probably occur due 
to the initial LH surge seen after injection. Therefore leuprolide acetate should be 
administered before the breeding season, otherwise it has no advantage over regular 
GnRH. In dogs, however, leuprolide acetate induces estrus.31 It is therefore uncertain 
whether this drug will be useful in neutering ferrets. 
Remarks: Slow-release implants suppress reproductive function in dogs.68 GnRH implants 
might therefore be an option for use in ferrets. 
 
GnRH receptor antagonist 
Principle: Competitive GnRH receptor occupancy with GnRH receptor antagonists results 
in a decreased release of gonadotropic hormones by the pituitary gland.30 
Method: The available GnRH receptor antagonists have to be injected, but orally active 
non-peptide GnRH antagonists are currently being developed for use in humans.48 
Effect: The initial increase in gonadotropic hormones, seen with GnRH agonists, are not 
seen with GnRH receptor antagonists. The use of these receptor antagonists will 
therefore result in an immediate decrease in gonadotrophic hormone concentrations. 
Remarks: Until now, only a few GnRH receptor antagonists have been registered for use in 
humans.30 New and longer-acting drugs are being developed. Degarelix (FE200486, 
Ferring) currently seems to be the most promising of these GnRH receptor 
antagonists.11 While older GnRH antagonists caused increased histamine release after 
injection, the newer drugs do not have this side-effect. Nevertheless, local reactions at 
the site of injection are still common.30 These drugs seem to be promising for future 
use in ferrets. 
 
Conclusion 
There are several potential ways to influence reproductive function in ferrets, other 
than surgical castration. Progestagens seem practical for use in jills but need to be studied 
for use in hobs. Possible future alternatives may be the use of slow-release GnRH implants, 
GnRH antagonists, or immunization against GnRH. Detailed studies are needed before 
these techniques can be recommended for neutering ferrets. 
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Hyperadrenocorticism is a common disease in ferrets.9 In recent years evidence has 
accumulated that this disease differs from hyperadrenocorticism in humans (Cushing’s 
syndrome), dogs, and cats, in that adrenocortical sex steroids, rather than cortisol play, an 
important role in the pathogenesis.10 In this study attention was focused on the possible 
pathogenetic role of high plasma concentrations of gonadotropic hormones as a result of 
neutering. In addition, diagnostic dilemmas were addressed, such as the apparently 
increased urinary excretion of cortisol in the absence of hypercortisolemia. 
First, the influence of sampling techniques on plasma concentrations of pituitary and 
adrenocortical hormones was studied (chapter 3). Manual restraint resulted in a significant 
increase in the plasma concentrations of cortisol and ACTH, whereas anesthesia did not 
have a significant effect. Plasma concentrations of 17α-hydroxyprogesterone were 
unaffected by either manual restraint or anesthesia, whereas plasma concentrations of α-
MSH were greatly influenced by both procedures. Manual restraint caused a decrease in 
plasma α-MSH concentrations, whereas isoflurane anesthesia resulted in an increase in α-
MSH concentrations. Medetomidine anesthesia had no effect on plasma concentrations of 
α-MSH. 
Although medetomidine anesthesia did not affect any of the hormones measured, 
isoflurane anesthesia was used to establish reference ranges for plasma concentrations of 
ACTH and α-MSH (chapter 4), because the depth of anesthesia is easy to control and 
recovery is quick.11 These reference ranges can be used in the clinic provided that the same 
sampling procedure is used. Reference ranges (percentiles P2.5 and P97.5 with a probability 
of 95%) for plasma concentrations of ACTH and α-MSH in healthy neutered ferrets were 
2.9 – 22 pmol/l (13 – 100 ng/l) and 4.8 – 108 pmol/l (8 – 180 ng/l), respectively. Ferrets 
with hyperadrenocorticism had plasma concentrations of ACTH and α-MSH of 0.2 – 58.3 
pmol/l (1 – 265 ng/l) (median 9.9 pmol/l [45 ng/l]) and 6 – 88.8 pmol/l (10 – 148 ng/l) 
(median 27.6 pmol/l [46 ng/l]), respectively. These values were not significantly different 
from those of healthy neutered ferrets. For this reason, we concluded that this disease 
should be regarded as a normocortisolemic and corticotropin-independent condition. 
In order to increase insight into the significance of the commonly increased urinary 
corticoid/creatinine ratios (UCCR) in hyperadrenocorticoid ferrets, cortisol metabolism, 
and urinary steroid profiles were studied. In both healthy ferrets and a ferret with 
hyperadrenocorticism, 10% of [1,2,6,7 3H]cortisol was cleared via the urine, thus allowing 
accurate measurement of cortisol by radioimmunoassay (chapter 5). High-performance 
liquid chromatography (HPLC) demonstrated that one third of the urinary corticoids was 
unconjugated cortisol, whereas the remaining peaks could be attributed to more hydrophilic 
conjugates or metabolites. None of the adrenal sex steroids appeared in the HPLC fractions. 
Together, this indicates that the UCCR in ferrets primarily reflects urinary cortisol 
excretion. 
A distinct seasonal variation in the UCCR was observed in healthy intact ferrets, and in 
two neutered hyperadrenocorticoid ferrets, and an increased UCCR was measured in 27 of 
31 privately owned ferrets with hyperadrenocorticism. However, no seasonal fluctuation in 
the UCCRs was seen in healthy neutered ferrets. Three explanations are postulated for the 
increased UCCR and the unaltered plasma concentrations of cortisol, namely (1) sexual 
arousal, (2) gonadotropin-dependent cortisol secretion, and (3) lowering of the plasma 
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concentration of cortisol-binding-globulin (CBG). Sexual arousal, which leads to activation 
of the pituitary-adrenocortical axis, may play a role in healthy ferrets and in the 
hyperadrenocorticoid ferrets with an elevated UCCR during the breeding season. This 
explanation would be in agreement with the largely unchanged plasma ACTH 
concentrations. However, in the hyperadrenocorticoid ferrets the resistance to 
dexamethasone suppression points to adrenocortical autonomy and/or ACTH-independent 
stimulation of the adrenal cortex. In these clinical cases, one has to assume that only small 
amounts of cortisol are produced by the adrenocortical hyperplasia and neoplasia, 
insufficient to cause suppression of ACTH. The latter effect may be reinforced by the 
increased concentrations of sex steroids affecting the binding capacity of CBG. A decrease 
in the binding capacity of CBG may be associated with an elevated fraction of free cortisol, 
while plasma total cortisol concentrations remain unchanged. 
Further support for the finding that hyperadrenocorticism in ferrets is an ACTH-
independent condition was provided by morphological studies of the pituitary gland of 
ferrets (Chapter 6). The distribution of melanotropes and corticotropes in the pituitary 
glands of healthy ferrets appeared to be similar to that in dogs. Gonadotropes were found in 
the pars distalis of neutered, but not in intact, ferrets. Two of the ten ferrets with 
hyperadrenocorticism had a pituitary tumor. These tumors did not stain for any of the 
pituitary hormones. The low prevalence of pituitary tumors in hyperadrenocorticoid ferrets 
is in sharp contrast to the high number of pituitary tumors found in human, canine, and 
feline patients with Cushing’s syndrome (60 – 80%). A large number of pituitary tumors 
are found in seemingly healthy humans (2 – 27%),6 which may suggest that the pituitary 
microadenomas found in two hyperadrenocorticoid ferrets were not related to adrenal 
disease, but were rather an incidental finding. The pituitary tumors found in our ferrets, 
however, had characteristics of clinically non-functional gonadotrope tumors, as seen in 
humans.4 Possibly the lack of gonadal feedback on hypothalamic GnRH, as a result of 
neutering, may have initiated pituitary tumor development. 
In the United States of America, it has been postulated that early neutering, at 6 weeks 
of age, contributes to the high incidence of hyperadrenocorticism in ferrets.9 In The 
Netherlands ferrets are neutered after 6 months of age. In a survey held among Dutch ferret 
owners (Chapter 7), a rather high prevalence of hyperadrenocorticism (0.55%: 95% 
confidence interval: 0.2 – 1.1%) was found, indicating that ferrets do not have to be 
neutered at an early age to develop hyperadrenocorticism. However, there was a linear 
correlation between age at neutering and age at time of diagnosis of hyperadrenocorticism, 
indicating that neutering did play a role in the development of this disease. On the basis of 
these findings we suspected that gonadotropic hormones play a role in the development of 
hyperadrenocorticism in ferrets. 
The next step was to study the presence and function of gonadotropin receptors in the 
adrenal glands of healthy ferrets and of ferrets with hyperadrenocorticism (Chapter 8 and 
9). Positive immunohistochemical staining with a luteinizing hormone receptor (LH-R) 
antibody was found in the zona glomerulosa and the zona fasciculata of adrenal glands 
from healthy, intact 6 to 15-month-old ferrets. In addition, 44 adrenal hyperplasias and 
neoplasias from 46 ferrets with hyperadrenocorticism stained positive for the LH-R. The 
presence of LH-R-positive cells in the outer layers of the adrenal cortex was an unexpected 
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finding since adrenal androgens are produced in the inner layer of the adrenal cortex, the 
zone where LH-R-positive cells have been found in the human adrenal cortex.7 The 
presence of LH receptors in the zona glomerulosa, however, is not unique to ferrets. In 
transgenic (TG) mice with chronically elevated serum LH concentrations, LH-R mRNA has 
been localized across the whole adrenal cortex, including the zona glomerulosa.3 The 
histological characteristics of the LH-R-positive cells in the adrenal adenomas and 
carcinomas in hyperadrenocorticoid ferrets did not allow us to define the zone of origin. 
Because of the mixed cell character of the adrenal tumors in ferrets, however, it is tempting 
to speculate that they originate from the zona intermedia, which contains the progenitors of 
all the cell types of the adrenal cortex. To investigate the functionality of the LH-Rs, in vivo 
GnRH stimulation tests were performed with healthy neutered ferrets and neutered ferrets 
with hyperadrenocorticism. In the healthy ferrets, plasma concentrations of cortisol, 
androstenedione, and 17α-hydroxyprogesterone did not rise after the intravenous 
administration of a GnRH agonist, whereas plasma concentrations of androstenedione and 
17α-hydroxyprogesterone did rise after the administration of this agonist in 
hyperadrenocorticoid ferrets. These findings indicate that although LH-Rs are present in the 
adrenals of young healthy ferrets, they are not functional. 
To find out which gonadotropic hormone is responsible for the observed increase in 
plasma concentrations of sex steroids in ferrets with hyperadrenocorticism, plasma 
concentrations of LH and FSH were measured in the ferrets subjected to GnRH stimulation. 
LH plasma concentrations clearly increased after GnRH administration whereas no clear-
cut increase in plasma FSH concentrations was seen. Administration of FSH did not 
promote the release of adrenocortical steroids, whereas hCG resulted in a gradual increase 
in the plasma concentrations of androstenedione and 17α-hydroxyprogesterone in one of 
two ferrets with hyperadrenocorticism. To rule out hormone production by other organs in 
the in vivo stimulations tests and the possibility of direct stimulation by GnRH of the 
adrenal cortex of ferrets, in vitro stimulation test were performed with adrenal cells 
suspended in culture medium. From these tests it became clear that neither GnRH nor FSH 
had a significant influence on the production of adrenocortical steroids, whereas hCG 
induced the production of these hormones. 
As mentioned above, the LH-R is not always functional in ferret adrenal glands. A 
diminished or absent response to an agonist may be due to receptor desensitization. This 
would explain why in neutered ferrets, with persistently high LH concentrations, the LH-Rs 
were not functional. In neutered ferrets with hyperadrenocorticism, however, the receptors 
were functional. A mutation in the receptor may be responsible for this regain of function. 
It is also possible that the expression of LH-Rs increases after hormonal stimulation.12 In 
mice there is increasing evidence that the LH-R can function as a tumor promoter when 
stimulated by the ligand hormone.5 
Plasma FSH concentrations were extremely low in some ferrets with 
hyperadrenocorticism. This was unexpected since the loss of the negative feed-back on 
gonadotropic hormone secretion after neutering usually results in increased gonadotropin 
concentrations.2 It is possible that inhibin, a hormone which is known to suppress FSH 
secretion, is produced by ferret adrenal tumors. The inhibin α subunit has been 
demonstrated in adrenal tumors of ferrets with hyperadrenocorticism.8 In humans virilizing 
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adrenal adenomas secrete inhibin α in much higher amounts than normal adrenal glands 
do.1 However, the possible role of this peptide or related peptides in the feedback control of 
FSH secretion in ferrets with hyperadrenocorticism remains to be elucidated. 
Since surgical neutering seems to be a major risk factor in the development of 
hyperadrenocorticism in ferrets, the literature was reviewed for current and future 
alternatives for surgical neutering of ferrets (Chapter 10). Of the alternatives, the use of 
progestagens seems the most practical in jills, but the effect of these drugs in hobs is 
uncertain. Other potential alternatives for the future may be slow-release GnRH implants, 
GnRH antagonists, or immunization against GnRH.
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X Medetomidine anesthesia has less effect than manual restraint and isoflurane 
anesthesia on plasma concentrations of pituitary and adrenocortical hormones. 
X Plasma concentrations of ACTH and α-MSH do not differ significantly between 
healthy ferrets and ferrets with hyperadrenocorticism. 
X Cortisol is predominantly excreted through the hepatobiliary route. Only 10% of 
cortisol is excreted via the urine. This is, however, sufficient to allow accurate 
measurement of urinary cortisol concentrations. 
X Urinary corticoid to creatinine ratios are increased in neutered hyperadrenocorticoid 
ferrets, and in intact ferrets during the breeding season. 
X Three explanations are postulated for the increased urinary cortisol/creatinine ratios 
and unaltered plasma concentrations of cortisol, namely (1) sexual arousal, (2) 
gonadotropin-dependent cortisol secretion, and (3) lowering of the plasma 
concentration of cortisol-binding-globulin (CBG). 
X Hyperadrenocorticism in ferrets is not associated with corticotropic adenomas. The 
tumors found in two of the 10 cases had similarities with clinically non-functioning 
gonadotrope tumors, which are known to occur in humans. 
X Age at neutering and age at time of diagnosis of hyperadrenocorticism are significantly 
correlated, indicating that neutering plays a role in the development of this disease. 
X Intravenous administration of a GnRH agonist results in elevation of plasma 
concentrations of androstenedione and 17α-hydroxyprogesterone in neutered ferrets 
with hyperadrenocorticism, but not in healthy neutered ferrets. This seems to indicate 
that cellular modification of LH-R is required for functionality, or that the cellular 
derailment is caused by (re)gain of functionality of the receptor. 
X Adrenocortical steroid secretion can be stimulated in vitro by hCG, while neither 
GnRH nor FSH influences the secretion of these steroids, indicating that LH is the 
gonadotropic hormone which most likely plays a role in the development of 
hyperadrenocorticism in ferrets. 
X The use of progestagens may provide a suitable alternative for surgical neutering in 
jills, but first of all possible effects on the release of growth hormone need to be 
studied. Currently there is no alternative for surgical neutering in hobs. 
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Hyperadrenocorticisme is een veel voorkomende aandoening bij fretten.10 In de 
afgelopen jaren is duidelijk geworden dat deze aandoening verschilt van 
hyperadrenocorticisme bij de mens (syndroom van Cushing), de hond en de kat. Bij mens, 
hond en kat zijn verhoogde cortisolconcentraties in het bloed verantwoordelijk voor de 
verschijnselen, terwijl de problemen bij het fret voornamelijk door geslachtssteroïden 
worden veroorzaakt.11 In dit onderzoek is nagegaan of de hoge concentraties aan 
gonadotrope hormonen, ten gevolge van castratie, een rol spelen bij het ontstaan van deze 
aandoening bij fretten. Tevens is aandacht besteed aan diagnostische dilemma’s zoals de 
verhoogde uitscheiding in de urine van als cortisol gemeten steroïden, in afwezigheid van 
verhoogde cortisolconcentraties in het bloed. 
Allereerst werd onderzocht wat de invloed van verschillende methoden voor 
bloedafname was op plasmaconcentraties van hypofyse– en bijnierschorshormonen 
(Hoofdstuk 3). Vasthouden van het fret resulteerde in een significante stijging van 
plasmaconcentraties van ACTH en cortisol, terwijl anesthesie hierop geen invloed had. 
Plasmaconcentraties van 17α-hydroxyprogesteron werden niet beïnvloed door vasthouden 
of anesthesie, terwijl plasmaconcentraties van α-MSH door deze benaderingen juist 
duidelijk veranderden. Vasthouden resulteerde in een daling van plasma α-MSH 
concentraties, terwijl isofluraananesthesie resulteerde in een stijging van dit hormoon. 
Medetomidineanesthesie had geen effect op plasmaconcentraties van α-MSH. 
Ondanks dat medetomidineanesthesie geen effect had op de gemeten hormonen, werd 
voor isofluraananesthesie gekozen bij de bepaling van referentiewaarden voor 
plasmaconcentraties van ACTH en α-MSH (Hoofdstuk 4). Het voordeel van 
isofluraananesthesie is dat de diepte hiervan eenvoudig is te regelen, en dat de fretten na 
bloedafname weer snel wakker zijn.12 Als steeds dezelfde afnamemethode wordt gebruikt, 
zijn de referentiewaarden toepasbaar. De referentiewaarden (percentilen P2.5 en P97.5 met 
een waarschijnlijkheid van 95%) voor plasmaconcentraties van ACTH en α-MSH voor 
gezonde, gecastreerde fretten zijn vastgelegd op respectievelijk 2,9 – 22 pmol/l (13 – 100 
ng/l) en 4,8 – 108 pmol/l (8 – 180 ng/l). De plasmaconcentraties van ACTH en α-MSH bij 
fretten met hyperadrenocorticisme waren respectievelijk 0,2 – 58,3 pmol/l (1 – 265 ng/l) 
(mediaan 9,9 pmol/l [45 ng/l]) en 6 – 88,8 pmol/l (10 – 148 ng/l) (mediaan 27,6 pmol/l [46 
ng/l]). Deze waarden weken niet significant af van die van gezonde, gecastreerde fretten. 
Deze bevinding leidde tot de conclusie dat hyperadrenocorticisme bij fretten zich voltrekt 
onafhankelijk van het hypofysaire ACTH en met normale cortisolconcentraties in het bloed. 
Om inzicht te krijgen in de betekenis van de verhoogde cortisol/creatinine ratio’s in de 
urine van fretten met hyperadrenocorticisme, werd onderzoek gedaan naar het 
cortisolmetabolisme en de steroïdprofielen in de urine. Zowel bij gezonde fretten, als bij 
een fret met hyperadrenocorticisme werd 10% van [1,2,6,7 3H]cortisol geklaard via de 
urine, wat voldoende is om cortisol betrouwbaar te meten in een radioimmunoassay 
(Hoofdstuk 5). Met behulp van high-performance liquid chromatography (HPLC) werd 
aangetoond dat een derde van de corticoïden in de urine ongeconjugeerd cortisol is. De 
andere pieken konden worden toegeschreven aan meer hydrofiele conjugaten of 
metabolieten. Geen van de uit de bijnier afkomstige geslachtssteroïden verscheen in de 
HPLC–fracties. Deze bevindingen rechtvaardigen de conclusie dat cortisol/creatinine 
ratio’s in de urine van fretten een goede weergave zijn van de cortisolexcretie. 
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Bij gezonde, intacte fretten werd een duidelijke stijging van de cortisol/creatinine ratio 
in de urine gevonden tijdens het voortplantingsseizoen. Deze stijging werd ook gezien bij 
twee gecastreerde fretten met hyperadrenocorticisme. Bij de gezonde, gecastreerde fretten 
werd deze stijging echter niet waargenomen. De cortisol/creatinine ratio’s in de urine van 
27 van 31 particulier gehouden fretten met hyperadrenocorticisme waren ook verhoogd. Er 
worden drie mogelijke verklaringen voor de verhoogde cortisol/creatinine ratio’s in de 
urine gepresenteerd: namelijk (1) opwinding samenhangend met de geslachtsdrift, (2) een 
gonadotrofine-afhankelijke cortisolsecretie en (3) een verlaging van plasmaconcentraties 
van cortisol-bindend-globuline (CBG). Bij gezonde, intacte fretten en fretten met 
hyperadrenocorticisme zou tijdens het voortplantingsseizoen de geslachtsdrift kunnen 
leiden tot activatie van de hypofyse-bijnierschorsas, met als gevolg verhoging van de 
cortisol/creatinine ratio’s in de urine. Deze verklaring zou in overeenstemming zijn met de 
grotendeels onveranderde plasma ACTH concentraties. De resistentie tegen 
dexamethasonsuppressie bij fretten met hyperadrenocorticisme wijst echter op autonomie 
van de veranderde bijnierschors en/of op een ACTH-onafhankelijke stimulatie van de 
bijnierschors. Bij deze klinische gevallen moet aangenomen worden dat slechts een geringe 
hoeveelheid cortisol wordt geproduceerd door de afwijkende bijnierschors, die 
onvoldoende is om de ACTH-afgifte te remmen. Dit laatste zou nog versterkt kunnen 
worden door de toegenomen concentraties aan geslachtssteroïden die een invloed hebben 
op CBG. Een afname van de CBG-bindingscapaciteit leidt tot een toename van de vrije 
fractie van cortisol, terwijl de concentratie aan totaal cortisol niet hoeft te veranderen. 
Aanvullende steun voor de bevinding dat hyperadrenocorticisme bij fretten ACTH-
onafhankelijk is, werd verkregen door morfologische studies van de hypofyse van fretten 
(Hoofdstuk 6). In de hypofyse van gezonde fretten lijkt de verdeling van de melanotrope 
en corticotrope cellen vergelijkbaar te zijn met die van de hond. Gonadotrope cellen werden 
in de pars distalis van gecastreerde fretten gevonden, maar niet in die van intacte fretten. Bij 
2 van de 10 fretten met hyperadrenocorticisme werd een hypofysetumor gevonden. Deze 
tumoren kleurden voor geen van de hypofysehormonen. De lage prevalentie van 
hypofysetumoren bij fretten met hyperadrenocorticisme staat in schril contrast tot het grote 
aantal hypofysetumoren bij mensen, honden en katten (60 – 80%) met het syndroom van 
Cushing. Hypofysetumoren worden ook gevonden bij schijnbaar gezonde mensen              
(2 – 27 %).6 Het is daarom mogelijk dat de bij 2 fretten gevonden hypofysetumoren niet 
gerelateerd zijn aan hyperadrenocorticisme, maar gezien moeten worden als een toevallige 
bevinding. De hypofysetumoren bij onze fretten vertoonden echter overeenkomsten met 
klinisch-niet-functionerende gonadotrope tumoren, zoals die bij de mens beschreven zijn.4 
De afwezige terugkoppeling vanuit de gonaden op hypothalamus en hypofyse, als gevolg 
van castratie, zou een initiërende rol gespeeld kunnen hebben bij het ontstaan van deze 
hypofysetumoren. 
In de Verenigde Staten van Amerika is gesuggereerd dat het castreren op jonge leeftijd 
(6 weken) een bijdrage levert aan de hoge incidentie van hyperadrenocorticisme bij 
fretten.10 In Nederland worden fretten vanaf een leeftijd van 6 maanden gecastreerd. 
Tijdens een enquête, die werd gehouden onder Nederlandse frettenhouders (Hoofdstuk 7), 
werd een hoge prevalentie voor hyperadrenocorticisme bij fretten van 0,55% (95% 
betrouwbaarheidsinterval: 0,2 – 1,1%) vastgesteld. Dit onderzoek liet zien dat castratie op 
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zeer jonge leeftijd geen voorwaarde is voor de ontwikkeling van hyperadrenocorticisme. Er 
bleek een lineaire correlatie te bestaan tussen de leeftijd waarop het fret werd gecastreerd 
en de leeftijd waarop hyperadrenocorticisme werd gediagnosticeerd. Deze bevindingen 
versterkte het vermoeden dat gonadotrope hormonen een rol spelen bij de ontwikkeling van 
hyperadrenocorticisme bij fretten. 
De volgende stap was een onderzoek naar de aanwezigheid en functie van 
gonadotrofinereceptoren in de bijnieren van gezonde fretten en fretten met 
hyperadrenocorticisme (Hoofdstuk 8 en 9). Met behulp van een antilichaam tegen de 
luteiniserendhormoon-receptor (LH-R) werd immunohistochemisch een positieve kleuring 
gevonden in de zona glomerulosa en de zona fasciculata van de bijnieren van gezonde, 
intacte 6 tot 15 maanden oude fretten. Daarnaast werd een LH-R-positieve aankleuring 
gevonden in 44 afwijkende bijnieren (hyperplasieën en tumoren) van 46 fretten met 
hyperadrenocorticisme. De aanwezigheid van LH-R positieve cellen in de buitenste lagen 
van de niet-afwijkende bijnierschors was een onverwachte bevinding, daar androgenen 
vooral in de binnenste laag van de bijnierschors (zona reticularis) worden geproduceerd. Dit 
is ook de zone waar bij mensen LH-R-positieve cellen zijn gevonden.8 De aanwezigheid 
van LH-R-positieve cellen in de zona glomerulosa is echter niet uniek voor fretten. Bij 
muizen met chronisch verhoogde serum-LH-concentraties is LH-R-mRNA aangetroffen in 
de gehele bijnierschors met inbegrip van de zona glomerulosa.3 Met behulp van de 
histologische kenmerken van LH-R-positieve cellen in de bijniertumoren van fretten met 
hyperadrenocorticisme was het niet mogelijk om aan te geven van welke zone de tumoren 
zijn uitgegaan. Daar deze tumoren een mengeling van celtypen bevatten is het echter 
verleidelijk om aan te nemen dat ze van de zona intermedia afkomstig zijn. Deze zone ligt 
tussen de zona glomerulosa en zona fasciculata en bevat de voorlopers van alle celtypen 
van de bijnierschors. 
Om de functionaliteit van de LH receptoren in vivo te onderzoeken werden GnRH-
stimulatietesten uitgevoerd bij gezonde gecastreerde fretten en gecastreerde fretten met 
hyperadrenocorticisme. Bij gezonde fretten stegen de plasmaconcentraties van cortisol, 
androsteendion en 17α-hydroxyprogesteron niet na de intraveneuze toediening van een 
GnRH-agonist, terwijl de plasmaconcentraties van androsteendion en 17α-
hydroxyprogesteron wel stegen na toediening van deze agonist bij fretten met 
hyperadrenocorticisme. Deze bevindingen duiden erop dat in de bijnieren van jonge 
gezonde intacte fretten weliswaar LH-receptoren aanwezig zijn, maar dat deze receptoren 
niet functioneel zijn. 
Om erachter te komen welke gonadotrope hormonen verantwoordelijk zijn voor de 
toegenomen plasmaconcentraties aan geslachtssteroïden bij fretten met 
hyperadrenocorticisme werden plasmaconcentraties van LH en FSH gemeten bij fretten die 
onderworpen werden aan een GnRH stimulatietest. Plasma LH concentraties stegen 
duidelijk na toediening van GnRH, terwijl er geen duidelijke stijging optrad van de plasma 
FSH concentraties. Toediening van FSH resulteerde niet in een stijging van 
bijnierschorshormonen, terwijl toediening van hCG resulteerde in een geleidelijke stijging 
van plasmaconcentraties van androsteendion en 17α-hydroxyprogesteron in één van de 
twee onderzochte fretten met hyperadrenocorticisme. Om na te gaan of tijdens de in vivo 
stimulatietesten andere organen een bijdrage leveren aan de hormoonproductie en voor 
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onderzoek naar een eventuele directe invloed op de bijnierschors van fretten, werden in 
vitro stimulatietesten uitgevoerd op bijniercellen in een kweekmedium. Uit deze testen 
werd duidelijk dat noch GnRH noch FSH een significante invloed hebben op de productie 
van bijnierschorshormonen, terwijl hCG de productie van deze hormonen stimuleert. 
De LH-R is, zoals hierboven al vermeld, niet altijd functioneel in de bijnierschors van 
fretten. De afname of afwezigheid van een respons na toediening van een agonist kan 
veroorzaakt worden door desensitisatie van de receptoren. Dit zou verklaren waarom bij 
gecastreerde fretten, met aanhoudend hoge LH-concentraties, de LH-receptoren niet 
functioneel waren. De receptoren waren echter wel functioneel bij gecastreerde fretten met 
hyperadrenocorticisme. Een mutatie van de receptor zou verantwoordelijk kunnen zijn voor 
het functieherstel. Het is ook mogelijk dat een toename van de expressie van de LH-
receptoren optreedt na blootstelling aan liganden.13 Bij muizen worden steeds meer 
aanwijzingen gevonden dat LH-receptoren het ontstaan van tumoren kunnen bevorderen bij 
stimulatie door LH.5 
Plasma-FSH-concentraties waren erg laag bij enkele fretten met 
hyperadrenocorticisme. Dit was een onverwachte bevinding, daar het verlies van de 
negatieve terugkoppeling op de gonadotrope hormonen door castratie gewoonlijk leidt tot 
een stijging van plasmaconcentraties van deze hormonen.2 Een mogelijke verklaring voor 
de lage plasma-FSH-concentraties is dat bijniertumoren van fretten inhibine, een hormoon 
dat de FSH secretie kan remmen, produceren. De inhibine α subunit is aangetoond in 
bijniertumoren van fretten met hyperadrenocorticisme.9 Androgeen-producerende tumoren 
bij de mens scheiden meer inhibine α af dan normale bijnieren.1 De mogelijke rol van dit 
eiwit, of aanverwante eiwitten, op de terugkoppeling van de afgifte van FSH bij fretten met 
hyperadrenocorticisme moet echter nog verder opgehelderd worden. 
Daar chirurgische castratie een belangrijke risicofactor lijkt te zijn bij het ontstaan van 
hyperadrenocorticisme bij fretten, is in de literatuur gezocht naar huidige en toekomstige 
alternatieven voor chirurgische castratie bij fretten (Hoofdstuk 10). Van deze alternatieven 
lijkt het gebruik van progestagenen het meest toepasbaar voor de vrouwelijke fretten. De 
bruikbaarheid van deze middelen bij mannelijke fretten is echter onzeker. “Slow-release” 
implantaten met gonadotropin-releasing hormone (GnRH), GnRH antagonisten of 
immunisatie tegen GnRH zijn wellicht opties voor de toekomst. 
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X Bij de vergelijking tussen het effect van vasthouden en anesthesie (medetomidine of 
isofluraan) op plasmaconcentraties van hypofyse– en bijnierschorshormonen, blijkt dat 
anesthesie met medetomidine het minste effect heeft op deze hormonen. 
X Er is geen significant verschil tussen plasmaconcentraties van ACTH en α-MSH van 
gezonde fretten en fretten met hyperadrenocorticisme. 
X Cortisol wordt voornamelijk uitgescheiden via de lever en gal. Slechts 10% van het 
cortisol wordt uitgescheiden via de urine. Dit is echter voldoende om 
cortisolconcentraties in de urine betrouwbaar te kunnen meten. 
X Bij gecastreerde fretten met hyperadrenocorticisme en bij intacte fretten is de 
cortisol/creatinine ratio in de urine is tijdens het voortplantingsseizoen verhoogd. 
X Als mogelijke verklaringen voor de stijging van de cortisol/creatinine ratio in de urine, 
bij onveranderde plasma-cortisolconcentraties, worden genoemd: (1) opwinding 
samenhangend met de geslachtsdrift, (2) gonadotrofine-afhankelijke cortisolsecretie, 
en (3) verlaging van de plasmaconcentratie van cortisol-bindend-globuline (CBG). 
X Fretten met hyperadrenocorticisme hebben geen corticotrope adenomen. De 
hypofysetumoren die werden gevonden bij 2 van de 10 fretten met 
hyperadrenocorticisme vertoonden overeenkomsten met klinisch niet-functionerende 
gonadotrope tumoren, zoals die bij de mens voorkomen. 
X Er bestaat een significante correlatie tussen de leeftijd waarop het fret wordt 
gecastreerd en de leeftijd waarop hyperadrenocorticisme wordt gediagnosticeerd. Dit 
duidt er op dat castratie een rol speelt bij het ontstaan van deze aandoening. 
X In tegenstelling tot bij gezonde gecastreerde fretten, leidt de intraveneuze toediening 
van een GnRH-agonist bij gecastreerde fretten met hyperadrenocorticisme tot een 
stijging van de plasmaconcentraties van androsteendion en 17α-hydroxyprogesteron. 
Dit wijst er mogelijk op dat een cellulaire verandering nodig is om de receptor te laten 
functioneren, of dat omgekeerd een ontsporing op cellulair niveau wordt veroorzaakt 
door de (weer) functionerende receptor. 
X De afgifte van bijnierschorshormonen kan in vitro gestimuleerd worden door hCG, 
terwijl GnRH en FSH geen invloed hebben op de secretie van deze hormonen. Dit 
duidt erop dat vooral LH een rol speelt bij het ontstaan van hyperadrenocorticisme bij 
fretten. 
X Het gebruik van progestagenen is mogelijk een geschikt alternatief voor chirurgische 
castratie van vrouwelijke fretten. Eerst moet echter onderzocht worden wat de 
mogelijke gevolgen van deze aanpak zijn voor de afgifte van groeihormoon. Op dit 
moment is er geen alternatief voor chirurgische castratie bij mannelijke fretten. 
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De totstandkoming van dit proefschrift was nooit mogelijk geweest zonder de hulp en 
ondersteuning van velen. Het risico van het schrijven van een dankwoord is dat vergeten 
wordt om iemand bij name te noemen. Om dit te vermijden wil ik op deze plaats iedereen 
bedanken die op enigerlei wijze mij ondersteunt heeft bij de totstandkoming van dit 
proefschrift. Een aantal personen zou ik graag nog bij name willen noemen. 
Allereerst mijn promotor Prof. dr. A. Rijnberk. Beste Ad, jouw jarenlange ervaring in 
de wetenschap is duidelijk terug te vinden in dit proefschrift. Ik heb heel veel geleerd van je 
kritische correcties op de door mij aangeleverde manuscripten. Dit waardeer ik zeer. Hier 
wil ik tevens even stilstaan bij jouw vrouw Carla, die mij na jouw emeritaat nog de 
gelegenheid gaf om van jullie gezamenlijke tijd gebruik te maken. Te vaak wordt hier niet 
bij stilgestaan, maar ik waardeer dit zeer. 
Mijn co-promotor Dr. J.T. Lumeij. Beste Sjeng, jij was de initiator van dit onderzoek. 
Ik ben je zeer erkentelijk dat je mij de gelegenheid hebt geboden om dit onderzoek uit te 
voeren. Ik ben je ook zeer erkentelijk voor de snelheid waarmee je de manuscripten van 
commentaar voorzag. 
Mijn co-promotor Dr. ir. J.A. Mol. Beste Jan, regelmatig kon ik bij je binnenlopen om 
even advies te vragen. Deze steun heeft mij regelmatig door lastige periodes geholpen. Mijn 
dank hiervoor. 
De dierverplegers (in alfabetische volgorde). Beste Alex, Ludi, Rosan en Sabrina, 
jullie hebben met z’n allen een zeer belangrijke bijdrage geleverd aan dit proefschrift, 
namelijk de verzorging van de fretten en het assisteren bij het onderzoek. Zonder jullie had 
ik het niet kunnen doen. Hartelijk dank hiervoor. 
De medewerkers van de diverse laboratoria. Eindeloos veel urine-, bloed- en 
weefselmonsters zijn door jullie bewerkt of onderzocht. Langs deze weg wil ik jullie 
daarvoor allemaal heel hartelijk bedanken. 
Beste Katja Teerds en Mieke de Boer, bij jullie heb ik de LH-R kleuringen uitgevoerd 
en bekeken. Ik dank jullie hartelijk voor de plezierige samenwerking en prettige 
begeleiding. 
Beste Marein Dorrestein-van der Hage, Marja Kik en Gerry Dorrestein, jullie hebben 
vele bijnieren histologisch voor mij beoordeeld en jullie hebben mij geleerd om ze ook te 
kunnen beoordelen. Ik voel(de) mij altijd welkom bij jullie op de afdeling, niet alleen om 
over het werk te praten, maar ook om even op adem te komen. Hartelijk dank hiervoor. 
Alle hiervoor genoemde personen zijn op enige wijze ook bij de diverse publicaties 
vermeld. Tijdens het onderzoek hebben echter ook diverse personen hun uiterste best 
gedaan om mij te ondersteunen. Door technische omstandigheden heeft hun inzet helaas 
niet kunnen leiden tot data die opgenomen konden worden in de publicaties. De personen 
die ik hier bij name zou willen noemen zijn mevr. C. Popp-Snijders, dhr. J. van der Molen 
en dhr. R. Kisjes. Hun inzet wordt zeer gewaardeerd. 
 
Dan zijn er nog een groot aantal personen die op een indirecte wijze mij gesteund 
hebben in de afgelopen jaren van het onderzoek. Ook hier zou ik een aantal personen bij 
name willen noemen. 
Beste Joop Fama, eindeloos veel tijd heb jij gestoken in het optimaliseren van de 
histologische figuren van dit proefschrift. Ook aan de omslag heb je een aanzienlijke 
bijdrage geleverd. Hiervoor wil ik je hartelijk bedanken. 
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Beste Ineke Westerhof, dank je voor het luisterend oor als ik weer eens in een dip zat. 
Het deed goed om met iemand te kunnen praten die reeds gepromoveerd is en met 
vergelijkbare problemen te maken heeft gehad. 
Beste Martine de Wit, op het werk heb jij het meeste te lijden gehad van mijn 
promotieonderzoek. Ik vind het heel plezierig dat jij de vele klinische werkzaamheden voor 
je rekening hebt genomen, zodat ik dit mijn promotie kon afronden. 
Lieve papa en mama, zonder jullie had ik dit onderzoek nooit kunnen uitvoeren. Jullie 
hebben er voor gezorgd dat ik dierenarts en specialist ben geworden. Ook de interesse voor 
onderzoek werd mij al op jonge leeftijd bijgebracht. In de afgelopen jaren hebben jullie mij 
o  vele wijzen bijgestaan en daarvoor ben ik jullie zeer erkentelijk. Heel veel dank 
hiervoor. 
Naast al deze personen hebben ook de fretten en hun eigenaren een wezenlijke bijdrage 
geleverd aan dit proefschrift. Niet alleen werd ik in de gelegenheid gesteld om handelingen 
uit te voeren bij fretten met hyperadrenocorticisme, maar mocht ik ook bij vele gezonde 
fretten bloed afnemen, en verzamelde de eigenaren urines van deze dieren. Ik dank hun alle 
hartelijk voor hun vertrouwen in mij. 
Als laatste wil ik mijn vrouw Christa bedanken. Lieve Christa, voor jou zijn de 
afgelopen jaren erg zwaar geweest. Het onderzoek en mijn andere werkzaamheden vergde 
zoveel tijd van mij dat ik minder aandacht aan je besteed heb, als dat je verdient. Ik zal mijn 
uiterste best doen om hier in de toekomst verandering in aan te brengen. Ondanks dat het 
moeilijk voor je was om precies te begrijpen waar ik nu weer mee bezig was, bleef je mij 
steunen. Dat heb ik heel erg in je gewaardeerd. Heel veel dank voor alle begrip!  
p
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Figure 1. Midsagittal sections of the pituitary gland of a 2-year-old neutered female ferret stained for 
ACTH1-24, α-MSH, TSH, prolactin, FSH and LH. For explanation of lettering see legend to 
Figure 1. Immunostain. Bar is 0.2 mm. 
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Figure 2. Midsagittal consecutive sections of the pituitary gland of a 5-year-old neutered male ferret 
immunohistochemically stained for adrenocorticotropic hormone (ACTH) with 3 different 
antibodies: [a] monoclonal mouse antibody to synthetic ACTH1-24; [b] polyclonal rabbit 
antibody to human ACTH18-39; [c] polyclonal rabbit antibody to synthetic carp ACTH10-23. 
For explanation of lettering see legend to Figure 1. Bar is 0.2 mm. 
 
 
 
 
 
Figure 3. Midsagittal section of the pituitary gland of a 2-year-old neutered female ferret [surrounded 
by the os basisphenoidale (OB)] stained for growth hormone (GH). For explanation of 
lettering see legend to Figure 1. Immunostain. Bar is 0.5 mm. 
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Figure 4. Midsagittal section of the pituitary gland of a 2-year-old neutered female ferret stained for 
luteinizing hormone (LH). Closed arrows indicate LH-positive cells within the pars 
intermedia adenohypophysis (PI). Open arrows indicate LH-positive cells within the pars 
distalis adenohypophysis (PD). For explanation of lettering see legend to Figure 1. 
Immunostain Bar is 0.05 mm. 
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Figure 5. Horizontal sections of the pituitary gland of a 5-year-old male ferret (No 3) with 
hyperadrenocorticism due to adrenocortical tumors. At the top there is a round 
chromophobic adenoma with a diameter of 1.2 mm. This adenoma is stained with antibodies 
against ACTH1-24, α-MSH, GH, prolactin, TSH and PAS. (PD: pars distalis 
adenohypophysis; A: adenoma). Immunostain. Bar is 0.2 mm. 
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Figure 6. Photomicrograph of an adrenal adenoma from a neutered hyperadrenocorticoid ferret and 
immunohistochemically stained with the P1B4 LH-R antibody. Multiple LH receptor 
positive (brown) cells (closed arrows) are surrounded by LH receptor negative cells, some 
of which are spindle-shaped (open arrows). (Bar = 25 µm) 
  174
 
 
Figure 7. Histological sections of testes and ovaries of healthy ferrets 
a. Serum control section of a ferret testes incubated with normal mouse antiserum. No 
background staining could be detected. 
b. LH-receptor-positive staining (brown) of the Leydig cells (arrowhead) of the same testes 
immunohistochemically stained with the P1B4 LH-R antibody 
c. Thecal cells (arrowhead) of a ferret ovary immunohistochemically stained with the P1B4 
LH-R antibody 
Bar = 60 µm 
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Figure 8. Histological sections of the adrenal cortex of a healthy 1-year-old ferret 
a. Serum control section incubated with normal mouse antiserum. No background staining 
could be detected. 
b. Immunohistochemically staining with the P1B4 LH-R antibody. Positive staining (brown) is 
seen throughout the entire cortex including the zona glomerulosa (asterisk) and zona 
fasciculata. 
c. Immunohistochemically staining with the P1B4 LH-R antibody. Positive staining (brown) is 
seen throughout the entire cortex including the zona glomerulosa (asterisk) and zona 
fasciculata. 
Bar =  60 µm 
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Figure 9. Representative microphotographs of different regions of an adrenal adenoma of a 
hyperadrenocorticoid ferret stained with the P1B4 LH-R antibody. (a) Serum control 
section incubated with normal mouse antiserum. No background staining could be detected. 
(b,c) LH-receptor positive (brown) cells are surrounded by small LH-R negative cells. The 
large clear cells (asterisk) of photos (a) and (b) are from the same region of the adenoma. 
(d) In between the LH-R-positive (brown) cells many spindle shaped cells (arrowheads) are 
visible in this part of the adenoma. Bar =  60 µm 
